>LQ894658.1 Sequence 5 from Patent EP3374506
AATAAAAATAAA
>LQ894656.1 Sequence 3 from Patent EP3374506
AATAAAAATAAA
>LQ894399.1 Sequence 517 from Patent WO2018161064
GCCGCCGCCANG
>LQ888365.1 Sequence 10 from Patent WO2018162986
TTTTTAATTTTT
>LQ883052.1 Sequence 21 from Patent WO2018162750
CCCTTCTACCAG
>LQ882849.1 Sequence 2 from Patent WO2018158771
TCTACCCGGCCC
>LQ882848.1 Sequence 1 from Patent WO2018158771
TCTACCCGGCCC
>LQ869947.1 Sequence 19 from Patent EP3366782
TCGATGTACAGC
>LQ869946.1 Sequence 18 from Patent EP3366782
TCTAGACTCGAG
>LQ869943.1 Sequence 15 from Patent EP3366782
TACGTCTGAGCA
>LQ869324.1 Sequence 98 from Patent EP3364974
ATGCAGTTCGCT
>MA360065.1 JP 2018509177-A/1: NOVEL USE
CGTTAACATATT
>MA356795.1 JP 2018509137-A/60: IL-17A BINDING PROTEINS
AAGGGGSGGGGS
>MA356464.1 WO 2018079861-A/16: Peptides that induce sperm or egg spawning
AGATTCAGACGA
>MA354566.1 JP 2018080178-A/3: SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
TTTTGCCGCGCC
>MA354564.1 JP 2018080178-A/1: SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
TTTTGCCGCGCC
>MA377322.1 JP 2018510657-A/13727: MODIFIED T CELLS AND METHODS OF MAKING AND USING THE SAME
ATCCAGCGTGAG
>LQ864308.1 Sequence 1120 from Patent EP3359523
GGATGTTCTCGA
>LQ864307.1 Sequence 1119 from Patent EP3359523
GGATGTTCTCGA
>LQ864306.1 Sequence 1118 from Patent EP3359523
GGATGTTCTCGA
>LQ864260.1 Sequence 1072 from Patent EP3359523
CAGTCTGCTTCG
>LQ864168.1 Sequence 980 from Patent EP3359523
ATTCACTTTCAT
>LQ864167.1 Sequence 979 from Patent EP3359523
TTCACTTTCATA
>LQ864166.1 Sequence 978 from Patent EP3359523
TCACTTTCATAA
>LQ864164.1 Sequence 976 from Patent EP3359523
CACTTTCATAAT
>LQ864162.1 Sequence 974 from Patent EP3359523
ACTTTCATAATG
>LQ864160.1 Sequence 972 from Patent EP3359523
GTTTCATAATGC
>LQ864158.1 Sequence 970 from Patent EP3359523
TTTCATAATGCT
>LQ864156.1 Sequence 968 from Patent EP3359523
TTCATAATGCTG
>LQ864154.1 Sequence 966 from Patent EP3359523
TCATAATGCTGG
>LQ864146.1 Sequence 958 from Patent EP3359523
CCTTAATTTAAG
>LQ864145.1 Sequence 957 from Patent EP3359523
CTTAATTTAAGG
>LQ864144.1 Sequence 956 from Patent EP3359523
TTAATTTAAGGA
>LQ864142.1 Sequence 954 from Patent EP3359523
TAATTTAAGGAA
>LQ864140.1 Sequence 952 from Patent EP3359523
AATTTAAGGAAT
>LQ864138.1 Sequence 950 from Patent EP3359523
ATTTAAGGAATG
>LQ864136.1 Sequence 948 from Patent EP3359523
TTTAAGGAATGT
>LQ864133.1 Sequence 945 from Patent EP3359523
TTAAGGAATGTG
>LQ864130.1 Sequence 942 from Patent EP3359523
TAAGGAATGTGA
>LQ864127.1 Sequence 939 from Patent EP3359523
AAGGAATGTGAG
>LQ864118.1 Sequence 930 from Patent EP3359523
TCTTTTTGATTT
>LQ864117.1 Sequence 929 from Patent EP3359523
CTTTTTGATTTT
>LQ864115.1 Sequence 927 from Patent EP3359523
TTTTTGATTTTG
>LQ864114.1 Sequence 926 from Patent EP3359523
TTTTGATTTTGT
>LQ864112.1 Sequence 924 from Patent EP3359523
TTTGATTTTGTC
>LQ864110.1 Sequence 922 from Patent EP3359523
TTGATTTTGTCT
>LQ864109.1 Sequence 921 from Patent EP3359523
TGATTTTGTCTA
>LQ864103.1 Sequence 915 from Patent EP3359523
ATTTTGTCTAAA
>LQ864101.1 Sequence 913 from Patent EP3359523
TTTTGTCTAAAA
>LQ864091.1 Sequence 903 from Patent EP3359523
ATATAGATATAG
>LQ864090.1 Sequence 902 from Patent EP3359523
TATAGATATAGA
>LQ864089.1 Sequence 901 from Patent EP3359523
ATAGATATAGAT
>LQ864087.1 Sequence 899 from Patent EP3359523
TAGATATAGATA
>LQ864085.1 Sequence 897 from Patent EP3359523
AGATATAGATAG
>LQ864083.1 Sequence 895 from Patent EP3359523
GATATAGATAGC
>LQ864081.1 Sequence 893 from Patent EP3359523
ATATAGATAGCT
>LQ864079.1 Sequence 891 from Patent EP3359523
TATAGATAGCTA
>LQ864077.1 Sequence 889 from Patent EP3359523
ATAGATAGCTAT
>LQ859752.1 Sequence 3 from Patent EP3360879
ATATCTANATAT
>LQ859751.1 Sequence 2 from Patent EP3360879
ATATCATGATAT
>LQ859750.1 Sequence 1 from Patent EP3360879
ATATCTAGATAT
>LQ850208.1 Sequence 11 from Patent EP3357507
AACGTCAGGAAC
>LQ844714.1 Sequence 1 from Patent EP3352792
CTGATTGGCCAA
>LQ840191.1 Sequence 6 from Patent EP3354732
AAGGCTAGTCCG
>LQ838955.1 Sequence 128 from Patent EP3350332
GGTGGTGGAGGT
>LQ838914.1 Sequence 87 from Patent EP3350332
GGTGGTGGAGGT
>LQ838500.1 Sequence 35 from Patent EP3351633
CCTGGAGTTCCT
>LQ838499.1 Sequence 34 from Patent EP3351633
GTTTGCCGCTGC
>LQ836235.1 Sequence 365 from Patent EP3351634
GGCTCAAACAGC
>LQ835957.1 Sequence 87 from Patent EP3351634
TGTAGGAGTCTC
>LQ830242.1 Sequence 57 from Patent WO2018130855
CATGACATGTTA
>LQ830238.1 Sequence 53 from Patent WO2018130855
CATGCCATGGGT
>LQ830234.1 Sequence 49 from Patent WO2018130855
CATGCCATGGGT
>LQ830230.1 Sequence 45 from Patent WO2018130855
CATGCCATGGGT
>LQ830226.1 Sequence 41 from Patent WO2018130855
CATGCCATGGGT
>LQ830222.1 Sequence 37 from Patent WO2018130855
CATGCCATGGGT
>LQ830218.1 Sequence 33 from Patent WO2018130855
CATGCCATGGGT
>LQ830214.1 Sequence 29 from Patent WO2018130855
CATGCCATGGGT
>LQ830210.1 Sequence 25 from Patent WO2018130855
CATGCCATGGGT
>LQ830206.1 Sequence 21 from Patent WO2018130855
CATGCCATGGGT
>LQ830202.1 Sequence 17 from Patent WO2018130855
CATGCCATGGGT
>LQ830198.1 Sequence 13 from Patent WO2018130855
CATGCCATGGGT
>LQ827679.1 Sequence 159 from Patent EP3347464
TTGCTGATGATT
>LQ827645.1 Sequence 125 from Patent EP3347464
ATATATAGATAT
>LQ827644.1 Sequence 124 from Patent EP3347464
ATATAATCATAT
>LQ826827.1 Sequence 27 from Patent EP3351631
TGCGTACTGAGC
>MA260941.1 JP 2016536021-A/15: CRISPR-RELATED METHODS AND COMPOSITIONS WITH GOVERNING gRNAS
AAGGCTAGTCCG
>MA259944.1 JP 2017505623-A/10: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES
GTTGACACTGTC
>MA155802.1 JP 2017014279-A/17: Treatment for alpha-Galactosidase A Deficiency
CTAGTCCTAGGA
>MA258524.1 JP 2017503169-A/29: DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS USING OLIGONUCLEOTIDES ANTIGENS
CGCGCGCGCGCG
>MA258525.1 JP 2017503169-A/30: DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS USING OLIGONUCLEOTIDES ANTIGENS
CGCGCGCGCGCG
>MA258042.1 JP 2016529884-A/10: TARGET ANTIGEN DISCOVERY, PHENOTYPIC SCREENS AND USE THEREOF FOR IDENTIFICATION OF TARGET CELL SPECIFIC TARGET EPITOPES
CGGCTTCCTGAT
>MA258041.1 JP 2016529884-A/9: TARGET ANTIGEN DISCOVERY, PHENOTYPIC SCREENS AND USE THEREOF FOR IDENTIFICATION OF TARGET CELL SPECIFIC TARGET EPITOPES
CCGGCTTTCCAA
>MA258040.1 JP 2016529884-A/8: TARGET ANTIGEN DISCOVERY, PHENOTYPIC SCREENS AND USE THEREOF FOR IDENTIFICATION OF TARGET CELL SPECIFIC TARGET EPITOPES
CCTCCTTCGACC
>MA258038.1 JP 2016529884-A/6: TARGET ANTIGEN DISCOVERY, PHENOTYPIC SCREENS AND USE THEREOF FOR IDENTIFICATION OF TARGET CELL SPECIFIC TARGET EPITOPES
GACACCGGGCCC
>MA258035.1 JP 2016529884-A/3: TARGET ANTIGEN DISCOVERY, PHENOTYPIC SCREENS AND USE THEREOF FOR IDENTIFICATION OF TARGET CELL SPECIFIC TARGET EPITOPES
TTCCCGATCCGA
>MA154281.1 JP 2016198110-A/7: Methods and Compositions for the Targeted Modification of a Genome
AAGGCTAGTCCG
>MA257993.1 JP 2016536006-A/28: METHODS AND COMPOSITIONS FOR GENERATION OF BINDING AGENTS AGAINST CELL SURFACE ANTIGENS
CGGCTTCCTGAT
>MA257992.1 JP 2016536006-A/27: METHODS AND COMPOSITIONS FOR GENERATION OF BINDING AGENTS AGAINST CELL SURFACE ANTIGENS
CCGGCTTTCCAA
>MA257991.1 JP 2016536006-A/26: METHODS AND COMPOSITIONS FOR GENERATION OF BINDING AGENTS AGAINST CELL SURFACE ANTIGENS
CCTCCTTCGACC
>MA257989.1 JP 2016536006-A/24: METHODS AND COMPOSITIONS FOR GENERATION OF BINDING AGENTS AGAINST CELL SURFACE ANTIGENS
GACACCGGGCCC
>MA257986.1 JP 2016536006-A/21: METHODS AND COMPOSITIONS FOR GENERATION OF BINDING AGENTS AGAINST CELL SURFACE ANTIGENS
TTCCCGATCCGA
>MA257836.1 JP 2016539655-A/7: Methods and Compositions for the Targeted Modification of a Genome
AAGGCTAGTCCG
>MA152812.1 JP 2016208993-A/9: Protein production in microorganisms of the phylum Labyrinthulomycota
CACGACGAGTTG
>MA256331.1 JP 2016537987-A/7: Synthetic Promoters
CCCATTAGGGAC
>MA151453.1 JP 2016192977-A/34: TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF
CCTCCCCCACGC
>MA346773.1 JP 2018505676-A/325: TAU ANTISENSE OLIGOMERS AND USES THEREOF
TGTGATGCAGGA
>MA346769.1 JP 2018505676-A/321: TAU ANTISENSE OLIGOMERS AND USES THEREOF
GTGATGCAGGAG
>MA346766.1 JP 2018505676-A/318: TAU ANTISENSE OLIGOMERS AND USES THEREOF
TGATGCAGGAGT
>MA346758.1 JP 2018505676-A/310: TAU ANTISENSE OLIGOMERS AND USES THEREOF
GATGCAGGAGTT
>MA346280.1 JP 2018508197-A/3: MET RECEPTOR AGONIST PROTEINS
TCAGAAGTTGAA
>MA344841.1 WO 2018070521-A/29: A fusion polypeptide inhibiting a complement activation pathway
GAGCAGAGCCTC
>MA343537.1 JP 2018064585-A/10: COMPOSITIONS AND KITS FOR MOLECULAR COUNTING
AGCATTACCGAC
>MA168756.1 JP 2017060529-A/4192: ANTIBODY LIBRARIES
NNGGTACTTCGA
>MA168755.1 JP 2017060529-A/4191: ANTIBODY LIBRARIES
CTGGTACTTCGA
>MA168752.1 JP 2017060529-A/4188: ANTIBODY LIBRARIES
NNATACTTCCAG
>MA168751.1 JP 2017060529-A/4187: ANTIBODY LIBRARIES
GAATACTTCCAG
>MA268752.1 JP 2018058835-A/36: COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF IRON-RELATED DISORDERS
GGAACTGGGCCC
>MA168544.1 JP 2017060529-A/3980: ANTIBODY LIBRARIES
GGABHCACACAA
>MA168543.1 JP 2017060529-A/3979: ANTIBODY LIBRARIES
GGABHCACAGCT
>MA168542.1 JP 2017060529-A/3978: ANTIBODY LIBRARIES
GGABHCGGACTA
>MA168541.1 JP 2017060529-A/3977: ANTIBODY LIBRARIES
GGABHCGGATGG
>MA168540.1 JP 2017060529-A/3976: ANTIBODY LIBRARIES
AGGAGAVHGTAC
>MA168539.1 JP 2017060529-A/3975: ANTIBODY LIBRARIES
GGTAGAVHGTAC
>MA168538.1 JP 2017060529-A/3974: ANTIBODY LIBRARIES
CCABHCGGATAC
>MA168537.1 JP 2017060529-A/3973: ANTIBODY LIBRARIES
AGCBHCGGATAC
>MA168536.1 JP 2017060529-A/3972: ANTIBODY LIBRARIES
AGABHCGGATAC
>MA168535.1 JP 2017060529-A/3971: ANTIBODY LIBRARIES
GGABHCGGATAC
>MA168464.1 JP 2017060529-A/3900: ANTIBODY LIBRARIES
VHABTCGGAGGT
>MA168463.1 JP 2017060529-A/3899: ANTIBODY LIBRARIES
VNCTACTACTHT
>MA168462.1 JP 2017060529-A/3898: ANTIBODY LIBRARIES
VBCTGGTTCGGT
>MA168461.1 JP 2017060529-A/3897: ANTIBODY LIBRARIES
BHCVGCTACAGT
>MA168460.1 JP 2017060529-A/3896: ANTIBODY LIBRARIES
NHCTACTACTHT
>MA168459.1 JP 2017060529-A/3895: ANTIBODY LIBRARIES
NHCTACGGAKCT
>MA168458.1 JP 2017060529-A/3894: ANTIBODY LIBRARIES
VBCGVCTACAGT
>MA168457.1 JP 2017060529-A/3893: ANTIBODY LIBRARIES
GACAGCAGCDBG
>MA168456.1 JP 2017060529-A/3892: ANTIBODY LIBRARIES
VBTCDAGGAGTT
>MA168455.1 JP 2017060529-A/3891: ANTIBODY LIBRARIES
VHAGTASSAGCT
>MA168454.1 JP 2017060529-A/3890: ANTIBODY LIBRARIES
BHCTACAGCKMT
>MA168453.1 JP 2017060529-A/3889: ANTIBODY LIBRARIES
VBTBTCGGAGAG
>MA168452.1 JP 2017060529-A/3888: ANTIBODY LIBRARIES
VHGGGARKCGCT
>MA168451.1 JP 2017060529-A/3887: ANTIBODY LIBRARIES
VHACAACTAKKG
>MA168450.1 JP 2017060529-A/3886: ANTIBODY LIBRARIES
VBCKMCGGATAT
>MA168449.1 JP 2017060529-A/3885: ANTIBODY LIBRARIES
NHCTACTACGVT
>MA168448.1 JP 2017060529-A/3884: ANTIBODY LIBRARIES
GTAGCAGCAVHA
>MA168447.1 JP 2017060529-A/3883: ANTIBODY LIBRARIES
VBCAYATTCGGT
>MA168446.1 JP 2017060529-A/3882: ANTIBODY LIBRARIES
GCAGCAGCAVBT
>MA168445.1 JP 2017060529-A/3881: ANTIBODY LIBRARIES
VHAGTAACARMG
>MA168444.1 JP 2017060529-A/3880: ANTIBODY LIBRARIES
BHCGGATACKMT
>MA168443.1 JP 2017060529-A/3879: ANTIBODY LIBRARIES
NHCAGCGGABGG
>MA168442.1 JP 2017060529-A/3878: ANTIBODY LIBRARIES
BHCGGATSGTAT
>MA168441.1 JP 2017060529-A/3877: ANTIBODY LIBRARIES
BHCGGAAGCKMT
>MA168440.1 JP 2017060529-A/3876: ANTIBODY LIBRARIES
VHACAACTAGNT
>MA168439.1 JP 2017060529-A/3875: ANTIBODY LIBRARIES
BHCAGCTGGTHT
>MA168438.1 JP 2017060529-A/3874: ANTIBODY LIBRARIES
NHCTMCTACGGT
>MA168437.1 JP 2017060529-A/3873: ANTIBODY LIBRARIES
AGCAGCAGCDBG
>MA168436.1 JP 2017060529-A/3872: ANTIBODY LIBRARIES
VBCACAGTARMG
>MA168435.1 JP 2017060529-A/3871: ANTIBODY LIBRARIES
VHAGTAGCAGNT
>MA168434.1 JP 2017060529-A/3870: ANTIBODY LIBRARIES
CAGTGGCTABHT
>MA168433.1 JP 2017060529-A/3869: ANTIBODY LIBRARIES
VHATACAGCRST
>MA168432.1 JP 2017060529-A/3868: ANTIBODY LIBRARIES
VHGRYGGCAACT
>MA168431.1 JP 2017060529-A/3867: ANTIBODY LIBRARIES
NHCTACGGAGVT
>MA168430.1 JP 2017060529-A/3866: ANTIBODY LIBRARIES
VBCGACGGATHT
>MA168429.1 JP 2017060529-A/3865: ANTIBODY LIBRARIES
VHGGTARSAGGT
>MA168428.1 JP 2017060529-A/3864: ANTIBODY LIBRARIES
TACAGCAGCVBT
>MA168427.1 JP 2017060529-A/3863: ANTIBODY LIBRARIES
BHCGGAKMCTAT
>MA168426.1 JP 2017060529-A/3862: ANTIBODY LIBRARIES
DBGTTCGGAGNG
>MA168425.1 JP 2017060529-A/3861: ANTIBODY LIBRARIES
VHGGBAGCAACT
>MA168424.1 JP 2017060529-A/3860: ANTIBODY LIBRARIES
BHCACAGCCAKS
>MA168393.1 JP 2017060529-A/3829: ANTIBODY LIBRARIES
GCCAAGCCAGTG
>MA168392.1 JP 2017060529-A/3828: ANTIBODY LIBRARIES
GCCAGACCGGTG
>MA168387.1 JP 2017060529-A/3823: ANTIBODY LIBRARIES
GCCAAGCCTACT
>MA168386.1 JP 2017060529-A/3822: ANTIBODY LIBRARIES
GCCAGACCTACT
>MA168383.1 JP 2017060529-A/3819: ANTIBODY LIBRARIES
GCCAAGCCGGCT
>MA168382.1 JP 2017060529-A/3818: ANTIBODY LIBRARIES
GCCAGACCAGCT
>MA168379.1 JP 2017060529-A/3815: ANTIBODY LIBRARIES
GCCAAGCCACCT
>MA168378.1 JP 2017060529-A/3814: ANTIBODY LIBRARIES
GCCAGACCACCT
>MA168369.1 JP 2017060529-A/3805: ANTIBODY LIBRARIES
GCCAAGACCGGA
>MA168368.1 JP 2017060529-A/3804: ANTIBODY LIBRARIES
GCCAGAACTGGA
>MA168357.1 JP 2017060529-A/3793: ANTIBODY LIBRARIES
GCCAAGCCCGGA
>MA168356.1 JP 2017060529-A/3792: ANTIBODY LIBRARIES
GCCAGACCAGGA
>MA168327.1 JP 2017060529-A/3763: ANTIBODY LIBRARIES
GCCAAGGAATTG
>MA168326.1 JP 2017060529-A/3762: ANTIBODY LIBRARIES
GCCAGAGAGTTG
>MA168325.1 JP 2017060529-A/3761: ANTIBODY LIBRARIES
GCCAAGGAGCCT
>MA168324.1 JP 2017060529-A/3760: ANTIBODY LIBRARIES
GCCAGAGAGCCT
>MA168267.1 JP 2017060529-A/3703: ANTIBODY LIBRARIES
TATATGGATGTC
>MA168266.1 JP 2017060529-A/3702: ANTIBODY LIBRARIES
TATTTCCAGCAC
>MA168265.1 JP 2017060529-A/3701: ANTIBODY LIBRARIES
TACTTCGATTAC
>MA168264.1 JP 2017060529-A/3700: ANTIBODY LIBRARIES
TATTTCGACTTA
>MA168263.1 JP 2017060529-A/3699: ANTIBODY LIBRARIES
TGGTTCGATCCA
>MA168262.1 JP 2017060529-A/3698: ANTIBODY LIBRARIES
GTTTTCGATTAT
>MA168261.1 JP 2017060529-A/3697: ANTIBODY LIBRARIES
ACATTTGACTAC
>MA168260.1 JP 2017060529-A/3696: ANTIBODY LIBRARIES
AGTTTCGATTAC
>MA168259.1 JP 2017060529-A/3695: ANTIBODY LIBRARIES
AGGTTTGACTAT
>MA168258.1 JP 2017060529-A/3694: ANTIBODY LIBRARIES
CCCTTCGACTAT
>MA168257.1 JP 2017060529-A/3693: ANTIBODY LIBRARIES
AACTTTGATTAC
>MA168256.1 JP 2017060529-A/3692: ANTIBODY LIBRARIES
TTATTTGATTAT
>MA168255.1 JP 2017060529-A/3691: ANTIBODY LIBRARIES
ATATTCGATTAC
>MA168254.1 JP 2017060529-A/3690: ANTIBODY LIBRARIES
CACTTTGACTAT
>MA168253.1 JP 2017060529-A/3689: ANTIBODY LIBRARIES
GGCATGGATGTA
>MA168252.1 JP 2017060529-A/3688: ANTIBODY LIBRARIES
GGGTTCGACTAC
>MA168251.1 JP 2017060529-A/3687: ANTIBODY LIBRARIES
GGGTTTGACCCA
>MA168250.1 JP 2017060529-A/3686: ANTIBODY LIBRARIES
TTCTTCGATTAC
>MA168249.1 JP 2017060529-A/3685: ANTIBODY LIBRARIES
GATTTCGACTAT
>MA168248.1 JP 2017060529-A/3684: ANTIBODY LIBRARIES
GCCTTCGATTAC
>MA168247.1 JP 2017060529-A/3683: ANTIBODY LIBRARIES
GCCTTCGATATC
>MA168246.1 JP 2017060529-A/3682: ANTIBODY LIBRARIES
GCCGCAAGACCT
>MA168243.1 JP 2017060529-A/3679: ANTIBODY LIBRARIES
GAGTACTCATCC
>MA168242.1 JP 2017060529-A/3678: ANTIBODY LIBRARIES
CAGTGGTTAGTT
>MA168241.1 JP 2017060529-A/3677: ANTIBODY LIBRARIES
TACTCAAGTGGT
>MA168240.1 JP 2017060529-A/3676: ANTIBODY LIBRARIES
AGTTCCGGTTGG
>MA168239.1 JP 2017060529-A/3675: ANTIBODY LIBRARIES
AGTGGTTGGTAT
>MA168234.1 JP 2017060529-A/3670: ANTIBODY LIBRARIES
CAGCAATTGGTT
>MA168232.1 JP 2017060529-A/3668: ANTIBODY LIBRARIES
TACAGCAGCTCC
>MA168231.1 JP 2017060529-A/3667: ANTIBODY LIBRARIES
AGTAGCTCTTGG
>MA168227.1 JP 2017060529-A/3663: ANTIBODY LIBRARIES
TATTCATATGGT
>MA168226.1 JP 2017060529-A/3662: ANTIBODY LIBRARIES
GATACTGCTATG
>MA168225.1 JP 2017060529-A/3661: ANTIBODY LIBRARIES
AGAGATGGTTAC
>MA168222.1 JP 2017060529-A/3658: ANTIBODY LIBRARIES
ACAGTAACTACT
>MA168221.1 JP 2017060529-A/3657: ANTIBODY LIBRARIES
ACAACTGTGACT
>MA168218.1 JP 2017060529-A/3654: ANTIBODY LIBRARIES
TACGGCGATTAT
>MA168217.1 JP 2017060529-A/3653: ANTIBODY LIBRARIES
GATTACGGCGAT
>MA168208.1 JP 2017060529-A/3644: ANTIBODY LIBRARIES
AGATACTTTGAT
>MA168207.1 JP 2017060529-A/3643: ANTIBODY LIBRARIES
TTGAGATATTTC
>MA168206.1 JP 2017060529-A/3642: ANTIBODY LIBRARIES
GTGTTGAGGTAT
>MA168191.1 JP 2017060529-A/3627: ANTIBODY LIBRARIES
AGCGGCTACTAT
>MA168190.1 JP 2017060529-A/3626: ANTIBODY LIBRARIES
GGTTACTATTAC
>MA168189.1 JP 2017060529-A/3625: ANTIBODY LIBRARIES
GACTCATCCGGT
>MA168171.1 JP 2017060529-A/3607: ANTIBODY LIBRARIES
TATTATTATGAC
>MA168170.1 JP 2017060529-A/3606: ANTIBODY LIBRARIES
TACTACGATTCC
>MA168162.1 JP 2017060529-A/3598: ANTIBODY LIBRARIES
ATGGTAAGAGGT
>MA168156.1 JP 2017060529-A/3592: ANTIBODY LIBRARIES
TACTACTATGGC
>MA168155.1 JP 2017060529-A/3591: ANTIBODY LIBRARIES
TATTATGGCAGT
>MA168154.1 JP 2017060529-A/3590: ANTIBODY LIBRARIES
AGTGGATCTTAT
>MA168153.1 JP 2017060529-A/3589: ANTIBODY LIBRARIES
TGGTTTGGGGAG
>MA168131.1 JP 2017060529-A/3567: ANTIBODY LIBRARIES
GTTGGCGCAACT
>MA168130.1 JP 2017060529-A/3566: ANTIBODY LIBRARIES
GCCAAGCAAGGA
>MA168127.1 JP 2017060529-A/3563: ANTIBODY LIBRARIES
GCAAAGGGCAAG
>MA168126.1 JP 2017060529-A/3562: ANTIBODY LIBRARIES
GCAAAGGCAAAG
>MA168125.1 JP 2017060529-A/3561: ANTIBODY LIBRARIES
GCAAAAGTCAGA
>MA168124.1 JP 2017060529-A/3560: ANTIBODY LIBRARIES
GCCAAAGGACAG
>MA168122.1 JP 2017060529-A/3558: ANTIBODY LIBRARIES
GCCAAAGTATCT
>MA168121.1 JP 2017060529-A/3557: ANTIBODY LIBRARIES
GCAAAAGACAAG
>MA168120.1 JP 2017060529-A/3556: ANTIBODY LIBRARIES
GCAAAAAGGAGA
>MA168119.1 JP 2017060529-A/3555: ANTIBODY LIBRARIES
GCAAAAGGGGAC
>MA168117.1 JP 2017060529-A/3553: ANTIBODY LIBRARIES
GCTAAAGCAGAG
>MA168115.1 JP 2017060529-A/3551: ANTIBODY LIBRARIES
GCTAAATTGCAC
>MA168114.1 JP 2017060529-A/3550: ANTIBODY LIBRARIES
GCAAAGAGCTTG
>MA168112.1 JP 2017060529-A/3548: ANTIBODY LIBRARIES
GCCAAGAGTAGA
>MA168110.1 JP 2017060529-A/3546: ANTIBODY LIBRARIES
GCCAAGGCATCT
>MA168109.1 JP 2017060529-A/3545: ANTIBODY LIBRARIES
GCCAAGGCAAGA
>MA168108.1 JP 2017060529-A/3544: ANTIBODY LIBRARIES
GCTAAAGACCAC
>MA168107.1 JP 2017060529-A/3543: ANTIBODY LIBRARIES
GCCAAGGATCAG
>MA168105.1 JP 2017060529-A/3541: ANTIBODY LIBRARIES
GCCAAGGTACCT
>MA168104.1 JP 2017060529-A/3540: ANTIBODY LIBRARIES
GCCAAGACGCCT
>MA168103.1 JP 2017060529-A/3539: ANTIBODY LIBRARIES
GCCAAGGCTCCT
>MA168102.1 JP 2017060529-A/3538: ANTIBODY LIBRARIES
GCCAAGCTACCT
>MA168101.1 JP 2017060529-A/3537: ANTIBODY LIBRARIES
GCCAAGAGTCCT
>MA168099.1 JP 2017060529-A/3535: ANTIBODY LIBRARIES
GCCAAGAGGCCT
>MA168097.1 JP 2017060529-A/3533: ANTIBODY LIBRARIES
GCCAAGCCGTTG
>MA168092.1 JP 2017060529-A/3528: ANTIBODY LIBRARIES
GCCAAGCCTTCT
>MA168090.1 JP 2017060529-A/3526: ANTIBODY LIBRARIES
GCCAAGCCTAGA
>MA168088.1 JP 2017060529-A/3524: ANTIBODY LIBRARIES
GCCAAGGTAGGA
>MA168087.1 JP 2017060529-A/3523: ANTIBODY LIBRARIES
GCCAAGGCTGGA
>MA168085.1 JP 2017060529-A/3521: ANTIBODY LIBRARIES
GCCAAGTTAGGA
>MA168082.1 JP 2017060529-A/3518: ANTIBODY LIBRARIES
GCCAAGTCTGGA
>MA168078.1 JP 2017060529-A/3514: ANTIBODY LIBRARIES
GCCAAGAGAGGA
>MA168066.1 JP 2017060529-A/3502: ANTIBODY LIBRARIES
GCCAAGGGCGTG
>MA168065.1 JP 2017060529-A/3501: ANTIBODY LIBRARIES
GCCAAGGACGTG
>MA168064.1 JP 2017060529-A/3500: ANTIBODY LIBRARIES
GCCAAGGAAGTG
>MA168063.1 JP 2017060529-A/3499: ANTIBODY LIBRARIES
GCCAAGGGAACT
>MA168062.1 JP 2017060529-A/3498: ANTIBODY LIBRARIES
GCCAAGGATACT
>MA168061.1 JP 2017060529-A/3497: ANTIBODY LIBRARIES
GCCAAGGAAACT
>MA168060.1 JP 2017060529-A/3496: ANTIBODY LIBRARIES
GCCAAGGGCGCT
>MA168059.1 JP 2017060529-A/3495: ANTIBODY LIBRARIES
GCCAAGGACGCT
>MA168058.1 JP 2017060529-A/3494: ANTIBODY LIBRARIES
GCCAAGGAAGCT
>MA168057.1 JP 2017060529-A/3493: ANTIBODY LIBRARIES
GCCAAGGGGTTG
>MA168056.1 JP 2017060529-A/3492: ANTIBODY LIBRARIES
GCCAAGGACTTG
>MA168055.1 JP 2017060529-A/3491: ANTIBODY LIBRARIES
GCCAAGGGTCCT
>MA168054.1 JP 2017060529-A/3490: ANTIBODY LIBRARIES
GCCAAGGATCCT
>MA168053.1 JP 2017060529-A/3489: ANTIBODY LIBRARIES
GCCAAGGGATCT
>MA168052.1 JP 2017060529-A/3488: ANTIBODY LIBRARIES
GCCAAGGATTCT
>MA168051.1 JP 2017060529-A/3487: ANTIBODY LIBRARIES
GCCAAGGAATCT
>MA168050.1 JP 2017060529-A/3486: ANTIBODY LIBRARIES
GCCAAGGGCAGA
>MA168049.1 JP 2017060529-A/3485: ANTIBODY LIBRARIES
GCCAAGGACAGA
>MA168048.1 JP 2017060529-A/3484: ANTIBODY LIBRARIES
GCCAAGGAAAGA
>MA168047.1 JP 2017060529-A/3483: ANTIBODY LIBRARIES
GCCAAGGGCGGA
>MA168046.1 JP 2017060529-A/3482: ANTIBODY LIBRARIES
GCCAAGGACGGA
>MA168045.1 JP 2017060529-A/3481: ANTIBODY LIBRARIES
GCCAAGGAAGGA
>MA168044.1 JP 2017060529-A/3480: ANTIBODY LIBRARIES
GCCAGGCAGGGA
>MA168041.1 JP 2017060529-A/3477: ANTIBODY LIBRARIES
GCCAGGGGTAAG
>MA168040.1 JP 2017060529-A/3476: ANTIBODY LIBRARIES
GCTAGGGCTAAG
>MA168039.1 JP 2017060529-A/3475: ANTIBODY LIBRARIES
GCCAGGGTCAGA
>MA168038.1 JP 2017060529-A/3474: ANTIBODY LIBRARIES
GCTAGGGGCCAG
>MA168036.1 JP 2017060529-A/3472: ANTIBODY LIBRARIES
GCTAGAGTATCT
>MA168035.1 JP 2017060529-A/3471: ANTIBODY LIBRARIES
GCTAGAGATAAG
>MA168034.1 JP 2017060529-A/3470: ANTIBODY LIBRARIES
GCTAGGAGGAGA
>MA168033.1 JP 2017060529-A/3469: ANTIBODY LIBRARIES
GCTAGAGGGGAC
>MA168031.1 JP 2017060529-A/3467: ANTIBODY LIBRARIES
GCAAGAGCCGAG
>MA168029.1 JP 2017060529-A/3465: ANTIBODY LIBRARIES
GCTAGGTTGCAC
>MA168028.1 JP 2017060529-A/3464: ANTIBODY LIBRARIES
GCTAGATCTTTG
>MA168026.1 JP 2017060529-A/3462: ANTIBODY LIBRARIES
GCTAGATCAAGA
>MA168024.1 JP 2017060529-A/3460: ANTIBODY LIBRARIES
GCTAGGGCATCT
>MA168023.1 JP 2017060529-A/3459: ANTIBODY LIBRARIES
GCAAGGGCTAGA
>MA168022.1 JP 2017060529-A/3458: ANTIBODY LIBRARIES
GCAAGAGACCAC
>MA168021.1 JP 2017060529-A/3457: ANTIBODY LIBRARIES
GCCAGGGACCAG
>MA168019.1 JP 2017060529-A/3455: ANTIBODY LIBRARIES
GCCAGAGTCCCT
>MA168018.1 JP 2017060529-A/3454: ANTIBODY LIBRARIES
GCCAGAACTCCT
>MA168017.1 JP 2017060529-A/3453: ANTIBODY LIBRARIES
GCCAGAGCCCCT
>MA168016.1 JP 2017060529-A/3452: ANTIBODY LIBRARIES
GCCAGACTTCCT
>MA168015.1 JP 2017060529-A/3451: ANTIBODY LIBRARIES
GCCAGATCACCT
>MA168013.1 JP 2017060529-A/3449: ANTIBODY LIBRARIES
GCCAGAAGGCCT
>MA168011.1 JP 2017060529-A/3447: ANTIBODY LIBRARIES
GCCAGACCGTTG
>MA168006.1 JP 2017060529-A/3442: ANTIBODY LIBRARIES
GCCAGACCATCT
>MA168004.1 JP 2017060529-A/3440: ANTIBODY LIBRARIES
GCCAGACCCAGA
>MA168002.1 JP 2017060529-A/3438: ANTIBODY LIBRARIES
GCCAGAGTGGGA
>MA168001.1 JP 2017060529-A/3437: ANTIBODY LIBRARIES
GCCAGAGCTGGA
>MA167999.1 JP 2017060529-A/3435: ANTIBODY LIBRARIES
GCCAGATTGGGA
>MA167996.1 JP 2017060529-A/3432: ANTIBODY LIBRARIES
GCCAGATCAGGA
>MA167992.1 JP 2017060529-A/3428: ANTIBODY LIBRARIES
GCCAGAAGAGGA
>MA268401.1 JP 2018050617-A/169: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
AGGACATTGGCA
>MA268385.1 JP 2018050617-A/153: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
AGGAAGATGGCA
>MA268380.1 JP 2018050617-A/148: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
ACAGATCTGTCA
>MA268321.1 JP 2018050617-A/89: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
NGGNNNNNGGNN
>MA268305.1 JP 2018050617-A/73: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
NGGNNGNNGGNN
>MA167980.1 JP 2017060529-A/3416: ANTIBODY LIBRARIES
GCCAGAGGGGTG
>MA167979.1 JP 2017060529-A/3415: ANTIBODY LIBRARIES
GCCAGAGATGTG
>MA167978.1 JP 2017060529-A/3414: ANTIBODY LIBRARIES
GCCAGAGAGGTG
>MA167977.1 JP 2017060529-A/3413: ANTIBODY LIBRARIES
GCCAGAGGCACT
>MA167976.1 JP 2017060529-A/3412: ANTIBODY LIBRARIES
GCCAGAGATACT
>MA167975.1 JP 2017060529-A/3411: ANTIBODY LIBRARIES
GCCAGAGAGACT
>MA167974.1 JP 2017060529-A/3410: ANTIBODY LIBRARIES
GCCAGAGGTGCT
>MA167973.1 JP 2017060529-A/3409: ANTIBODY LIBRARIES
GCCAGAGATGCT
>MA167972.1 JP 2017060529-A/3408: ANTIBODY LIBRARIES
GCCAGAGAGGCT
>MA167971.1 JP 2017060529-A/3407: ANTIBODY LIBRARIES
GCCAGAGGGTTG
>MA167970.1 JP 2017060529-A/3406: ANTIBODY LIBRARIES
GCCAGAGACTTG
>MA167969.1 JP 2017060529-A/3405: ANTIBODY LIBRARIES
GCCAGAGGGCCT
>MA167968.1 JP 2017060529-A/3404: ANTIBODY LIBRARIES
GCCAGAGACCCT
>MA167967.1 JP 2017060529-A/3403: ANTIBODY LIBRARIES
GCCAGAGGTTCT
>MA167966.1 JP 2017060529-A/3402: ANTIBODY LIBRARIES
GCCAGAGACTCT
>MA167965.1 JP 2017060529-A/3401: ANTIBODY LIBRARIES
GCCAGAGAATCT
>MA167964.1 JP 2017060529-A/3400: ANTIBODY LIBRARIES
GCCAGAGGCAGA
>MA167963.1 JP 2017060529-A/3399: ANTIBODY LIBRARIES
GCCAGAGACAGA
>MA167962.1 JP 2017060529-A/3398: ANTIBODY LIBRARIES
GCCAGAGAGAGA
>MA167961.1 JP 2017060529-A/3397: ANTIBODY LIBRARIES
GCCAGAGGTGGA
>MA167960.1 JP 2017060529-A/3396: ANTIBODY LIBRARIES
GCCAGAGACGGA
>MA167959.1 JP 2017060529-A/3395: ANTIBODY LIBRARIES
GCCAGAGAGGGA
>MA268300.1 JP 2018050617-A/68: RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
NNNGNNNNGNNN
>MA267245.1 JP 2018057341-A/2: Mouse cell
GAATTCGGGCCC
>MA266265.1 JP 2017503502-A/32: Artificial cell membrane comprising supported lipid bilayer connected with probes having controllable mobility and method for analyzing interaction between molecules using the same
GACAATGTAGCT
>MA265743.1 JP 2017506911-A/196: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265741.1 JP 2017506911-A/194: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265699.1 JP 2017506911-A/152: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265648.1 JP 2017506911-A/101: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265647.1 JP 2017506911-A/100: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265645.1 JP 2017506911-A/98: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265644.1 JP 2017506911-A/97: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265643.1 JP 2017506911-A/96: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265642.1 JP 2017506911-A/95: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265641.1 JP 2017506911-A/94: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265640.1 JP 2017506911-A/93: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265639.1 JP 2017506911-A/92: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265638.1 JP 2017506911-A/91: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265637.1 JP 2017506911-A/90: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265636.1 JP 2017506911-A/89: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265607.1 JP 2017506911-A/60: CHIRAL DESIGN
GGATGTTCTCGA
>MA265606.1 JP 2017506911-A/59: CHIRAL DESIGN
GGATGTTCTCGA
>MA265605.1 JP 2017506911-A/58: CHIRAL DESIGN
GGATGTTCTCGA
>MA265559.1 JP 2017506911-A/12: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265557.1 JP 2017506911-A/10: CHIRAL DESIGN
CAGTCTGCTTCG
>MA265404.1 JP 2017508459-A/225: Expression constructs and methods for selecting host cells expressing polypeptides
CTRAYYNNCAGG
>MA164393.1 JP 2017060527-A/10: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLYCYL-tRNA SYNTHETASES
CATATGGGATCC
>MA164392.1 JP 2017060527-A/9: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLYCYL-tRNA SYNTHETASES
CTCGAGTAATGA
>MA164385.1 JP 2017060527-A/2: INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLYCYL-tRNA SYNTHETASES
TAATGACTCGAG
>MA163948.1 JP 2017060521-A/2: Compositions and Methods for Monitoring Transmembrane Trafficking
GGCTCGAGCGGA
>MA163844.1 JP 2017060513-A/10: A method for making an enriched library
GAACAGGACCGA
>MA163828.1 JP 2017042169-A/6: Kit and method
AAGTGTGGTTGA
>MA163822.1 JP 2017012195-A/1609: Neisseria Meningitidis Antigens and Compositions
AAAAAAGTCGAC
>MA163820.1 JP 2017012195-A/1607: Neisseria Meningitidis Antigens and Compositions
AAAAAATCTAGA
>MA163819.1 JP 2017012195-A/1606: Neisseria Meningitidis Antigens and Compositions
AAAAAACTGCAG
>MA163818.1 JP 2017012195-A/1605: Neisseria Meningitidis Antigens and Compositions
AAAAAAGGTACC
>MA163817.1 JP 2017012195-A/1604: Neisseria Meningitidis Antigens and Compositions
AAAAAAGAATTC
>MA161502.1 JP 2017060499-A/140: Heavy Metal Reduction in Planta
GTGCCATGTCCT
>MA161487.1 JP 2017060499-A/125: Heavy Metal Reduction in Planta
AAAGAGAAACTG
>MA161450.1 JP 2017060499-A/88: Heavy Metal Reduction in Planta
AGTTCTTGTACT
>MA161425.1 JP 2017060499-A/63: Heavy Metal Reduction in Planta
ATTGTAAATTAT
>MA161416.1 JP 2017060499-A/54: Heavy Metal Reduction in Planta
GAAGCTGGAATG
>MA161350.1 JP 2017046716-A/109: METHODS AND COMPOSITIONS FOR IDENTIFYING AND VALIDATING MODULATORS OF CELL FATE
RACCACGTGCTC
>MA161344.1 JP 2017046716-A/103: METHODS AND COMPOSITIONS FOR IDENTIFYING AND VALIDATING MODULATORS OF CELL FATE
AACATCCGTGCA
>MA161329.1 JP 2017046716-A/88: METHODS AND COMPOSITIONS FOR IDENTIFYING AND VALIDATING MODULATORS OF CELL FATE
AAGTATGCAAAG
>MA161303.1 JP 2017046716-A/62: METHODS AND COMPOSITIONS FOR IDENTIFYING AND VALIDATING MODULATORS OF CELL FATE
CTCCGATAACTG
>MA161296.1 JP 2017046716-A/55: METHODS AND COMPOSITIONS FOR IDENTIFYING AND VALIDATING MODULATORS OF CELL FATE
AGTTTCACTTCT
>MA161289.1 JP 2017046716-A/48: METHODS AND COMPOSITIONS FOR IDENTIFYING AND VALIDATING MODULATORS OF CELL FATE
GGGGAATCTCCC
>MA161275.1 JP 2017046716-A/34: METHODS AND COMPOSITIONS FOR IDENTIFYING AND VALIDATING MODULATORS OF CELL FATE
TAGCATATGCTA
>MA161256.1 JP 2017046716-A/15: METHODS AND COMPOSITIONS FOR IDENTIFYING AND VALIDATING MODULATORS OF CELL FATE
ACTTTCCACACC
>MA161253.1 JP 2017046716-A/12: METHODS AND COMPOSITIONS FOR IDENTIFYING AND VALIDATING MODULATORS OF CELL FATE
TAAGTTGGAGAA
>MA160704.1 JP 2017061471-A/92: GENETICALLY ENGINEERED GROWTH FACTOR VARIANTS
CTTGCTGCTGCT
>MA160698.1 JP 2017061471-A/86: GENETICALLY ENGINEERED GROWTH FACTOR VARIANTS
GGTGGTTCTGGT
>MA160485.1 JP 2016222709-A/1609: Neisseria Meningitidis Antigens and Compositions
AAAAAAGTCGAC
>MA160483.1 JP 2016222709-A/1607: Neisseria Meningitidis Antigens and Compositions
AAAAAATCTAGA
>MA160482.1 JP 2016222709-A/1606: Neisseria Meningitidis Antigens and Compositions
AAAAAACTGCAG
>MA160481.1 JP 2016222709-A/1605: Neisseria Meningitidis Antigens and Compositions
AAAAAAGGTACC
>MA160480.1 JP 2016222709-A/1604: Neisseria Meningitidis Antigens and Compositions
AAAAAAGAATTC
>MA262942.1 JP 2016539660-A/9: COMPOSITIONS AND METHODS FOR PRODUCING GENETICALLY MODIFIED ANIMALS
TAATGATGGGCG
>MA262836.1 JP 2017505621-A/34: METHODS AND COMPOSITIONS FOR PRODUCING A CELL EXPRESSING A T CELL RECEPTOR
TCTGGATCTGGC
>MA262835.1 JP 2017505621-A/33: METHODS AND COMPOSITIONS FOR PRODUCING A CELL EXPRESSING A T CELL RECEPTOR
AGGGCCAAGAGA
>MA158873.1 JP 2016214248-A/19: Modified Oligonucleotides for Telomerase Inhibition
CGCCCTTCTCAG
>MA158872.1 JP 2016214248-A/18: Modified Oligonucleotides for Telomerase Inhibition
CCCTTCTCAGTT
>LQ825274.1 Sequence 19 from Patent EP3342425
CGCCCTTCTCAG
>LQ825273.1 Sequence 18 from Patent EP3342425
CCCTTCTCAGTT
>LQ825224.1 Sequence 221 from Patent EP3342415
GGGGCTGACCCC
>LQ795290.1 Sequence 249 from Patent EP3338799
GCCTATGACTTG
>LQ786456.1 Sequence 11 from Patent EP3336185
GGATTCACTTTC
>LQ784867.1 Sequence 10 from Patent EP3334449
GGCGCGCACTCC
>LQ781847.1 Sequence 4 from Patent EP3339447
GGCTGCGGGGCC
>LQ780812.1 Sequence 19 from Patent EP3337909
AATCCCAATCCC
>MA143378.1 JP 2018503596-A/2: ANTIBODIES AGAINST PATHOLOGICAL FORMS OF TDP-43 AND USES THEREOF
TGGGTCTCTCTG
>MA143377.1 JP 2018503596-A/1: ANTIBODIES AGAINST PATHOLOGICAL FORMS OF TDP-43 AND USES THEREOF
CTTTTTGCCTGT
>MA141200.1 JP 2018038408-A/24: Method for the expression of polypeptides using modified nucleic acids
GAAGAGGAAGAA
>MA141199.1 JP 2018038408-A/23: Method for the expression of polypeptides using modified nucleic acids
GAAGAAGAGGAA
>MA141198.1 JP 2018038408-A/22: Method for the expression of polypeptides using modified nucleic acids
GAAGAAGAAGAG
>MA141243.1 JP 2018038408-A/67: Method for the expression of polypeptides using modified nucleic acids
AGGCGGAGACGC
>MA141242.1 JP 2018038408-A/66: Method for the expression of polypeptides using modified nucleic acids
AGGAGACGGCGC
>MA141214.1 JP 2018038408-A/38: Method for the expression of polypeptides using modified nucleic acids
TTCTTCTTCTTT
>MA141215.1 JP 2018038408-A/39: Method for the expression of polypeptides using modified nucleic acids
TTCTTCTTTTTC
>MA141216.1 JP 2018038408-A/40: Method for the expression of polypeptides using modified nucleic acids
TTCTTTTTCTTC
>MA138325.1 JP 2018029601-A/49: Process of Producing Aptamers
GGAGGCGGCCGG
>MA138287.1 JP 2018029601-A/11: Process of Producing Aptamers
GGGGGATGGGGG
>MA136737.1 JP 2018038391-A/130: ANTI-CGRP COMPOSITIONS AND USE THEREOF
GATCTTGACTTG
>MA136572.1 JP 2018042548-A/2059: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGGG
>MA136571.1 JP 2018042548-A/2058: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGGC
>MA136570.1 JP 2018042548-A/2057: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGGT
>MA136569.1 JP 2018042548-A/2056: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGGA
>MA136568.1 JP 2018042548-A/2055: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGCG
>MA136567.1 JP 2018042548-A/2054: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGCC
>MA136566.1 JP 2018042548-A/2053: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGCT
>MA136565.1 JP 2018042548-A/2052: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGCA
>MA136564.1 JP 2018042548-A/2051: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGTG
>MA136563.1 JP 2018042548-A/2050: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGTC
>MA136562.1 JP 2018042548-A/2049: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGTT
>MA136561.1 JP 2018042548-A/2048: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGTA
>MA136560.1 JP 2018042548-A/2047: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGAG
>MA136559.1 JP 2018042548-A/2046: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGAC
>MA136558.1 JP 2018042548-A/2045: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGAT
>MA136557.1 JP 2018042548-A/2044: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGAA
>MA135473.1 JP 2018042548-A/960: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGTGTTCCACTG
>MA135472.1 JP 2018042548-A/959: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGCCATCATCAG
>MA135471.1 JP 2018042548-A/958: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GATAGATCGCAT
>MA135470.1 JP 2018042548-A/957: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GAGACTGCACTC
>MA135469.1 JP 2018042548-A/956: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CGTCGATCATCA
>MA135468.1 JP 2018042548-A/955: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GCGCGCTTATGA
>MA135467.1 JP 2018042548-A/954: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGTTGGATCAAC
>MA135466.1 JP 2018042548-A/953: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AAGAGCTGTGCC
>MA135465.1 JP 2018042548-A/952: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GTTCGATGATGG
>MA135464.1 JP 2018042548-A/951: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACGATACGTGGA
>MA135463.1 JP 2018042548-A/950: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACGATCATAGCC
>MA135462.1 JP 2018042548-A/949: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGCTCAGTAACA
>MA135461.1 JP 2018042548-A/948: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGCTCATTACGG
>MA135460.1 JP 2018042548-A/947: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CGCTAGGATCAC
>MA135459.1 JP 2018042548-A/946: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTGGTACCACGT
>MA135458.1 JP 2018042548-A/945: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CAAGTGTGATGA
>MA135457.1 JP 2018042548-A/944: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGTTAAGTTGGA
>MA135456.1 JP 2018042548-A/943: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CGCATGTTGTGC
>MA135455.1 JP 2018042548-A/942: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTCGCAGTTCCT
>MA135454.1 JP 2018042548-A/941: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AACATGGATACG
>MA135453.1 JP 2018042548-A/940: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GTCGATATATGG
>MA135452.1 JP 2018042548-A/939: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTGGTCACACGC
>MA135451.1 JP 2018042548-A/938: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGACGGTCTAGT
>MA135450.1 JP 2018042548-A/937: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TCTATGTAGACG
>MA135449.1 JP 2018042548-A/936: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AAGGCTAATGTC
>MA135448.1 JP 2018042548-A/935: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGAGCGTACACG
>MA135447.1 JP 2018042548-A/934: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GAATCTTCCGCG
>MA135446.1 JP 2018042548-A/933: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GTTGCTCACGTG
>MA135445.1 JP 2018042548-A/932: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AACCGGCTGTCT
>MA135444.1 JP 2018042548-A/931: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CGCAGGACGATT
>MA135443.1 JP 2018042548-A/930: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGCTTAGGTATG
>MA135442.1 JP 2018042548-A/929: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GTCAACGCTAAG
>MA135441.1 JP 2018042548-A/928: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACGCTGTTAGCA
>MA135440.1 JP 2018042548-A/927: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CAGTTGTGCTAT
>MA135439.1 JP 2018042548-A/926: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACTAACGCGACT
>MA135438.1 JP 2018042548-A/925: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGTGGAACCATG
>MA135437.1 JP 2018042548-A/924: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ATTAAGCCTAAG
>MA135436.1 JP 2018042548-A/923: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CACCTGCACGAT
>MA135435.1 JP 2018042548-A/922: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTCTCGTGTGCG
>MA135434.1 JP 2018042548-A/921: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTAAGACTTAAG
>MA135433.1 JP 2018042548-A/920: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGCCGAGACTTC
>MA135432.1 JP 2018042548-A/919: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTTGGCATGTAC
>MA135431.1 JP 2018042548-A/918: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGAGTAGGTCAG
>MA135430.1 JP 2018042548-A/917: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAGTCAACGTAG
>MA135429.1 JP 2018042548-A/916: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CGTCAACGTGGT
>MA135428.1 JP 2018042548-A/915: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTCGATATAGTT
>MA135427.1 JP 2018042548-A/914: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TACCGTCAAGTG
>MA135426.1 JP 2018042548-A/913: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACCGTCGCTTGA
>MA135425.1 JP 2018042548-A/912: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGGCATCCGTTG
>MA135424.1 JP 2018042548-A/911: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACGTCGGAAGGT
>MA135423.1 JP 2018042548-A/910: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AATTGGCTATAG
>MA135422.1 JP 2018042548-A/909: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGTCTGTATCAT
>MA135421.1 JP 2018042548-A/908: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TCCATCAGATAA
>MA135420.1 JP 2018042548-A/907: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGAAGTGATTAA
>MA135419.1 JP 2018042548-A/906: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACACACTTCTAG
>MA135418.1 JP 2018042548-A/905: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGTTACCGAGGA
>MA135417.1 JP 2018042548-A/904: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TACCTGGTCGGT
>MA135416.1 JP 2018042548-A/903: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTCGCGTTATTG
>MA135415.1 JP 2018042548-A/902: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGAAGTCGCCTC
>MA135414.1 JP 2018042548-A/901: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGTTATGAAGAA
>MA135413.1 JP 2018042548-A/900: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GCAGAATTGCGA
>MA135412.1 JP 2018042548-A/899: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGTTCGCATACA
>MA135411.1 JP 2018042548-A/898: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGGCTGACAT
>MA135410.1 JP 2018042548-A/897: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACTGAGGCGTTC
>MA135409.1 JP 2018042548-A/896: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGTCAAGAGATT
>MA135408.1 JP 2018042548-A/895: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GCCTCTGGTAAC
>MA135407.1 JP 2018042548-A/894: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CATCCACTAATC
>MA135406.1 JP 2018042548-A/893: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ATGTCGATCTAG
>MA135405.1 JP 2018042548-A/892: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTCCTCGTGGTT
>MA135404.1 JP 2018042548-A/891: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ATATATCTCAGC
>MA135403.1 JP 2018042548-A/890: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGATGCTTGA
>MA135402.1 JP 2018042548-A/889: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CCTGTTCTGATT
>MA135401.1 JP 2018042548-A/888: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CGCATGTATGCC
>MA135400.1 JP 2018042548-A/887: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GTGTTGCTACCA
>MA135399.1 JP 2018042548-A/886: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTACGTCCGCAA
>MA135398.1 JP 2018042548-A/885: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TCTCTAGTTCGG
>MA135397.1 JP 2018042548-A/884: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGCTAACTCTCC
>MA135396.1 JP 2018042548-A/883: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTGTCACAACTC
>MA135395.1 JP 2018042548-A/882: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTGCATGCATAA
>MA135394.1 JP 2018042548-A/881: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AATACTGGCTAA
>MA135393.1 JP 2018042548-A/880: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGAGCCAGTCGT
>MA135392.1 JP 2018042548-A/879: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTACTGGCACAA
>MA135391.1 JP 2018042548-A/878: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TCGCTAATGTAG
>MA135390.1 JP 2018042548-A/877: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ATTGAGAGCTAT
>MA135389.1 JP 2018042548-A/876: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTGTGCTGGACT
>MA135388.1 JP 2018042548-A/875: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGGATCCTTCAT
>MA135387.1 JP 2018042548-A/874: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTGCATTCACGA
>MA135386.1 JP 2018042548-A/873: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GCGGTCACATAT
>MA135385.1 JP 2018042548-A/872: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CCTACCTGTGGA
>MA135384.1 JP 2018042548-A/871: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GACGCATACCTC
>MA135383.1 JP 2018042548-A/870: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GTGCTTCAGGAG
>MA135382.1 JP 2018042548-A/869: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAGTGGTCGTCA
>MA135381.1 JP 2018042548-A/868: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TATACTACAAGC
>MA135380.1 JP 2018042548-A/867: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTTAAGGAGCGC
>MA135379.1 JP 2018042548-A/866: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ATACTCCGAGAT
>MA135378.1 JP 2018042548-A/865: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GCTGTTGAACCG
>MA133967.1 JP 2018033377-A/16: Method, reagent, and kit for detecting nucleic acid
GGCTGCGGGGCC
>MA149256.1 JP 2018504093-A/109: INDUCED HEPATOCYTES AND USES THEREOF
GGTGACGTCACC
>MA149254.1 JP 2018504093-A/107: INDUCED HEPATOCYTES AND USES THEREOF
GGTGACGTCAGC
>MA145629.1 JP 2018504380-A/146: REVERSIR TM COMPOUNDS
AGAGTTCCACTA
>MA145607.1 JP 2018504380-A/124: REVERSIR TM COMPOUNDS
CATTTACTTCAA
>MA145600.1 JP 2018504380-A/117: REVERSIR TM COMPOUNDS
CATTTACTTCAA
>MA145170.1 JP 2018504102-A/69: PARENTAL RNAI SUPPRESSION OF CHROMATIN REMODELING GENES TO CONTROL HEMIPTERAN PESTS
ACCGCCGCTGCC
>LM537510.1 Amyda cartilaginea mitochondrial partial ND4 gene for NADH dehydrogenase subunit 4, specimen voucher NMW 18249
GAACTAATCTGA
>LQ777402.1 Sequence 116 from Patent EP3331355
TGTGGAGAATTC
>LQ753667.1 Sequence 325 from Patent EP3330292
GGGAAAGGGAAA
>LQ750700.1 Sequence 33 from Patent WO2018100010
ACATCAGGGAGC
>LQ750699.1 Sequence 32 from Patent WO2018100010
ACATCNGGGAGC
>MI815668.1 Sequence 45 from patent US 9988671
AGCAGAAGCGGG
>MI815572.1 Sequence 28 from patent US 9988670
AATAAATCATAA
>MI813864.1 Sequence 245 from patent US 9988636
CTGATTCTCACG
>MI811877.1 Sequence 325 from patent US 9988457
GGGAAAGGGAAA
>MI810997.1 Sequence 2 from patent US 9988416
TTTTGCCGCGCC
>MI739131.1 Sequence 99 from patent US 9982271
GAACNNNNGTTC
>MI739079.1 Sequence 39 from patent US 9982271
AAGAAACGCAAG
>MI739040.1 Sequence 148 from patent US 9982270
TTGGTACCTACT
>MI736003.1 Sequence 2300 from patent US 9982257
CCAGGTAAGTAT
>MI733831.1 Sequence 125 from patent US 9982257
CAGTCTGCTTCG
>MI733814.1 Sequence 108 from patent US 9982257
CAGTCTGCTTCG
>MI733777.1 Sequence 69 from patent US 9982257
TCAGCGTGCGCC
>MI730980.1 Sequence 2 from patent US 9977708
AGCTGGCTGGCG
>MI730979.1 Sequence 1 from patent US 9977708
AGCTTTTTGGGG
>MI730961.1 Sequence 29 from patent US 9977020
GGTTCCGGGGGT
>MI730960.1 Sequence 27 from patent US 9977020
ATGAGGGGATCC
>MI672584.1 Sequence 15 from patent US 9976184
TGCCTACGCCAT
>MI662551.1 Sequence 19 from patent US 9970061
CCGCCTGGGGAG
>MI657742.1 Sequence 15 from patent US 9970058
GCTGGTGGTGTA
>MI657741.1 Sequence 14 from patent US 9970058
GCTGCTGGCGTA
>MI657740.1 Sequence 13 from patent US 9970058
GCTGATGGCGTA
>MI657737.1 Sequence 10 from patent US 9970058
GCTCGTGGCGTA
>MI657736.1 Sequence 9 from patent US 9970058
GCTGGTGACGTA
>MI657735.1 Sequence 8 from patent US 9970058
GCTAGTGGCGTA
>MI657734.1 Sequence 7 from patent US 9970058
GCTGGTGGCGTA
>MI657107.1 Sequence 113 from patent US 9970028
TGGGGCCACTAG
>MI657106.1 Sequence 112 from patent US 9970028
GGAACTGGATGG
>MI657104.1 Sequence 110 from patent US 9970028
ATCAAGCTTATC
>MI655624.1 Sequence 51 from patent US 9970009
ATCTAATAAGCT
>MI655623.1 Sequence 50 from patent US 9970009
AATCTAATAAGC
>MI655617.1 Sequence 44 from patent US 9970009
TCTAATAAGCTA
>MI655610.1 Sequence 37 from patent US 9970009
GTCTGATAAGCT
>MI655609.1 Sequence 36 from patent US 9970009
AGTCTGATAAGC
>MI655595.1 Sequence 22 from patent US 9970009
TCTGATAAGCTA
>MI655566.1 Sequence 13 from patent US 9970007
TGTGCCTGCTGT
>MI652412.1 Sequence 2 from patent US 9969812
ACATCACTCCGT
>MI652055.1 Sequence 16 from patent US 9969792
GAAGCAGTGGTA
>MI647577.1 Sequence 20 from patent US 9963705
ATGGGGTGGGGT
>MI647576.1 Sequence 19 from patent US 9963705
TTAGGGTTAGGG
>MI647528.1 Sequence 35 from patent US 9963703
CCGCGGATCGCC
>MI647507.1 Sequence 14 from patent US 9963703
CTGCCCGCGGAT
>MI641279.1 Sequence 105 from patent US 9963687
GGCCGCATTCAT
>MI641278.1 Sequence 104 from patent US 9963687
GGCCGCGAATAT
>MI640963.1 Sequence 2825 from patent US 9963554
GAAGACTTAGCA
>MI638365.1 Sequence 14 from patent US 9957574
CCCGGAGGGTCT
>MI638364.1 Sequence 13 from patent US 9957574
TCCTTGGTAGGG
>MI638363.1 Sequence 12 from patent US 9957574
ATCAGGCTCTAC
>MI638215.1 Sequence 44 from patent US 9957570
CCGGGCAGAAAG
>MI637809.1 Sequence 244 from patent US 9957564
CGACTAGTACTA
>MI637808.1 Sequence 243 from patent US 9957564
CACTGTATAGCT
>MI637807.1 Sequence 242 from patent US 9957564
CAGTAGCACTAC
>MI637806.1 Sequence 241 from patent US 9957564
CGACGTAGAGTC
>MI637805.1 Sequence 240 from patent US 9957564
CGACTAGTACTA
>MI637804.1 Sequence 239 from patent US 9957564
CACTGTATAGCT
>MI637795.1 Sequence 230 from patent US 9957564
CAGTAGCACTAC
>MI637794.1 Sequence 229 from patent US 9957564
CGACGTAGAGTC
>MI637793.1 Sequence 228 from patent US 9957564
TACAGACTGCAC
>MI637792.1 Sequence 227 from patent US 9957564
TGCAGCTCATAG
>MI637791.1 Sequence 226 from patent US 9957564
CTAGATATCGTC
>MI637790.1 Sequence 225 from patent US 9957564
TGATCGACGCTC
>MI637789.1 Sequence 224 from patent US 9957564
AGATAGCACATC
>MI637788.1 Sequence 223 from patent US 9957564
TAGCATCGATAT
>MI637787.1 Sequence 222 from patent US 9957564
CTCTACAGTCAC
>MI637786.1 Sequence 221 from patent US 9957564
ATCATATGTAGC
>MI637785.1 Sequence 220 from patent US 9957564
CAGCTCGACTAC
>MI637784.1 Sequence 219 from patent US 9957564
ATCGATGTCACG
>MI637783.1 Sequence 218 from patent US 9957564
TACATGCACTCA
>MI637782.1 Sequence 217 from patent US 9957564
TAGATGCTATAC
>MI637781.1 Sequence 216 from patent US 9957564
TCGATCATGCAG
>MI637780.1 Sequence 215 from patent US 9957564
TGAGTAGCACGC
>MI637779.1 Sequence 214 from patent US 9957564
CTAGTATCATGA
>MI637778.1 Sequence 213 from patent US 9957564
TACATAGTCTCG
>MI637777.1 Sequence 212 from patent US 9957564
ACAGTAGCGCAC
>MI637776.1 Sequence 211 from patent US 9957564
ACACGCTCTACT
>MI637775.1 Sequence 210 from patent US 9957564
ATCTACTGACGT
>MI637774.1 Sequence 209 from patent US 9957564
TCGCGTGACATC
>MI637773.1 Sequence 208 from patent US 9957564
TACTCGTAGCGC
>MI637772.1 Sequence 207 from patent US 9957564
TAGATGACGCTC
>MI637771.1 Sequence 206 from patent US 9957564
TATGTGACATAC
>MI637770.1 Sequence 205 from patent US 9957564
TACTATCGCTCT
>MI637769.1 Sequence 204 from patent US 9957564
TGTCTATCACAT
>MI637768.1 Sequence 203 from patent US 9957564
TAGAGTCTGTAT
>MI637767.1 Sequence 202 from patent US 9957564
ACTCGATGAGCT
>MI637766.1 Sequence 201 from patent US 9957564
CGCGAGCTCGTC
>MI637765.1 Sequence 200 from patent US 9957564
CGCTGCATAGCG
>MI637764.1 Sequence 199 from patent US 9957564
TACTGCTATCTC
>MI637763.1 Sequence 198 from patent US 9957564
ATGATCGTATAC
>MI637762.1 Sequence 197 from patent US 9957564
TGTATCACGAGC
>MI637761.1 Sequence 196 from patent US 9957564
TAGTACAGAGCT
>MI637760.1 Sequence 195 from patent US 9957564
TCGCTCATCTAT
>MI637759.1 Sequence 194 from patent US 9957564
CACTACATCGCT
>MI637758.1 Sequence 193 from patent US 9957564
CACTGACGCTCA
>MI637757.1 Sequence 192 from patent US 9957564
TCATGCTGACGA
>MI637756.1 Sequence 191 from patent US 9957564
ATACTAGCATCA
>MI637755.1 Sequence 190 from patent US 9957564
CGATCATATGAG
>MI637754.1 Sequence 189 from patent US 9957564
ATCGACTATGCT
>MI637753.1 Sequence 188 from patent US 9957564
TCATATGATCGA
>MI637752.1 Sequence 187 from patent US 9957564
TGTCACAGTGAC
>MI637751.1 Sequence 186 from patent US 9957564
AGACGCTGTCGA
>MI637750.1 Sequence 185 from patent US 9957564
TAGTCTATACAT
>MI637749.1 Sequence 184 from patent US 9957564
TCGTGATCACTA
>MI637748.1 Sequence 183 from patent US 9957564
ATATCGTAGCAT
>MI637747.1 Sequence 182 from patent US 9957564
CGACACGTACTA
>MI637746.1 Sequence 181 from patent US 9957564
CACTATACAGAT
>MI637745.1 Sequence 180 from patent US 9957564
TCGTGTCACTAC
>MI637744.1 Sequence 179 from patent US 9957564
CATACTATCACG
>MI637743.1 Sequence 178 from patent US 9957564
ACTGCATGATCG
>MI637742.1 Sequence 177 from patent US 9957564
CAGTACACTCTA
>MI637741.1 Sequence 176 from patent US 9957564
CACTGTGCTCAT
>MI637740.1 Sequence 175 from patent US 9957564
TGTATGATCTCG
>MI637739.1 Sequence 174 from patent US 9957564
TCGTACATGCTC
>MI637738.1 Sequence 173 from patent US 9957564
TACATGTGACGA
>MI637737.1 Sequence 172 from patent US 9957564
TGACGCTCATCT
>MI637736.1 Sequence 171 from patent US 9957564
TACACTCGTGCT
>MI637735.1 Sequence 170 from patent US 9957564
TCGTCTGTGATA
>MI637734.1 Sequence 169 from patent US 9957564
TACAGATAGTCT
>MI637733.1 Sequence 168 from patent US 9957564
CACTCATATCGA
>MI637732.1 Sequence 167 from patent US 9957564
ACACGAGCTCAT
>MI637731.1 Sequence 166 from patent US 9957564
ACTCATATCGCA
>MI637730.1 Sequence 165 from patent US 9957564
CTGCACTAGACA
>MI637729.1 Sequence 164 from patent US 9957564
CACGTATAGTGA
>MI637728.1 Sequence 163 from patent US 9957564
TCTACTCGTGAC
>MI637727.1 Sequence 162 from patent US 9957564
TACATAGATGTC
>MI637726.1 Sequence 161 from patent US 9957564
CATACTGTATCT
>MI637725.1 Sequence 160 from patent US 9957564
TGCTATCACTGA
>MI637724.1 Sequence 159 from patent US 9957564
ACTCGTCTGACG
>MI637723.1 Sequence 158 from patent US 9957564
ACGCGAGTGATA
>MI637722.1 Sequence 157 from patent US 9957564
ACTCGACGTGAG
>MI637721.1 Sequence 156 from patent US 9957564
CAGTCGTGAGCA
>MI637720.1 Sequence 155 from patent US 9957564
CGTGTCGACAGA
>MI637719.1 Sequence 154 from patent US 9957564
TCGACGCTAGCG
>MI637718.1 Sequence 153 from patent US 9957564
TGCAGCGAGTAC
>MI637717.1 Sequence 152 from patent US 9957564
TATAGCGATGAC
>MI637716.1 Sequence 151 from patent US 9957564
CGTCATATGCAG
>MI637715.1 Sequence 150 from patent US 9957564
TGACGCGTATAC
>MI637714.1 Sequence 149 from patent US 9957564
TAGCATACACGC
>MI637713.1 Sequence 148 from patent US 9957564
TCATGACTAGTA
>MI637712.1 Sequence 147 from patent US 9957564
ACGACTCGCTAC
>MI637711.1 Sequence 146 from patent US 9957564
TACACGTATGAG
>MI637710.1 Sequence 145 from patent US 9957564
TAGCATATCGAG
>MI637709.1 Sequence 144 from patent US 9957564
CTAGCTGACGTA
>MI637708.1 Sequence 143 from patent US 9957564
CATGAGTATAGC
>MI637707.1 Sequence 142 from patent US 9957564
ACACGCAGATCG
>MI637706.1 Sequence 141 from patent US 9957564
TCTATCGATGCA
>MI637705.1 Sequence 140 from patent US 9957564
ATGCAGATATCT
>MI637704.1 Sequence 139 from patent US 9957564
CAGCTATAGTCT
>MI637703.1 Sequence 138 from patent US 9957564
TCGTGATACAGA
>MI637702.1 Sequence 137 from patent US 9957564
CAGCATACTATC
>MI637701.1 Sequence 136 from patent US 9957564
TCGTAGTCTACA
>MI637700.1 Sequence 135 from patent US 9957564
CGAGACACTCGC
>MI637699.1 Sequence 134 from patent US 9957564
CGCATAGCGTAT
>MI637698.1 Sequence 133 from patent US 9957564
ATAGAGTCTCAT
>MI637697.1 Sequence 132 from patent US 9957564
TGTCTCGACATC
>MI637696.1 Sequence 131 from patent US 9957564
TCGCTCACTACA
>MI637695.1 Sequence 130 from patent US 9957564
ATCGCGAGTGAC
>MI637694.1 Sequence 129 from patent US 9957564
CTCATAGACTAC
>MI637693.1 Sequence 128 from patent US 9957564
CTGATAGTATCA
>MI637692.1 Sequence 127 from patent US 9957564
AGACTCTGAGTC
>MI637691.1 Sequence 126 from patent US 9957564
ACGAGCTGATAT
>MI637690.1 Sequence 125 from patent US 9957564
TAGTGATGCTCT
>MI637689.1 Sequence 124 from patent US 9957564
TCGTGACAGATC
>MI637688.1 Sequence 123 from patent US 9957564
TGTATGCTCGTC
>MI637687.1 Sequence 122 from patent US 9957564
TGCATAGAGCGC
>MI637686.1 Sequence 121 from patent US 9957564
TATACTCTAGAT
>MI637685.1 Sequence 120 from patent US 9957564
CACTGCAGACGA
>MI637684.1 Sequence 119 from patent US 9957564
CAGCTATCATAC
>MI637683.1 Sequence 118 from patent US 9957564
AGCAGAGTGCTC
>MI637682.1 Sequence 117 from patent US 9957564
CATATGAGATCG
>MI637681.1 Sequence 116 from patent US 9957564
ACGTAGATCTAT
>MI637680.1 Sequence 115 from patent US 9957564
ACACTCTAGTCA
>MI637679.1 Sequence 114 from patent US 9957564
TCACGCGATGAG
>MI637678.1 Sequence 113 from patent US 9957564
CACTCTATCGAC
>MI637677.1 Sequence 112 from patent US 9957564
TGATATGCTACA
>MI637676.1 Sequence 111 from patent US 9957564
ACAGTGTAGCGC
>MI637675.1 Sequence 110 from patent US 9957564
TACTATAGTCGA
>MI637674.1 Sequence 109 from patent US 9957564
CGCTAGACTGTA
>MI637673.1 Sequence 108 from patent US 9957564
ACATGACTCACG
>MI637672.1 Sequence 107 from patent US 9957564
TGTCGTGCTATC
>MI637671.1 Sequence 106 from patent US 9957564
CATACTCACGTA
>MI637670.1 Sequence 105 from patent US 9957564
AGCGTATACTAG
>MI637669.1 Sequence 104 from patent US 9957564
CTATCATGACAC
>MI637668.1 Sequence 103 from patent US 9957564
ACACTCATAGAT
>MI637667.1 Sequence 102 from patent US 9957564
TAGCGATGAGAC
>MI637666.1 Sequence 101 from patent US 9957564
CGCGACATCACG
>MI637665.1 Sequence 100 from patent US 9957564
TACATCTCGTAT
>MI637664.1 Sequence 99 from patent US 9957564
CAGACGCGTGAG
>MI637663.1 Sequence 98 from patent US 9957564
ACATACTGAGAC
>MI637662.1 Sequence 97 from patent US 9957564
TAGACTGAGCTA
>MI637661.1 Sequence 96 from patent US 9957564
AGCGAGTCTACT
>MI637660.1 Sequence 95 from patent US 9957564
CTAGTACTGACG
>MI637659.1 Sequence 94 from patent US 9957564
TGTGATAGACAC
>MI637658.1 Sequence 93 from patent US 9957564
TGTACTATCATA
>MI637657.1 Sequence 92 from patent US 9957564
CTGCTAGTGTAT
>MI637656.1 Sequence 91 from patent US 9957564
CACAGTACTCGC
>MI637655.1 Sequence 90 from patent US 9957564
CAGCACATAGAT
>MI637654.1 Sequence 89 from patent US 9957564
TACACTGTCTAT
>MI637653.1 Sequence 88 from patent US 9957564
TAGAGCTGTCAC
>MI637652.1 Sequence 87 from patent US 9957564
ACTCATCGTGCT
>MI637651.1 Sequence 86 from patent US 9957564
ATCTGCTATGAC
>MI637650.1 Sequence 85 from patent US 9957564
TGAGATACAGTA
>MI637649.1 Sequence 84 from patent US 9957564
CTATGCACTGAT
>MI637648.1 Sequence 83 from patent US 9957564
ACGCACTCTAGA
>MI637647.1 Sequence 82 from patent US 9957564
TCTAGCTCATGA
>MI637646.1 Sequence 81 from patent US 9957564
CATCTGCTATAG
>MI637645.1 Sequence 80 from patent US 9957564
ACGTAGCGCACA
>MI637644.1 Sequence 79 from patent US 9957564
ACTGTCTCGAGC
>MI637643.1 Sequence 78 from patent US 9957564
TGTATACACGAT
>MI637642.1 Sequence 77 from patent US 9957564
CGAGATGACTCT
>MI637641.1 Sequence 76 from patent US 9957564
CTAGTATCGCAG
>MI637640.1 Sequence 75 from patent US 9957564
ACGCATCTATAC
>MI637639.1 Sequence 74 from patent US 9957564
CGCGTACTGCAG
>MI637638.1 Sequence 73 from patent US 9957564
CGACGTGCTCGC
>MI637637.1 Sequence 72 from patent US 9957564
AGCGATGCTCAT
>MI637636.1 Sequence 71 from patent US 9957564
CACTCGTACATC
>MI637635.1 Sequence 70 from patent US 9957564
TCTGATCGAGCA
>MI637634.1 Sequence 69 from patent US 9957564
TGTGCTCGAGTC
>MI637633.1 Sequence 68 from patent US 9957564
CATAGCAGTGTC
>MI637632.1 Sequence 67 from patent US 9957564
TGCTGTCTCGAG
>MI637631.1 Sequence 66 from patent US 9957564
TAGTGAGCGCAC
>MI637630.1 Sequence 65 from patent US 9957564
CACGATGACATC
>MI637629.1 Sequence 64 from patent US 9957564
TGTATCGTGCTC
>MI637628.1 Sequence 63 from patent US 9957564
ATACTAGTGCTC
>MI637627.1 Sequence 62 from patent US 9957564
TACTAGCTGACG
>MI637626.1 Sequence 61 from patent US 9957564
AGACTCGCGTAT
>MI637625.1 Sequence 60 from patent US 9957564
ATAGTCACGCGT
>MI637624.1 Sequence 59 from patent US 9957564
ACTACACGTCTC
>MI637623.1 Sequence 58 from patent US 9957564
ACTAGTACACGC
>MI637622.1 Sequence 57 from patent US 9957564
TAGATCGTACAT
>MI637621.1 Sequence 56 from patent US 9957564
ATCTCGTGACAG
>MI637620.1 Sequence 55 from patent US 9957564
ACAGATGCACGC
>MI637619.1 Sequence 54 from patent US 9957564
AGATCGTATAGC
>MI637618.1 Sequence 53 from patent US 9957564
TCATATCGCGAT
>MI637617.1 Sequence 52 from patent US 9957564
ACGTGTCTATCA
>MI637616.1 Sequence 51 from patent US 9957564
TACATGCTGAGC
>MI637615.1 Sequence 50 from patent US 9957564
AGATATCGAGCT
>MI637614.1 Sequence 49 from patent US 9957564
TATCTGCTCATA
>MI637613.1 Sequence 48 from patent US 9957564
TGCTGTAGTGAC
>MI637612.1 Sequence 47 from patent US 9957564
TCTGTATACTCA
>MI637611.1 Sequence 46 from patent US 9957564
ACGTCTAGACAC
>MI637610.1 Sequence 45 from patent US 9957564
CTCGATGAGTAC
>MI637609.1 Sequence 44 from patent US 9957564
TACAGATGCTGA
>MI637608.1 Sequence 43 from patent US 9957564
TACATCGCACTA
>MI637607.1 Sequence 42 from patent US 9957564
TGACACGATGCT
>MI637606.1 Sequence 41 from patent US 9957564
TCGCAGACATCA
>MI637509.1 Sequence 3 from patent US 9957561
GGGAAAGGAAGA
>MI637481.1 Sequence 11 from patent US 9957560
TTTNTTNNTTTN
>MI637480.1 Sequence 10 from patent US 9957560
AAAAAAAAAAAA
>MI631945.1 Sequence 118 from patent US 9957509
TTAGTTAGTTAG
>MI631936.1 Sequence 109 from patent US 9957509
TTAGTTAGTTAG
>MI631877.1 Sequence 50 from patent US 9957509
TTAGTTAGTTAG
>MI631868.1 Sequence 41 from patent US 9957509
TTAGTTAGTTAG
>MI631105.1 Sequence 279 from patent US 9957503
GTCTGATGGAGA
>MI631104.1 Sequence 278 from patent US 9957503
GCTAGTCTGTTG
>MI631088.1 Sequence 261 from patent US 9957503
GTCTGATGGAGA
>MI631087.1 Sequence 260 from patent US 9957503
GCTAGTCTGTTG
>MI631041.1 Sequence 214 from patent US 9957503
GCTAGTCTGTTG
>MI631025.1 Sequence 198 from patent US 9957503
TTTGCCATTTGG
>MI631024.1 Sequence 197 from patent US 9957503
TGCCATTTGGAT
>MI631023.1 Sequence 196 from patent US 9957503
TGCCATTTGGAT
>MI631022.1 Sequence 195 from patent US 9957503
GCCATTTGGATC
>MI631021.1 Sequence 194 from patent US 9957503
CCATTTGGATCT
>MI631019.1 Sequence 192 from patent US 9957503
CATTTGGATCTG
>MI630963.1 Sequence 136 from patent US 9957503
CAACAGACTAGC
>MI630947.1 Sequence 120 from patent US 9957503
CCAAATGGCAAA
>MI630946.1 Sequence 119 from patent US 9957503
TCCAAATGGCAA
>MI630945.1 Sequence 118 from patent US 9957503
ATCCAAATGGCA
>MI630944.1 Sequence 117 from patent US 9957503
GATCCAAATGGC
>MI630943.1 Sequence 116 from patent US 9957503
AGATCCAAATGG
>MI630941.1 Sequence 114 from patent US 9957503
CAGATCCAAATG
>MI630697.1 Sequence 16 from patent US 9957502
CCNNNGGTCTCN
>MI630695.1 Sequence 14 from patent US 9957502
CGNNNCGTCTCN
>MI630688.1 Sequence 7 from patent US 9957502
GTATCCNNNNNN
>MI630686.1 Sequence 3 from patent US 9957502
GAAGACNNNNNN
>MI629644.1 Sequence 249 from patent US 9957321
GCCTATGACTTG
>MI624146.1 Sequence 33 from patent US 9956284
GGTGCAGCTGGA
>MI623739.1 Sequence 103213 from patent US 9951380
ATGCAGAGGTCC
>MI623727.1 Sequence 103201 from patent US 9951380
TCACTTCTAATG
>MI623694.1 Sequence 103168 from patent US 9951380
TGCTGCTCTGAA
>MI520397.1 Sequence 172 from patent US 9952202
GTTTGCTATAAC
>MI520021.1 Sequence 278 from patent US 9951391
CCCACCACGCTC
>MI519553.1 Sequence 41 from patent US 9951377
CCTCCCCCCTCC
>MI519073.1 Sequence 80 from patent US 9951368
CCGGGTGACCGT
>MI519072.1 Sequence 79 from patent US 9951368
ATCACTGACCGT
>MI519071.1 Sequence 78 from patent US 9951368
GGATCTGACCGT
>MI519070.1 Sequence 77 from patent US 9951368
GTCGACGATCGT
>MI518500.1 Sequence 38 from patent US 9951344
TGGGTGGTATGT
>MI518458.1 Sequence 1 from patent US 9951343
ATCACCTCCTTA
>MI515404.1 Sequence 58 from patent US 9951337
GTTTGCTATAAC
>MI515109.1 Sequence 66 from patent US 9951321
AACCGGTTAACC
>MI515108.1 Sequence 65 from patent US 9951321
ACGTACGTACGT
>MI514491.1 Sequence 1 from patent US 9951118
GGCCCTGGGCCC
>MI514367.1 Sequence 1 from patent US 9951097
CGCGAATTCGCG
>MI512843.1 Sequence 14 from patent US 9945856
TCTCAACTAAAC
>MI512521.1 Sequence 123 from patent US 9944996
CGTGWGCGACGT
>MI512520.1 Sequence 122 from patent US 9944996
CGTGAGCGAGTG
>MI512519.1 Sequence 121 from patent US 9944996
CGTGTGCGACGT
>MI512513.1 Sequence 115 from patent US 9944996
AGCCGAAGCGYC
>MI511549.1 Sequence 17 from patent US 9944984
ACATTAACGGAC
>MI511480.1 Sequence 13 from patent US 9944978
TTAGGGTTAGGG
>MI511071.1 Sequence 5 from patent US 9944955
TTTCCTCCACTA
>MI510366.1 Sequence 23 from patent US 9944937
TTCATGTATGAA
>MI510364.1 Sequence 21 from patent US 9944937
TACCAGCATGAA
>MI510363.1 Sequence 20 from patent US 9944937
TTCATGCTTTCA
>MI509408.1 Sequence 24 from patent US 9944929
GCCACAAGTTCT
>MI506977.1 Sequence 102 from patent US 9944690
GGCAGCGGAAGC
>MI506975.1 Sequence 98 from patent US 9944690
CGCGCAAAGCGT
>MI506954.1 Sequence 29 from patent US 9944690
GGCAGCGGAAGC
>MI506952.1 Sequence 25 from patent US 9944690
CGCGCAAAGCGT
>MI506923.1 Sequence 11 from patent US 9944685
GGGSGGGSGGGS
>MI504001.1 Sequence 621 from patent US 9943612
ACAYNNNNNGTA
>MI504000.1 Sequence 620 from patent US 9943612
TACNNNNNRTGT
>MI503999.1 Sequence 619 from patent US 9943612
GACNNNNNNGTC
>MI503996.1 Sequence 616 from patent US 9943612
CCANNNNNNNTC
>MI503993.1 Sequence 613 from patent US 9943612
GACNNNNNNTGG
>MI503990.1 Sequence 610 from patent US 9943612
TGANNNNNNTCA
>MI503989.1 Sequence 609 from patent US 9943612
GACNNNNNNGTC
>MI503935.1 Sequence 326 from patent US 9943612
NNNNNNGTCTTC
>MI503934.1 Sequence 325 from patent US 9943612
GAAGACNNNNNN
>MI503915.1 Sequence 149 from patent US 9943612
CAANNNNNGTGG
>MI503878.1 Sequence 79 from patent US 9943612
NNNNNNGGATAC
>MI503877.1 Sequence 78 from patent US 9943612
GTATCCNNNNNN
>MI503621.1 Sequence 99 from patent US 9943573
CCGGTCGCCACC
>MI496343.1 Sequence 38 from patent US 9938521
AAGGCTAGTCCG
>LQ749863.1 Sequence 1381 from Patent WO2018081459
CCGCCGCCGCCG
>LQ743499.1 Sequence 546 from Patent WO2018078369
GTCACCAATGAC
>LQ743470.1 Sequence 517 from Patent WO2018078369
ACCTCCAAAGGT
>LQ743436.1 Sequence 483 from Patent WO2018078369
GCCCTCCAGGGT
>LQ743762.1 Sequence 809 from Patent WO2018078369
AATTATTCATAA
>LQ743759.1 Sequence 806 from Patent WO2018078369
GCATCAAACAGC
>LQ743754.1 Sequence 801 from Patent WO2018078369
GTAACGCACAGT
>LQ743728.1 Sequence 775 from Patent WO2018078369
ACATAGTGACAG
>LQ743717.1 Sequence 764 from Patent WO2018078369
CCATACAATACT
>LQ743681.1 Sequence 728 from Patent WO2018078369
CAAAGAGAAGAG
>LQ743665.1 Sequence 712 from Patent WO2018078369
ATTGGAGGAAAT
>LQ743558.1 Sequence 605 from Patent WO2018078369
TTCCACCAGGGG
>LQ743533.1 Sequence 580 from Patent WO2018078369
CTTGAACCCAGG
>LQ743307.1 Sequence 354 from Patent WO2018078369
GTTAGTTAGAAC
>LQ743289.1 Sequence 336 from Patent WO2018078369
GCGGTTCCCCGC
>LQ743283.1 Sequence 330 from Patent WO2018078369
GCGGATCAACGT
>LQ743277.1 Sequence 324 from Patent WO2018078369
TTGGCTCTCCAA
>LQ743264.1 Sequence 311 from Patent WO2018078369
GGCCAGCTCTCC
>LQ743256.1 Sequence 303 from Patent WO2018078369
TGGAGTTCACCA
>LQ743252.1 Sequence 299 from Patent WO2018078369
GGTGCTCTCACC
>LQ743241.1 Sequence 288 from Patent WO2018078369
GCTATGATAGGC
>LQ743173.1 Sequence 220 from Patent WO2018078369
TGTCTGCTAACA
>LQ743151.1 Sequence 198 from Patent WO2018078369
CCTGTTAATTGG
>LQ743140.1 Sequence 187 from Patent WO2018078369
CATGATCATATG
>LQ743129.1 Sequence 176 from Patent WO2018078369
GGGGCTGTACCC
>LQ743080.1 Sequence 127 from Patent WO2018078369
CCATTGCTAAGG
>LQ743063.1 Sequence 110 from Patent WO2018078369
TTGGATTTTCAA
>LQ743032.1 Sequence 79 from Patent WO2018078369
GTTGATTATTGC
>LQ742992.1 Sequence 39 from Patent WO2018078369
TAGAGGTTTCTA
>LQ742969.1 Sequence 16 from Patent WO2018078369
GACCGATTCGTC
>LQ742968.1 Sequence 15 from Patent WO2018078369
CATGTTTTGATG
>LQ742958.1 Sequence 5 from Patent WO2018078369
GTCTGGTGAGAT
>LQ743369.1 Sequence 416 from Patent WO2018078369
GCCCCACCGGGC
>LQ731027.1 Sequence 63 from Patent EP3324980
CCAGGTAAGTAT
>LQ730616.1 Sequence 33 from Patent EP3325668
TTACCGACCACC
>LQ728687.1 Sequence 108 from Patent EP3324978
GGATGTTCTCGA
>LQ728686.1 Sequence 107 from Patent EP3324978
GGATGTTCTCGA
>LQ728685.1 Sequence 106 from Patent EP3324978
GGATGTTCTCGA
>LQ728639.1 Sequence 60 from Patent EP3324978
CAGTCTGCTTCG
>LQ726464.1 Sequence 42 from Patent WO2018094385
GAGGGTTTTAAG
>LQ726463.1 Sequence 41 from Patent WO2018094385
ATGTTGTGGGTA
>LQ726462.1 Sequence 40 from Patent WO2018094385
GAGTTGGATGAG
>LQ726461.1 Sequence 39 from Patent WO2018094385
ATGGGAAAAAGT
>LQ726460.1 Sequence 38 from Patent WO2018094385
GTTAGTGGGAAA
>LQ726459.1 Sequence 37 from Patent WO2018094385
TTTGGGTTTAGG
>LQ726458.1 Sequence 36 from Patent WO2018094385
GTTGTTATTGTG
>LQ726457.1 Sequence 35 from Patent WO2018094385
TGAGAAGGGTAG
>LQ726456.1 Sequence 34 from Patent WO2018094385
AGCGTGGAAAAG
>LQ726455.1 Sequence 33 from Patent WO2018094385
GAGGGCGAAAAG
>LQ726454.1 Sequence 32 from Patent WO2018094385
CGAGAGGAAAAG
>LQ726453.1 Sequence 31 from Patent WO2018094385
AGCCGAGAAAAG
>LQ726452.1 Sequence 30 from Patent WO2018094385
GTGAGGGAAAAG
>LQ726451.1 Sequence 29 from Patent WO2018094385
GGGGATGAAAAG
>LQ726450.1 Sequence 28 from Patent WO2018094385
GAAGGAGAAAAG
>LQ726449.1 Sequence 27 from Patent WO2018094385
TGGATGGAAAAG
>LQ726448.1 Sequence 26 from Patent WO2018094385
AGGGTGGATGAC
>LQ726447.1 Sequence 25 from Patent WO2018094385
AGCCGAGATGAC
>LQ726446.1 Sequence 24 from Patent WO2018094385
AGTGGGGAGGAG
>LQ726445.1 Sequence 23 from Patent WO2018094385
AGAGGGGATGAC
>LQ726444.1 Sequence 22 from Patent WO2018094385
AGGGGTGAGGAG
>LQ726443.1 Sequence 21 from Patent WO2018094385
AGGAGTGATGAC
>LQ726442.1 Sequence 20 from Patent WO2018094385
GTATCGGATGAC
>LQ726441.1 Sequence 19 from Patent WO2018094385
AGGACAGATGAC
>LQ726420.1 Sequence 3 from Patent EP3317440
ACGTCACATTTC
>LQ723359.1 Sequence 40 from Patent EP3312278
AAAAAAAAAAAA
>LQ723358.1 Sequence 39 from Patent EP3312278
GCAAAAATTATT
>LQ723357.1 Sequence 38 from Patent EP3312278
GCAAAAATTAAA
>LQ723356.1 Sequence 37 from Patent EP3312278
TCTAAAAAAAAA
>LQ723355.1 Sequence 36 from Patent EP3312278
TCTAAAATTATT
>LQ723324.1 Sequence 5 from Patent EP3312278
TCGAAGATCAAG
>LQ723323.1 Sequence 4 from Patent EP3312278
TCTAAAATAAAA
>MA057530.1 JP 2018027087-A/122: Antisense Nucleic Acid
CGCCGCCATTTC
>MA057529.1 JP 2018027087-A/121: Antisense Nucleic Acid
CTGTTAGCCACT
>MA057526.1 JP 2018027087-A/118: Antisense Nucleic Acid
TCTGTTAGCCAC
>MA057525.1 JP 2018027087-A/117: Antisense Nucleic Acid
TTGTGTCTTTCT
>MA057522.1 JP 2018027087-A/114: Antisense Nucleic Acid
CCGCCATTTCTC
>MA133186.1 JP 2018502120-A/183: COMBINATION TUMOR IMMUNOTHERAPY
GTCGGCGTTGAC
>MA131538.1 JP 2018500899-A/20: PARENTAL RNAI SUPPRESSION OF KRUPPEL GENE TO CONTROL HEMIPTERAN PESTS
ACCGCCGCTGCC
>MA131505.1 JP 2018501786-A/242: METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
GCATGCGCCACC
>MA131482.1 JP 2018501786-A/219: METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
GCATGCGCCACC
>MA131380.1 JP 2018501786-A/117: METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
AAAGATCCCAAA
>MA131376.1 JP 2018501786-A/113: METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
GGGGATCCCGCC
>MA131366.1 JP 2018501786-A/103: METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
AAAGATCCCAAA
>MA131362.1 JP 2018501786-A/99: METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
GGGGATCCCGCC
>MA131064.1 JP 2018500019-A/259: METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS
GCTAGCAGAGCC
>MA131047.1 JP 2018500019-A/242: METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS
GCATGCGCCACC
>MA131024.1 JP 2018500019-A/219: METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS
GCATGCGCCACC
>MA130922.1 JP 2018500019-A/117: METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS
AAAGATCCCAAA
>MA130918.1 JP 2018500019-A/113: METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS
GGGGATCCCGCC
>MA130908.1 JP 2018500019-A/103: METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS
AAAGATCCCAAA
>MA130904.1 JP 2018500019-A/99: METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS
GGGGATCCCGCC
>MA129920.1 JP 2018501816-A/340: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
TTATTAATGCCT
>MA129919.1 JP 2018501816-A/339: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
CTTTATTAATGC
>MA129915.1 JP 2018501816-A/335: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
GTCTATGACGAG
>MA129914.1 JP 2018501816-A/334: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
CGGTCTATGACG
>MA129910.1 JP 2018501816-A/330: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
GGACGCGTATCG
>MA129909.1 JP 2018501816-A/329: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
GTGGACGCGTAT
>MA129905.1 JP 2018501816-A/325: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
ACTACCAAATAG
>MA129904.1 JP 2018501816-A/324: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
ACACTACCAAAT
>MA129900.1 JP 2018501816-A/320: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
CCCTAAACACTA
>MA129899.1 JP 2018501816-A/319: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
CTCCCTAAACAC
>MA129895.1 JP 2018501816-A/315: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
TGGTCCATTCAT
>MA129894.1 JP 2018501816-A/314: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
ACTGGTCCATTC
>MA129893.1 JP 2018501816-A/313: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
TTTATTAATGCC
>MA129890.1 JP 2018501816-A/310: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
GGTCTATGACGA
>MA129887.1 JP 2018501816-A/307: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
TGGACGCGTATC
>MA129884.1 JP 2018501816-A/304: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
CACTACCAAATA
>MA129881.1 JP 2018501816-A/301: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
TCCCTAAACACT
>MA129878.1 JP 2018501816-A/298: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
CTGGTCCATTCA
>MA129865.1 JP 2018501816-A/285: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
GCATTAATAAAG
>MA129852.1 JP 2018501816-A/272: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
TATTTGGTAGTG
>MA129839.1 JP 2018501816-A/259: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
AGTGTTTAGGGA
>MA129826.1 JP 2018501816-A/246: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
ATACGCGTCCAC
>MA129813.1 JP 2018501816-A/233: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
TCGTCATAGACC
>MA129800.1 JP 2018501816-A/220: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
TGAATGGACCAG
>MA129780.1 JP 2018501816-A/200: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
GACATGCCGCGT
>MA129761.1 JP 2018501816-A/181: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
TTAACGCGGTAG
>MA129759.1 JP 2018501816-A/179: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
TAACGCGGTAGC
>MA129746.1 JP 2018501816-A/166: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
TGGCGATACGCG
>MA129744.1 JP 2018501816-A/164: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
GGCGATACGCGT
>MA129739.1 JP 2018501816-A/159: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
GCGATACGCGTC
>MA129735.1 JP 2018501816-A/155: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
CGATACGCGTCC
>MA129720.1 JP 2018501816-A/140: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
ATAGACCGAGCC
>MA129714.1 JP 2018501816-A/134: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
TCGTCGCTCCGT
>MA129692.1 JP 2018501816-A/112: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
CGAGTGACTCAC
>MA129654.1 JP 2018501816-A/74: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
NCATTAATAAAN
>MA129653.1 JP 2018501816-A/73: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
NGAATGGACCAN
>MA129652.1 JP 2018501816-A/72: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
NATTTGGTAGTN
>MA129651.1 JP 2018501816-A/71: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
NGTGTTTAGGGN
>MA129650.1 JP 2018501816-A/70: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
NTACGCGTCCAN
>MA129649.1 JP 2018501816-A/69: Antisense-Oligonucleotides as Inhibitors of TGF-R signaling
NCGTCATAGACN
>MA128048.1 WO 2018025826-A/11: LABEL PROTEIN-FUSED ANTIBODY
AAAAAAAAAAAA
>MA128047.1 WO 2018025826-A/10: LABEL PROTEIN-FUSED ANTIBODY
GCAAAAATTATT
>MA128046.1 WO 2018025826-A/9: LABEL PROTEIN-FUSED ANTIBODY
GCAAAAATTAAA
>MA128045.1 WO 2018025826-A/8: LABEL PROTEIN-FUSED ANTIBODY
TCTAAAATTATT
>MA128044.1 WO 2018025826-A/7: LABEL PROTEIN-FUSED ANTIBODY
TCTAAAAAAAAA
>MA128043.1 WO 2018025826-A/6: LABEL PROTEIN-FUSED ANTIBODY
TCGAAGATCAAG
>MA128042.1 WO 2018025826-A/5: LABEL PROTEIN-FUSED ANTIBODY
TCTAAAATAAAA
>MA019589.1 JP 2018027080-A/194: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
CNGGCNGGCNGG
>MA019588.1 JP 2018027080-A/193: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NAGGNAGGNAGG
>MA019573.1 JP 2018027080-A/178: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NGGNGGNGGNGG
>MA019563.1 JP 2018027080-A/168: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
GGNGGNGGNGGN
>MA019543.1 JP 2018027080-A/148: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NNCNNCNNCNNC
>MA019542.1 JP 2018027080-A/147: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
TTNTTNTTNTTN
>MA019529.1 JP 2018027080-A/134: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
CNGCNGCNGCNG
>MA019528.1 JP 2018027080-A/133: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NNGNNGNNGNNG
>MA019515.1 JP 2018027080-A/120: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NGCNGCNGCNGC
>MA019514.1 JP 2018027080-A/119: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NGNNGNNGNNGN
>MA019458.1 JP 2018027080-A/63: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NNGGNNGGNNGG
>MA019444.1 JP 2018027080-A/49: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NGGNGGNGGNGG
>MA019435.1 JP 2018027080-A/40: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
GGNGGNGGNGGN
>MA019417.1 JP 2018027080-A/22: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NNGNNGNNGNNG
>MA019408.1 JP 2018027080-A/13: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NGNNGNNGNNGN
>MA019399.1 JP 2018027080-A/4: RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
NNGNNGNNGNNG
>MA126750.1 JP 2018023392-A/34111: Genetic Polymorphisms Associated with Liver Fibrosis Methods of Detection and Uses Thereof
CGCGGCCGAAGG
>MA126749.1 JP 2018023392-A/34110: Genetic Polymorphisms Associated with Liver Fibrosis Methods of Detection and Uses Thereof
CGCGGCCGAAGC
>MA047823.1 JP 2018019694-A/258: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAG
>MA047822.1 JP 2018019694-A/257: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAG
>MA047821.1 JP 2018019694-A/256: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACAGGAAAAG
>MA047820.1 JP 2018019694-A/255: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAACTGGAAAAA
>MA047819.1 JP 2018019694-A/254: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAG
>MA047818.1 JP 2018019694-A/253: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGAAAAAG
>MA047817.1 JP 2018019694-A/252: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACAGCAAAAG
>MA047816.1 JP 2018019694-A/251: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACCGCAAATG
>MA047815.1 JP 2018019694-A/250: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGAAAGAG
>MA047814.1 JP 2018019694-A/249: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAG
>MA047813.1 JP 2018019694-A/248: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAG
>MA047812.1 JP 2018019694-A/247: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TAACTGCAAAAT
>MA047811.1 JP 2018019694-A/246: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGGAACAG
>MA047810.1 JP 2018019694-A/245: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AATCTGCATAAG
>MA047809.1 JP 2018019694-A/244: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TCACTGCAAAAG
>MA047808.1 JP 2018019694-A/243: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CAATTGCTAAAG
>MA047807.1 JP 2018019694-A/242: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AGACTGCAAAAG
>MA047806.1 JP 2018019694-A/241: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TAACTGCAAAAG
>MA047805.1 JP 2018019694-A/240: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGTAAATG
>MA047804.1 JP 2018019694-A/239: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAAATGTAATAG
>MA047803.1 JP 2018019694-A/238: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAA
>MA047802.1 JP 2018019694-A/237: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGGAAAAG
>MA047801.1 JP 2018019694-A/236: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAATG
>MA047800.1 JP 2018019694-A/235: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGAAAAAG
>MA047799.1 JP 2018019694-A/234: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AATGTTCAAAAG
>MA047798.1 JP 2018019694-A/233: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCCTTAG
>MA047797.1 JP 2018019694-A/232: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGTAAAGT
>MA047796.1 JP 2018019694-A/231: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAAGAACAAAGG
>MA047795.1 JP 2018019694-A/230: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAACTGCAAAAC
>MA047794.1 JP 2018019694-A/229: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACAGCAGAAG
>MA047793.1 JP 2018019694-A/228: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ACAATGCAAAAG
>MA047792.1 JP 2018019694-A/227: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGAAAAAG
>MA047791.1 JP 2018019694-A/226: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAAATGCAAAAG
>MA047790.1 JP 2018019694-A/225: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGGCTAAT
>MA047789.1 JP 2018019694-A/224: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAT
>MA047788.1 JP 2018019694-A/223: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAA
>MA047787.1 JP 2018019694-A/222: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAG
>MA047786.1 JP 2018019694-A/221: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTTTTGCTCCTG
>MA047785.1 JP 2018019694-A/220: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGAATGCCCATC
>MA047784.1 JP 2018019694-A/219: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCATCCTCAAC
>MA047783.1 JP 2018019694-A/218: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCCGCATC
>MA047782.1 JP 2018019694-A/217: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCTTGCTGTTG
>MA047781.1 JP 2018019694-A/216: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GACATCCAAATT
>MA047780.1 JP 2018019694-A/215: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATAATCCTTTTC
>MA047779.1 JP 2018019694-A/214: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCTTCCTCTTT
>MA047778.1 JP 2018019694-A/213: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GAAGTCCTCATC
>MA047777.1 JP 2018019694-A/212: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CTCATTCTGTTC
>MA047776.1 JP 2018019694-A/211: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GCCAGTCTCAGC
>MA047775.1 JP 2018019694-A/210: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CTCATGCTCATC
>MA047774.1 JP 2018019694-A/209: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTTATCCTCAGC
>MA047773.1 JP 2018019694-A/208: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTGATACTCATC
>MA047772.1 JP 2018019694-A/207: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCTTCCTCCTC
>MA047771.1 JP 2018019694-A/206: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCCTCCTC
>MA047770.1 JP 2018019694-A/205: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCAACCTCAAC
>MA047769.1 JP 2018019694-A/204: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTTTTGCACATT
>MA047768.1 JP 2018019694-A/203: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GGCTTCCTGACC
>MA047767.1 JP 2018019694-A/202: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCTTCCTCATT
>MA047766.1 JP 2018019694-A/201: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AACATCCACATC
>MA047765.1 JP 2018019694-A/200: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCTTCCTGATG
>MA047764.1 JP 2018019694-A/199: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATGTTCCTCATC
>MA047763.1 JP 2018019694-A/198: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCCTGCTCAGC
>MA047762.1 JP 2018019694-A/197: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
ATCATCCTCATC
>MA047761.1 JP 2018019694-A/196: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCCTCATA
>MA047760.1 JP 2018019694-A/195: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCTTCATC
>MA047759.1 JP 2018019694-A/194: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCCTCATC
>MA047758.1 JP 2018019694-A/193: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCTTCATC
>MA047757.1 JP 2018019694-A/192: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCCTCAGC
>MA047756.1 JP 2018019694-A/191: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
CTCATCCTCATC
>MA047755.1 JP 2018019694-A/190: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCCCAATC
>MA047754.1 JP 2018019694-A/189: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
TAAATCCTCATC
>MA047753.1 JP 2018019694-A/188: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCCTCATC
>MA047752.1 JP 2018019694-A/187: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTTTTCCTCATC
>MA047751.1 JP 2018019694-A/186: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCGTCCTCATC
>MA047750.1 JP 2018019694-A/185: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCCTCATC
>MA047695.1 JP 2018019694-A/130: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAG
>MA047694.1 JP 2018019694-A/129: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCCTCATC
>MA047691.1 JP 2018019694-A/126: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAG
>MA047689.1 JP 2018019694-A/124: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GATGAGGATGAC
>MA047604.1 JP 2018019694-A/39: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAG
>MA047603.1 JP 2018019694-A/38: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCCTCATC
>MA047602.1 JP 2018019694-A/37: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GATGAGGATGAC
>MA047601.1 JP 2018019694-A/36: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAG
>MA047600.1 JP 2018019694-A/35: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAG
>MA047598.1 JP 2018019694-A/33: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GATGAGGATGAC
>MA047597.1 JP 2018019694-A/32: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GATGAGGATGAC
>MA047579.1 JP 2018019694-A/14: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGGAAAAA
>MA047578.1 JP 2018019694-A/13: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAAATGGAACAG
>MA047577.1 JP 2018019694-A/12: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGGAAAAG
>MA047576.1 JP 2018019694-A/11: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GATACAGATGAC
>MA047575.1 JP 2018019694-A/10: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GCTGAGGATAAC
>MA047574.1 JP 2018019694-A/9: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GATGAGGCACGA
>MA047573.1 JP 2018019694-A/8: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GATGAGGGGCGA
>MA047572.1 JP 2018019694-A/7: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GATGAGGATGAC
>MA047571.1 JP 2018019694-A/6: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
AAACTGCAAAAG
>MA047570.1 JP 2018019694-A/5: EVALUATION AND IMPROVEMENT OF NUCLEASE CLEAVAGE SPECIFICITY
GTCATCCTCATC
>MA091911.1 JP 2018016633-A/41: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
GATATCCTGCAG
>MA091872.1 JP 2018016633-A/2: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
GCCTGGCTTAGC
>MA091871.1 JP 2018016633-A/1: Production and Utilization of A Novel Anti-Cancer Drug In Therapy
GCTAAGCCAGGC
>MA091782.1 JP 2018023391-A/34111: Genetic Polymorphisms Associated with Liver Fibrosis Methods of Detection and Uses Thereof
CGCGGCCGAAGG
>MA091781.1 JP 2018023391-A/34110: Genetic Polymorphisms Associated with Liver Fibrosis Methods of Detection and Uses Thereof
CGCGGCCGAAGC
>LQ714067.1 Sequence 9 from Patent WO2018005289
GTACTAGTACTA
>LQ712074.1 Sequence 26 from Patent WO2018001858
CCACTCTAAACG
>LQ712073.1 Sequence 25 from Patent WO2018001858
GCCACTCTAAAC
>LQ712062.1 Sequence 14 from Patent WO2018001858
CCCTCCACACTG
>LQ712061.1 Sequence 13 from Patent WO2018001858
GCCCTCCACACT
>LQ712840.1 Sequence 3 from Patent WO2017129365
TCACCGTAAAGG
>LQ711127.1 Sequence 2617 from Patent EP3215623
ATCCAGCGTGAG
>LQ707765.1 Sequence 3 from Patent WO2018006022
ACGTCACATTTC
>LP995808.1 Sequence 3 from Patent WO2017134100
GGATCCGCCACC
>LP995420.1 Sequence 183 from Patent EP3216879
CCTCTGACACAT
>LP995407.1 Sequence 170 from Patent EP3216879
ATCAGAGGCTAC
>LP995405.1 Sequence 168 from Patent EP3216879
CTGCAGCAGAAT
>LP992719.1 Sequence 9 from Patent WO2018005782
GTACTAGTACTA
>LP956435.1 Sequence 20 from Patent WO2017216340
GGCATGAGCTTC
>LP778584.1 Sequence 3 from Patent WO2018020024
GCCTACGACAGA
>LP777547.1 Sequence 11 from Patent WO2018020050
GTTTTAGAGCTA
>LP838421.1 Sequence 1 from Patent EP3198036
GAAAGTGAAAGT
>LP897555.1 Sequence 30 from Patent EP3180430
TGCGCACCCTTA
>LP834566.1 Sequence 71 from Patent WO2017109087
AGCAGGAGCGGC
>LP834565.1 Sequence 70 from Patent WO2017109087
GCCGCTCCTGCT
>LP834564.1 Sequence 69 from Patent WO2017109087
GGCGGCTGGTGC
>LP834563.1 Sequence 68 from Patent WO2017109087
GCCGCTCCTGCT
>LP769284.1 Sequence 8 from Patent WO2018053209
CTCTTATTTCCC
>LP769283.1 Sequence 7 from Patent WO2018053209
GGGAAATAAGAG
>LP769277.1 Sequence 1 from Patent WO2018053209
CTCTTATTTCCC
>LP948195.1 Sequence 22 from Patent EP3238727
TGCATCGATGCA
>LP830899.1 Sequence 94 from Patent EP3257859
CCTACGATGCAT
>LP889097.1 Sequence 42 from Patent WO2017199038
GAGCCCGAGGCC
>LP944220.1 Sequence 13 from Patent EP3202897
GGTGGCGGATCT
>LP944171.1 Sequence 73 from Patent EP3228187
AAGGAAGTTTAA
>LP943993.1 Sequence 3 from Patent EP3202783
GGATCCGCCACC
>LP943983.1 Sequence 11 from Patent EP3202905
TGGTCCAGAGCC
>LP887985.1 Sequence 25 from Patent WO2017201497
TTGAAGGTGAGG
>LP887966.1 Sequence 6 from Patent WO2017201497
GGAGTGCAGTGG
>LP887768.1 Sequence 69 from Patent WO2017201073
TTTGCTTGCTCT
>LP887767.1 Sequence 68 from Patent WO2017201073
GATGCCTGCTCT
>LP887766.1 Sequence 67 from Patent WO2017201073
ATTCGGTGCTCT
>LP887765.1 Sequence 66 from Patent WO2017201073
GTTCAATGCTCT
>LP887764.1 Sequence 65 from Patent WO2017201073
TCCTGTCGGTTC
>LP887763.1 Sequence 64 from Patent WO2017201073
AGGCATCGTCCT
>LP887762.1 Sequence 63 from Patent WO2017201073
AGGCATTTGCAC
>LP887761.1 Sequence 62 from Patent WO2017201073
AGGCATACCTAC
>LP887760.1 Sequence 61 from Patent WO2017201073
AGGCATTTCTAC
>LP887759.1 Sequence 60 from Patent WO2017201073
AGGCATTGCTCT
>LP887758.1 Sequence 59 from Patent WO2017201073
AGGCATTGTGCT
>LP887757.1 Sequence 58 from Patent WO2017201073
AGGCATGCGATG
>LP887756.1 Sequence 57 from Patent WO2017201073
CTTTTCTGACCT
>LP887755.1 Sequence 56 from Patent WO2017201073
CTTTTCCGTCCT
>LP887754.1 Sequence 55 from Patent WO2017201073
CTTTTCGTACCT
>LP887753.1 Sequence 54 from Patent WO2017201073
CTTTTCGTTCCT
>LP887752.1 Sequence 53 from Patent WO2017201073
CTTTTCACTCCT
>LP887751.1 Sequence 52 from Patent WO2017201073
CTTTTCTGTCCT
>LP887750.1 Sequence 51 from Patent WO2017201073
CTTTTCTGTGCT
>LP887749.1 Sequence 50 from Patent WO2017201073
CTTTTCTGTACT
>LP887748.1 Sequence 49 from Patent WO2017201073
CTTTTCTGCTCT
>LP887747.1 Sequence 48 from Patent WO2017201073
CTTTTCGACTCT
>LP887746.1 Sequence 47 from Patent WO2017201073
CTTTTCCTCTCT
>LP887745.1 Sequence 46 from Patent WO2017201073
CTTTTCACCTCT
>LP887744.1 Sequence 45 from Patent WO2017201073
GTCATCCGTCCT
>LP887743.1 Sequence 44 from Patent WO2017201073
GTCATCTTGCCT
>LP887742.1 Sequence 43 from Patent WO2017201073
GTCATCTTGCAC
>LP887741.1 Sequence 42 from Patent WO2017201073
GTCATCACAAAC
>LP887740.1 Sequence 41 from Patent WO2017201073
GTCATCCGAAAC
>LP887739.1 Sequence 40 from Patent WO2017201073
GTCATCCGTAAC
>LP887738.1 Sequence 39 from Patent WO2017201073
GTCATCAACTAC
>LP887737.1 Sequence 38 from Patent WO2017201073
GTCATCTTCGAC
>LP887736.1 Sequence 37 from Patent WO2017201073
GTCATCACTCAC
>LP887735.1 Sequence 36 from Patent WO2017201073
GTCATCACCTAC
>LP887734.1 Sequence 35 from Patent WO2017201073
GTCATCTTCTAC
>LP887733.1 Sequence 34 from Patent WO2017201073
GTCATCGACTAC
>LP887732.1 Sequence 33 from Patent WO2017201073
GTCATCCGCTAC
>LP887731.1 Sequence 32 from Patent WO2017201073
GTCATCTCCTAC
>LP887730.1 Sequence 31 from Patent WO2017201073
CATCGCATGCCT
>LP887729.1 Sequence 30 from Patent WO2017201073
CACGAACGTCAG
>LP942124.1 Sequence 249 from Patent EP3187506
GCCTATGACTTG
>LP762846.1 Sequence 26 from Patent EP3291839
GGGGTTTTGGGG
>LP885371.1 Sequence 71 from Patent WO2017173004
GTTTTAGAGCTA
>LP885282.1 Sequence 10 from Patent WO2017172914
CTTCTTCTTCTT
>LP885278.1 Sequence 6 from Patent WO2017172914
GAAGAAGAAGAA
>LP885274.1 Sequence 2 from Patent WO2017172914
TTCTTCTTCTTC
>LP884250.1 Sequence 41 from Patent WO2017178368
TAAGTAAAGAGA
>LP756556.1 Sequence 26 from Patent WO2018026958
GGGGTTTTGGGG
>LP989982.1 Sequence 230 from Patent EP3188799
ANNNNAGNAAAA
>LP989942.1 Sequence 190 from Patent EP3188799
AGNNGGNNNAAA
>LP989923.1 Sequence 171 from Patent EP3188799
GANGNNNAGNNA
>LP989981.1 Sequence 229 from Patent EP3188799
ANNNNAGNAAAA
>LP989678.1 Sequence 72 from Patent EP3183358
CGAACAATCGTA
>LP989677.1 Sequence 71 from Patent EP3183358
CGTAACTAACGA
>LP989676.1 Sequence 70 from Patent EP3183358
TCGAATAGTCGT
>LP989675.1 Sequence 69 from Patent EP3183358
CCAGACGAATCG
>LP989674.1 Sequence 68 from Patent EP3183358
TCGTTACGACCA
>LP989673.1 Sequence 67 from Patent EP3183358
CGAAGTACTACG
>LP989672.1 Sequence 66 from Patent EP3183358
CGTACTGAACGA
>LP989671.1 Sequence 65 from Patent EP3183358
TCGATAGTACGT
>LP989670.1 Sequence 64 from Patent EP3183358
CCATACTCGTCG
>LP989669.1 Sequence 63 from Patent EP3183358
CGTCGATTACCA
>LP936933.1 Sequence 181 from Patent EP3182988
AGAGGTGACATG
>LP879612.1 Sequence 221 from Patent WO2017178119
CTGATTCTCACG
>LP754855.1 Sequence 3 from Patent EP3290531
GTATCCACATGC
>LP935613.1 Sequence 11 from Patent EP3183364
TGCGTCATAACT
>LP935612.1 Sequence 10 from Patent EP3183364
GTCGTCATAACT
>LP935611.1 Sequence 9 from Patent EP3183364
CGCCAATATTTA
>LP935606.1 Sequence 4 from Patent EP3183364
CTCTTGAGTGTG
>LP934839.2 Sequence 8 from Patent WO2017121494
GGGGGGGGGGGG
>LP934835.2 Sequence 4 from Patent WO2017121494
GGGGGGGGGGGG
>LP934832.2 Sequence 1 from Patent WO2017121494
TAGGGTTAGGGT
>LP934093.1 Sequence 42 from Patent EP3205352
TATCCCCGGGAC
>LP751177.1 Sequence 19 from Patent EP3272865
ATGTCTATGTTC
>LP874568.1 Sequence 2 from Patent WO2017103593
ATGCCGTCTGAA
>LP814866.1 Sequence 4 from Patent WO2018049362
TTTGTANNTTTG
>LP749779.1 Sequence 4 from Patent EP3293292
GTAATTGGATCC
>LP749778.1 Sequence 3 from Patent EP3293292
GGGTTTAATTAC
>LP931133.1 Sequence 109 from Patent EP3224347
GGTGACGTCACC
>LP931131.1 Sequence 107 from Patent EP3224347
GGTGACGTCAGC
>LP814316.1 Sequence 2 from Patent WO2018046521
CGTATGTGCAAT
>LP813791.1 Sequence 98 from Patent EP3308788
ATTCACTTTCAT
>LP813790.1 Sequence 97 from Patent EP3308788
TTCACTTTCATA
>LP813789.1 Sequence 96 from Patent EP3308788
TCACTTTCATAA
>LP813787.1 Sequence 94 from Patent EP3308788
CACTTTCATAAT
>LP813785.1 Sequence 92 from Patent EP3308788
ACTTTCATAATG
>LP813783.1 Sequence 90 from Patent EP3308788
CTTTCATAATGC
>LP813781.1 Sequence 88 from Patent EP3308788
TTTCATAATGCT
>LP813779.1 Sequence 86 from Patent EP3308788
TTCATAATGCTG
>LP813777.1 Sequence 84 from Patent EP3308788
TCATAATGCTGG
>LP813769.1 Sequence 76 from Patent EP3308788
CCTTAATTTAAG
>LP813768.1 Sequence 75 from Patent EP3308788
CTTAATTTAAGG
>LP813767.1 Sequence 74 from Patent EP3308788
TTAATTTAAGGA
>LP813765.1 Sequence 72 from Patent EP3308788
TAATTTAAGGAA
>LP813763.1 Sequence 70 from Patent EP3308788
AATTTAAGGAAT
>LP813761.1 Sequence 68 from Patent EP3308788
ATTTAAGGAATG
>LP813759.1 Sequence 66 from Patent EP3308788
TTTAAGGAATGT
>LP813756.1 Sequence 63 from Patent EP3308788
TTAAGGAATGTG
>LP813753.1 Sequence 60 from Patent EP3308788
TAAGGAATGTGA
>LP813750.1 Sequence 57 from Patent EP3308788
AAGGAATGTGAG
>LP813741.1 Sequence 48 from Patent EP3308788
TCTTTTTGATTT
>LP813740.1 Sequence 47 from Patent EP3308788
CTTTTTGATTTT
>LP813738.1 Sequence 45 from Patent EP3308788
TTTTTGATTTTG
>LP813737.1 Sequence 44 from Patent EP3308788
TTTTGATTTTGT
>LP813735.1 Sequence 42 from Patent EP3308788
TTTGATTTTGTC
>LP813733.1 Sequence 40 from Patent EP3308788
TTGATTTTGTCT
>LP813732.1 Sequence 39 from Patent EP3308788
TGATTTTGTCTA
>LP813728.1 Sequence 35 from Patent EP3308788
GATTTTGTCTAA
>LP813726.1 Sequence 33 from Patent EP3308788
ATTTTGTCTAAA
>LP813724.1 Sequence 31 from Patent EP3308788
TTTTGTCTAAAA
>LP871804.1 Sequence 7 from Patent EP3255144
AACGACAGCGTT
>LP871803.1 Sequence 6 from Patent EP3255144
AAAGAAAGAGTT
>LP813714.1 Sequence 21 from Patent EP3308788
ATATAGATATAG
>LP813713.1 Sequence 20 from Patent EP3308788
TATAGATATAGA
>LP813712.1 Sequence 19 from Patent EP3308788
ATAGATATAGAT
>LP813710.1 Sequence 17 from Patent EP3308788
TAGATATAGATA
>LP813708.1 Sequence 15 from Patent EP3308788
AGATATAGATAG
>LP813706.1 Sequence 13 from Patent EP3308788
GATATAGATAGC
>LP813704.1 Sequence 11 from Patent EP3308788
ATATAGATAGCT
>LP813702.1 Sequence 9 from Patent EP3308788
TATAGATAGCTA
>LP813700.1 Sequence 7 from Patent EP3308788
ATAGATAGCTAT
>LP813386.1 Sequence 1 from Patent EP3309154
CTTGGGATGAAC
>LP811460.1 Sequence 458 from Patent EP3283169
GATCTTGACTTG
>LP811420.1 Sequence 418 from Patent EP3283169
GATCTTGACTTG
>LP871369.1 Sequence 74 from Patent EP3255155
GTGGGCCATTAC
>LP928523.1 Sequence 1 from Patent EP3224359
CGANNNNNNTGC
>LP869629.1 Sequence 2 from Patent EP3222723
GCCTGGCTTAGC
>LP869628.1 Sequence 1 from Patent EP3222723
GCTAAGCCAGGC
>LP810414.1 Sequence 818 from Patent EP3283168
AATCTAGAGATC
>LP810374.1 Sequence 778 from Patent EP3283168
AATTTTGAGTTG
>LP810334.1 Sequence 738 from Patent EP3283168
AATTTTGACTTG
>LP868725.1 Sequence 6 from Patent WO2017165289
CGATCATGATCG
>LP868720.1 Sequence 1 from Patent WO2017165289
CGATCATGATCG
>LP868670.1 Sequence 178 from Patent EP3222715
GAAGTCTGCCGT
>LP868649.1 Sequence 157 from Patent EP3222715
AAAGCGGCTCCG
>LP868644.1 Sequence 152 from Patent EP3222715
ACTCTGTGGAAG
>LP868606.1 Sequence 114 from Patent EP3222715
ACTCTGTGGAAG
>LP868576.1 Sequence 84 from Patent EP3222715
AACTCGGATAAT
>LP868565.1 Sequence 73 from Patent EP3222715
AAGGTGAACGTG
>LP868560.1 Sequence 68 from Patent EP3222715
GGGCAGTAACGG
>LP868545.1 Sequence 53 from Patent EP3222715
TACAAGAACTCG
>LP868535.1 Sequence 43 from Patent EP3222715
AACTCGGATAAT
>LP868524.1 Sequence 32 from Patent EP3222715
GCGGCGCCGGCG
>LP868519.1 Sequence 27 from Patent EP3222715
CATGGGGTTCCT
>LP868449.1 Sequence 2 from Patent WO2017163186
TTTTGCCGCGCC
>LP868035.1 Sequence 15 from Patent WO2017162704
AGCAAAAGCAGG
>LP809124.1 Sequence 2 from Patent EP3284752
ACATCACTCCGT
>LP745413.1 Sequence 4 from Patent EP3286339
TCTCGTACGTAC
>LP745411.1 Sequence 2 from Patent EP3286339
TCTCGTACGTAC
>LP866565.1 Sequence 35 from Patent WO2017138924
CCGCGGATCGCC
>LP866544.1 Sequence 14 from Patent WO2017138924
CTGCCCGCGGAT
>LP745013.1 Sequence 204 from Patent EP3274476
GCCACCCCACTC
>LP744983.1 Sequence 174 from Patent EP3274476
GAGCCAAACGCC
>LP744965.1 Sequence 156 from Patent EP3274476
AGAACCAGCAGC
>LP744944.1 Sequence 135 from Patent EP3274476
TCCAGCAGAGCT
>LP744899.1 Sequence 90 from Patent EP3274476
TGCGGGTACTGG
>LP744833.1 Sequence 24 from Patent EP3274476
CAGCGTTCCCGG
>LP744608.1 Sequence 14 from Patent EP3286305
GGTGGGGNTCCC
>LP744604.1 Sequence 10 from Patent EP3286305
ACTNTANANCTG
>LP744537.1 Sequence 16 from Patent EP3286336
AGGAGGAAGATG
>LP808214.1 Sequence 9 from Patent EP3283635
GACNNNNNNGTC
>LP808213.1 Sequence 8 from Patent EP3283635
CCANNNNNNTGG
>LP808208.1 Sequence 3 from Patent EP3283635
CGANNNNNNTGC
>LP923609.1 Sequence 10 from Patent EP3200825
TGGGTCTCTCTG
>LP923608.1 Sequence 9 from Patent EP3200825
CTTTTTGCCTGT
>LP807784.1 Sequence 9 from Patent EP3265587
CATTCAATACCC
>LP865200.1 Sequence 35 from Patent WO2017138925
CCGCGGATCGCC
>LP865179.1 Sequence 14 from Patent WO2017138925
CTGCCCGCGGAT
>LP742688.1 Sequence 108 from Patent EP3298171
CTGAGTCGGAGB
>LP742680.1 Sequence 100 from Patent EP3298171
CTGAGTCGGAHB
>LP742670.1 Sequence 90 from Patent EP3298171
CTGAGTCGGAGB
>LP742660.1 Sequence 80 from Patent EP3298171
CTGAGTCGGAGA
>LP742650.1 Sequence 70 from Patent EP3298171
CTGAGTCGGAGB
>LP742642.1 Sequence 62 from Patent EP3298171
CTGAGTCGGAHB
>LP742633.1 Sequence 53 from Patent EP3298171
CTGAGTCGGAGB
>LP742625.1 Sequence 45 from Patent EP3298171
CTGAGTCGGAGA
>LP742616.1 Sequence 36 from Patent EP3298171
GATCGGAAGAGD
>LP742612.1 Sequence 32 from Patent EP3298171
GATCGGAAGAHD
>LP742606.1 Sequence 26 from Patent EP3298171
GATCGGAAGAGD
>LP742600.1 Sequence 20 from Patent EP3298171
GATCGGAAGAGC
>LP742595.1 Sequence 15 from Patent EP3298171
GATCGGAAGAGD
>LP742591.1 Sequence 11 from Patent EP3298171
GATCGGAAGAHD
>LP742586.1 Sequence 6 from Patent EP3298171
GATCGGAAGAGD
>LP742584.1 Sequence 4 from Patent EP3298171
GATCGGAAGAGC
>LP921369.1 Sequence 76 from Patent EP3227476
AGGAGAAGGAGA
>LP921368.1 Sequence 75 from Patent EP3227476
CTCCATAACCCA
>LP920804.1 Sequence 6 from Patent EP3240795
CAGCCAGGATAG
>LP740089.1 Sequence 1 from Patent EP3298151
ATCAACACTGCA
>LP805434.1 Sequence 4 from Patent EP3265561
ACATTGCAGTTC
>LP805433.1 Sequence 3 from Patent EP3265561
TCTTTTGGTGCA
>LP804058.1 Sequence 70 from Patent EP3305323
TGGGTCCTGTCC
>LP803947.1 Sequence 18 from Patent EP3305903
GGGTCGCCACGT
>LP803945.1 Sequence 16 from Patent EP3305903
CTATTCTATGGT
>LP803942.1 Sequence 13 from Patent EP3305903
ATACCAACGGCT
>LP803937.1 Sequence 8 from Patent EP3305903
TTGTAATGATGA
>LP803936.1 Sequence 7 from Patent EP3305903
TTGTARTGATGW
>LP804204.1 Sequence 23 from Patent EP3305302
ATTCACTTTCAT
>LP804203.1 Sequence 22 from Patent EP3305302
TTCACTTTCATA
>LP804202.1 Sequence 21 from Patent EP3305302
TCACTTTCATAA
>LP804200.1 Sequence 19 from Patent EP3305302
CACTTTCATAAT
>LP804198.1 Sequence 17 from Patent EP3305302
ACTTTCATAATG
>LP804196.1 Sequence 15 from Patent EP3305302
CTTTCATAATGC
>LP804194.1 Sequence 13 from Patent EP3305302
TTTCATAATGCT
>LP804192.1 Sequence 11 from Patent EP3305302
TTCATAATGCTG
>LP804190.1 Sequence 9 from Patent EP3305302
TCATAATGCTGG
>LP983121.1 Sequence 152 from Patent WO2017143042
TCTTCCGAGCAG
>LP983111.1 Sequence 142 from Patent WO2017143042
TCTTCCGAGCAG
>LP983110.1 Sequence 141 from Patent WO2017143042
CTGCTCGGAAGA
>LP982991.1 Sequence 22 from Patent WO2017143042
TCTCTTTCTTTC
>LP982990.1 Sequence 21 from Patent WO2017143042
CTTTCTTTCTCT
>LP982984.1 Sequence 15 from Patent WO2017143042
GAAAGAAAGAGA
>LP982947.1 Sequence 152 from Patent WO2017143061
TCTTCCGAGCAG
>LP982937.1 Sequence 142 from Patent WO2017143061
TCTTCCGAGCAG
>LP982936.1 Sequence 141 from Patent WO2017143061
CTGCTCGGAAGA
>LP982818.1 Sequence 22 from Patent WO2017143061
TCTCTTTCTTTC
>LP982817.1 Sequence 21 from Patent WO2017143061
CTTTCTTTCTCT
>LP982811.1 Sequence 15 from Patent WO2017143061
GAAAGAAAGAGA
>LP801002.1 Sequence 16 from Patent EP3307786
GAAGCAGTGGTA
>LP860333.1 Sequence 21 from Patent EP3248618
ACCGGTGCTCGC
>LP736261.1 Sequence 120 from Patent EP3303610
GGCGGTGGTGGT
>LP735488.1 Sequence 86 from Patent EP3302574
GGAGGAGGAGGA
>LP735487.1 Sequence 85 from Patent EP3302574
GGTGGAGGAGGA
>LP735486.1 Sequence 84 from Patent EP3302574
GGAGGTGGAGGA
>LP735485.1 Sequence 83 from Patent EP3302574
GGAGGAGGTGGA
>LP735484.1 Sequence 82 from Patent EP3302574
GGAGGAGGAGGT
>LP735483.1 Sequence 81 from Patent EP3302574
GGAGGTGGAGGT
>LP735482.1 Sequence 80 from Patent EP3302574
GGAGGAGGTGGT
>LP735481.1 Sequence 79 from Patent EP3302574
GGAGGTGGTGGA
>LP735480.1 Sequence 78 from Patent EP3302574
GGTGGAGGAGGT
>LP735479.1 Sequence 77 from Patent EP3302574
GGTGGAGGTGGA
>LP735478.1 Sequence 76 from Patent EP3302574
GGTGGTGGAGGA
>LP859366.1 Sequence 29 from Patent WO2017140815
CATTCTGGACTG
>LP859345.1 Sequence 8 from Patent WO2017140815
CATTCTGACGAG
>LP859343.1 Sequence 6 from Patent WO2017140815
CTCGTCAGAATG
>LP733985.1 Sequence 148 from Patent EP3262196
AGCGGGGGGGCA
>LP733983.1 Sequence 146 from Patent EP3262196
AGTGGGGGGGCG
>LP733981.1 Sequence 144 from Patent EP3262196
AGTGGGGGGGCA
>LP914332.1 Sequence 68 from Patent WO2017155973
GGTGACGTGTAC
>LP914331.1 Sequence 67 from Patent WO2017155973
GGTGACGTGTAC
>LP914330.1 Sequence 66 from Patent WO2017155973
GGTGACGTGTAC
>LP914327.1 Sequence 63 from Patent WO2017155973
CATTCCCAGACG
>LP914320.1 Sequence 56 from Patent WO2017155973
CATTCCCAGACG
>LP859341.1 Sequence 4 from Patent WO2017140815
CATTCAGGATCG
>LP976016.1 Sequence 18 from Patent EP3231871
CTAGTCCTAGGA
>LP914302.1 Sequence 38 from Patent WO2017155973
CATTCCCAGACG
>LP914295.1 Sequence 31 from Patent WO2017155973
CATTCCCAGACG
>LP858717.1 Sequence 1 from Patent WO2017144908
AGCAAAAGCAGG
>LP857371.1 Sequence 137 from Patent WO2017147294
CGATACTGGAAG
>LP857370.1 Sequence 136 from Patent WO2017147294
TCACACATGAAG
>LP857369.1 Sequence 135 from Patent WO2017147294
AGACGAGTGAAG
>LP857368.1 Sequence 134 from Patent WO2017147294
ACTGACTGGAAG
>LP857367.1 Sequence 133 from Patent WO2017147294
GTCACGCGCAGA
>LP857366.1 Sequence 132 from Patent WO2017147294
ATAGTCGACAGA
>LP857365.1 Sequence 131 from Patent WO2017147294
GATAGAGACAGA
>LP857364.1 Sequence 130 from Patent WO2017147294
ATAGATGCCAGA
>LP857363.1 Sequence 129 from Patent WO2017147294
TCTACTATCAGA
>LP857362.1 Sequence 128 from Patent WO2017147294
CTCGTATACAGA
>LP857361.1 Sequence 127 from Patent WO2017147294
ACGCGCGTCAGA
>LP857360.1 Sequence 126 from Patent WO2017147294
GCAGATGCCAGA
>LP857359.1 Sequence 125 from Patent WO2017147294
ATGTAGCACAGA
>LP857358.1 Sequence 124 from Patent WO2017147294
ACGCTGTCCAGA
>LP857357.1 Sequence 123 from Patent WO2017147294
CTATGTGTCAGA
>LP857356.1 Sequence 122 from Patent WO2017147294
GCGTCTGTCAGA
>LP857355.1 Sequence 121 from Patent WO2017147294
ATGTCAGACAGA
>LP857354.1 Sequence 120 from Patent WO2017147294
TAGATAGCCAGA
>LP857353.1 Sequence 119 from Patent WO2017147294
AGATGCTACAGA
>LP857352.1 Sequence 118 from Patent WO2017147294
ATCTATGCCAGA
>LP857351.1 Sequence 117 from Patent WO2017147294
CTATGCGCGTTC
>LP857350.1 Sequence 116 from Patent WO2017147294
ACATGTCGGTTC
>LP857349.1 Sequence 115 from Patent WO2017147294
TATGCTGTGTTC
>LP857348.1 Sequence 114 from Patent WO2017147294
AGACGTGCGTTC
>LP857347.1 Sequence 113 from Patent WO2017147294
CGATACTGCCAG
>LP857346.1 Sequence 112 from Patent WO2017147294
TCACACATCCAG
>LP857345.1 Sequence 111 from Patent WO2017147294
AGACGAGTCCAG
>LP857344.1 Sequence 110 from Patent WO2017147294
ACTGACTGCCAG
>LP857343.1 Sequence 109 from Patent WO2017147294
GTCACGCGCTAA
>LP857342.1 Sequence 108 from Patent WO2017147294
ATAGTCGACTAA
>LP857341.1 Sequence 107 from Patent WO2017147294
GATAGAGACTAA
>LP857340.1 Sequence 106 from Patent WO2017147294
ATAGATGCCTAA
>LP857339.1 Sequence 105 from Patent WO2017147294
TCTACTATGAAG
>LP857338.1 Sequence 104 from Patent WO2017147294
CTCGTATAGAAG
>LP857337.1 Sequence 103 from Patent WO2017147294
ACGCGCGTGAAG
>LP857336.1 Sequence 102 from Patent WO2017147294
GCAGATGCGAAG
>LP857335.1 Sequence 101 from Patent WO2017147294
ATGTAGCACCAG
>LP857334.1 Sequence 100 from Patent WO2017147294
ACGCTGTCCCAG
>LP857333.1 Sequence 99 from Patent WO2017147294
CTATGTGTCCAG
>LP857332.1 Sequence 98 from Patent WO2017147294
GCGTCTGTCCAG
>LP857331.1 Sequence 97 from Patent WO2017147294
ATGTCAGAGGTC
>LP857330.1 Sequence 96 from Patent WO2017147294
TAGATAGCGGTC
>LP857329.1 Sequence 95 from Patent WO2017147294
AGATGCTAGGTC
>LP857328.1 Sequence 94 from Patent WO2017147294
ATCTATGCGGTC
>LP857327.1 Sequence 93 from Patent WO2017147294
CTATGCGCGGTC
>LP857326.1 Sequence 92 from Patent WO2017147294
ACATGTCGGGTC
>LP857325.1 Sequence 91 from Patent WO2017147294
TATGCTGTGGTC
>LP857324.1 Sequence 90 from Patent WO2017147294
AGACGTGCGGTC
>LP856376.1 Sequence 29 from Patent WO2017141067
CATTCTGGACTG
>LP911286.1 Sequence 21 from Patent EP3234158
ACCGCCGCTGCC
>LP911175.1 Sequence 76 from Patent EP3234138
ACCGCCGCTGCC
>LP856355.1 Sequence 8 from Patent WO2017141067
CATTCTGACGAG
>LP856353.1 Sequence 6 from Patent WO2017141067
CTCGTCAGAATG
>LP856351.1 Sequence 4 from Patent WO2017141067
CATTCAGGATCG
>LP732540.1 Sequence 960 from Patent WO2018003727
GGTGTTCCACTG
>LP732539.1 Sequence 959 from Patent WO2018003727
GGCCATCATCAG
>LP732538.1 Sequence 958 from Patent WO2018003727
GATAGATCGCAT
>LP732537.1 Sequence 957 from Patent WO2018003727
GAGACTGCACTC
>LP732536.1 Sequence 956 from Patent WO2018003727
CGTCGATCATCA
>LP732535.1 Sequence 955 from Patent WO2018003727
GCGCGCTTATGA
>LP732534.1 Sequence 954 from Patent WO2018003727
GGTTGGATCAAC
>LP732533.1 Sequence 953 from Patent WO2018003727
AAGAGCTGTGCC
>LP732532.1 Sequence 952 from Patent WO2018003727
GTTCGATGATGG
>LP732531.1 Sequence 951 from Patent WO2018003727
ACGATACGTGGA
>LP732530.1 Sequence 950 from Patent WO2018003727
ACGATCATAGCC
>LP732529.1 Sequence 949 from Patent WO2018003727
TGCTCAGTAACA
>LP732528.1 Sequence 948 from Patent WO2018003727
TGCTCATTACGG
>LP732527.1 Sequence 947 from Patent WO2018003727
CGCTAGGATCAC
>LP732526.1 Sequence 946 from Patent WO2018003727
CTGGTACCACGT
>LP732525.1 Sequence 945 from Patent WO2018003727
CAAGTGTGATGA
>LP732524.1 Sequence 944 from Patent WO2018003727
TGTTAAGTTGGA
>LP732523.1 Sequence 943 from Patent WO2018003727
CGCATGTTGTGC
>LP732522.1 Sequence 942 from Patent WO2018003727
TTCGCAGTTCCT
>LP732521.1 Sequence 941 from Patent WO2018003727
AACATGGATACG
>LP732520.1 Sequence 940 from Patent WO2018003727
GTCGATATATGG
>LP732519.1 Sequence 939 from Patent WO2018003727
TTGGTCACACGC
>LP732518.1 Sequence 938 from Patent WO2018003727
AGACGGTCTAGT
>LP732517.1 Sequence 937 from Patent WO2018003727
TCTATGTAGACG
>LP732516.1 Sequence 936 from Patent WO2018003727
AAGGCTAATGTC
>LP732515.1 Sequence 935 from Patent WO2018003727
AGAGCGTACACG
>LP732514.1 Sequence 934 from Patent WO2018003727
GAATCTTCCGCG
>LP972393.1 Sequence 13 from Patent EP3240910
TTAGGGTTAGGG
>LP971917.1 Sequence 83 from Patent EP3216878
AAAAAAAAAAAA
>LP732513.1 Sequence 933 from Patent WO2018003727
GTTGCTCACGTG
>LP910597.1 Sequence 2 from Patent EP3218519
ATGATGATGATG
>LP795192.1 Sequence 46 from Patent EP3259354
AAAGAGGAGAAA
>LP732512.1 Sequence 932 from Patent WO2018003727
AACCGGCTGTCT
>LP732511.1 Sequence 931 from Patent WO2018003727
CGCAGGACGATT
>LP732510.1 Sequence 930 from Patent WO2018003727
AGCTTAGGTATG
>LP732509.1 Sequence 929 from Patent WO2018003727
GTCAACGCTAAG
>LP732508.1 Sequence 928 from Patent WO2018003727
ACGCTGTTAGCA
>LP732507.1 Sequence 927 from Patent WO2018003727
CAGTTGTGCTAT
>LP732506.1 Sequence 926 from Patent WO2018003727
ACTAACGCGACT
>LP732505.1 Sequence 925 from Patent WO2018003727
GGTGGAACCATG
>LP732504.1 Sequence 924 from Patent WO2018003727
ATTAAGCCTAAG
>LP732503.1 Sequence 923 from Patent WO2018003727
CACCTGCACGAT
>LP732502.1 Sequence 922 from Patent WO2018003727
TTCTCGTGTGCG
>LP732501.1 Sequence 921 from Patent WO2018003727
CTAAGACTTAAG
>LP732500.1 Sequence 920 from Patent WO2018003727
TGCCGAGACTTC
>LP732499.1 Sequence 919 from Patent WO2018003727
CTTGGCATGTAC
>LP732498.1 Sequence 918 from Patent WO2018003727
TGAGTAGGTCAG
>LP732497.1 Sequence 917 from Patent WO2018003727
TAGTCAACGTAG
>LP732496.1 Sequence 916 from Patent WO2018003727
CGTCAACGTGGT
>LP732495.1 Sequence 915 from Patent WO2018003727
CTCGATATAGTT
>LP732494.1 Sequence 914 from Patent WO2018003727
TACCGTCAAGTG
>LP732493.1 Sequence 913 from Patent WO2018003727
ACCGTCGCTTGA
>LP732492.1 Sequence 912 from Patent WO2018003727
AGGCATCCGTTG
>LP732491.1 Sequence 911 from Patent WO2018003727
ACGTCGGAAGGT
>LP732490.1 Sequence 910 from Patent WO2018003727
AATTGGCTATAG
>LP732489.1 Sequence 909 from Patent WO2018003727
TGTCTGTATCAT
>LP732488.1 Sequence 908 from Patent WO2018003727
TCCATCAGATAA
>LP732487.1 Sequence 907 from Patent WO2018003727
GGAAGTGATTAA
>LP732486.1 Sequence 906 from Patent WO2018003727
ACACACTTCTAG
>LP732485.1 Sequence 905 from Patent WO2018003727
GGTTACCGAGGA
>LP732484.1 Sequence 904 from Patent WO2018003727
TACCTGGTCGGT
>LP732483.1 Sequence 903 from Patent WO2018003727
TTCGCGTTATTG
>LP732482.1 Sequence 902 from Patent WO2018003727
AGAAGTCGCCTC
>LP732481.1 Sequence 901 from Patent WO2018003727
GGTTATGAAGAA
>LP732480.1 Sequence 900 from Patent WO2018003727
GCAGAATTGCGA
>LP732479.1 Sequence 899 from Patent WO2018003727
AGTTCGCATACA
>LP732478.1 Sequence 898 from Patent WO2018003727
TAAGGCTGACAT
>LP732477.1 Sequence 897 from Patent WO2018003727
ACTGAGGCGTTC
>LP732476.1 Sequence 896 from Patent WO2018003727
AGTCAAGAGATT
>LP732475.1 Sequence 895 from Patent WO2018003727
GCCTCTGGTAAC
>LP732474.1 Sequence 894 from Patent WO2018003727
CATCCACTAATC
>LP732473.1 Sequence 893 from Patent WO2018003727
ATGTCGATCTAG
>LP732472.1 Sequence 892 from Patent WO2018003727
TTCCTCGTGGTT
>LP732471.1 Sequence 891 from Patent WO2018003727
ATATATCTCAGC
>LP732470.1 Sequence 890 from Patent WO2018003727
TAAGATGCTTGA
>LP732469.1 Sequence 889 from Patent WO2018003727
CCTGTTCTGATT
>LP732468.1 Sequence 888 from Patent WO2018003727
CGCATGTATGCC
>LP732467.1 Sequence 887 from Patent WO2018003727
GTGTTGCTACCA
>LP732466.1 Sequence 886 from Patent WO2018003727
TTACGTCCGCAA
>LP732465.1 Sequence 885 from Patent WO2018003727
TCTCTAGTTCGG
>LP732464.1 Sequence 884 from Patent WO2018003727
TGCTAACTCTCC
>LP732463.1 Sequence 883 from Patent WO2018003727
TTGTCACAACTC
>LP732462.1 Sequence 882 from Patent WO2018003727
CTGCATGCATAA
>LP732461.1 Sequence 881 from Patent WO2018003727
AATACTGGCTAA
>LP732460.1 Sequence 880 from Patent WO2018003727
AGAGCCAGTCGT
>LP732459.1 Sequence 879 from Patent WO2018003727
CTACTGGCACAA
>LP732458.1 Sequence 878 from Patent WO2018003727
TCGCTAATGTAG
>LP732457.1 Sequence 877 from Patent WO2018003727
ATTGAGAGCTAT
>LP732456.1 Sequence 876 from Patent WO2018003727
TTGTGCTGGACT
>LP732455.1 Sequence 875 from Patent WO2018003727
TGGATCCTTCAT
>LP732454.1 Sequence 874 from Patent WO2018003727
CTGCATTCACGA
>LP732453.1 Sequence 873 from Patent WO2018003727
GCGGTCACATAT
>LP732452.1 Sequence 872 from Patent WO2018003727
CCTACCTGTGGA
>LP732451.1 Sequence 871 from Patent WO2018003727
GACGCATACCTC
>LP732450.1 Sequence 870 from Patent WO2018003727
GTGCTTCAGGAG
>LP732449.1 Sequence 869 from Patent WO2018003727
TAGTGGTCGTCA
>LP732448.1 Sequence 868 from Patent WO2018003727
TATACTACAAGC
>LP732447.1 Sequence 867 from Patent WO2018003727
CTTAAGGAGCGC
>LP732446.1 Sequence 866 from Patent WO2018003727
ATACTCCGAGAT
>LP732445.1 Sequence 865 from Patent WO2018003727
GCTGTTGAACCG
>LP795058.1 Sequence 1 from Patent WO2018069470
CTTGGGATGAAC
>LP852854.1 Sequence 134 from Patent WO2017191076
GGAAGGGCATTT
>LP852833.1 Sequence 113 from Patent WO2017191076
TAAGCAAGCAGG
>LP852832.1 Sequence 112 from Patent WO2017191076
TAAGCAAGCAGG
>LP852825.1 Sequence 105 from Patent WO2017191076
TGACCTAAGCAA
>LP852798.1 Sequence 78 from Patent WO2017191076
TATCCAGCTGAG
>LP852797.1 Sequence 77 from Patent WO2017191076
TATCCAGCTGAG
>LP852795.1 Sequence 75 from Patent WO2017191076
ATATGATAGATT
>LP852794.1 Sequence 74 from Patent WO2017191076
ATATGATAGATT
>LP852782.1 Sequence 62 from Patent WO2017191076
CTCTATAATAAT
>LP852781.1 Sequence 61 from Patent WO2017191076
CTCTATAATAAT
>LP852764.1 Sequence 44 from Patent WO2017191076
CCTTTCGTATCT
>LP852739.1 Sequence 19 from Patent WO2017191076
GCTGATACTGAC
>LP970636.1 Sequence 71 from Patent WO2017207979
CCCCGGCCCCGG
>LP970221.1 Sequence 66 from Patent EP3250693
AAGCTTGGATCC
>LP730231.1 Sequence 20 from Patent EP3263716
GGAATTCCTGTC
>LP730214.1 Sequence 3 from Patent EP3263716
GGAATTCCTGTC
>LP729362.1 Sequence 17 from Patent EP3263707
AAAAAAGAAAAA
>LP729358.1 Sequence 13 from Patent EP3263707
CCCCCCTCCCCC
>LP968096.1 Sequence 29 from Patent EP3242939
ACTAGTACTAGT
>LP906245.1 Sequence 7 from Patent EP3192869
TCCTAAGACCGC
>LP906244.1 Sequence 6 from Patent EP3192869
TCGAGCTTGTCT
>LP792222.1 Sequence 540 from Patent WO2018033254
GGGTTTTTTGGG
>LP792212.1 Sequence 529 from Patent WO2018033254
GGTTTTTTTTGG
>LP967329.1 Sequence 26 from Patent EP3194595
CCTTGCCAAACT
>LP967328.1 Sequence 25 from Patent EP3194595
CCTTGCCAAACT
>LP967327.1 Sequence 24 from Patent EP3194595
CCTTTTCAAACT
>LP967326.1 Sequence 23 from Patent EP3194595
CCTTTACAAACT
>LP904734.1 Sequence 39 from Patent EP3230744
ACGTGGTGGTTT
>LP904726.1 Sequence 31 from Patent EP3230744
GACGAACGCACG
>LP904723.1 Sequence 28 from Patent EP3230744
GTTGGCGCGGTA
>LP904587.1 Sequence 51 from Patent EP3231866
CGGAGCNGCAGC
>LP904578.1 Sequence 42 from Patent EP3231866
CGGAGCAGCAGC
>LP904573.1 Sequence 37 from Patent EP3231866
CGGAGCTGCAGC
>LP904568.1 Sequence 32 from Patent EP3231866
CGGAGCAGCAGC
>LP904566.1 Sequence 30 from Patent EP3231866
CGGAGCAGCAGC
>LP904560.1 Sequence 24 from Patent EP3231866
CGGAGCNGCAGC
>LP904556.1 Sequence 20 from Patent EP3231866
CGGAGCNGCAGC
>LP904554.1 Sequence 18 from Patent EP3231866
CGGAGCNGCAGC
>LP904552.1 Sequence 16 from Patent EP3231866
CGNAGCGGCNGC
>LP904550.1 Sequence 14 from Patent EP3231866
GTGCGNGATCGA
>LP904546.1 Sequence 10 from Patent EP3231866
CGGAGCNGCTGC
>LP904545.1 Sequence 9 from Patent EP3231866
CGGTGCNGCAGC
>LP904542.1 Sequence 6 from Patent EP3231866
GCTGCNGCTCCG
>LP904539.1 Sequence 3 from Patent EP3231866
CGGAGCNGCAGC
>LP904520.1 Sequence 62 from Patent EP3230476
ATCGGTTTCGTT
>LP904513.1 Sequence 55 from Patent EP3230476
CGGCGTTCGCGA
>LP904504.1 Sequence 46 from Patent EP3230476
AACGTAAACCAC
>LP904497.1 Sequence 39 from Patent EP3230476
ACGTGGTGGTTT
>LP904489.1 Sequence 31 from Patent EP3230476
GACGAACGCACG
>LP904486.1 Sequence 28 from Patent EP3230476
GTTGGCGCGGTA
>LP965178.1 Sequence 4 from Patent WO2017177017
GTCAGTCAGTCA
>LP847292.1 Sequence 9 from Patent EP3222728
AGCGGCCAGGGC
>LP966373.1 Sequence 474 from Patent EP3193892
CTTTGTGTTTGA
>LP845839.1 Sequence 76 from Patent EP3246406
CAGCCCTACACT
>LP845836.1 Sequence 73 from Patent EP3246406
GCTACCTGGACT
>LP845777.1 Sequence 14 from Patent EP3246406
ACCAAACAAGAG
>LP845776.1 Sequence 13 from Patent EP3246406
ACCAGACAAGAG
>LP845775.1 Sequence 12 from Patent EP3246406
CTCTTGTTTGGT
>LP845774.1 Sequence 11 from Patent EP3246406
CTCTTGTCTGGT
>LP904741.1 Sequence 46 from Patent EP3230744
AACGTAAACCAC
>LP790156.1 Sequence 44 from Patent EP3272356
GGACGAAACACC
>LP964394.1 Sequence 101 from Patent WO2017177131
TGTGCAAATCTA
>LP964388.1 Sequence 95 from Patent WO2017177131
ATGCAAAACTGA
>LP964350.1 Sequence 57 from Patent WO2017177131
ATCTAAACGTGT
>LP964339.1 Sequence 46 from Patent WO2017177131
CCCCCTTCCCCC
>LP964338.1 Sequence 45 from Patent WO2017177131
TTTTCCCCTTTT
>LP964337.1 Sequence 44 from Patent WO2017177131
CCCCCTCCCCCC
>LP964332.1 Sequence 39 from Patent WO2017177131
TCTCTCCTCCCT
>LP964331.1 Sequence 38 from Patent WO2017177131
GCCCCCCCCCCC
>LP964330.1 Sequence 37 from Patent WO2017177131
ATTATTATTATT
>LP964329.1 Sequence 36 from Patent WO2017177131
TCTCTCCTCTCT
>LP964328.1 Sequence 35 from Patent WO2017177131
TTATATTATATT
>LP964325.1 Sequence 32 from Patent WO2017177131
TTTCCCCCCTTT
>LP964311.1 Sequence 18 from Patent WO2017177131
CCGCCGCCGCCG
>LP964309.1 Sequence 16 from Patent WO2017177131
ATTTATTTATTT
>LP962904.1 Sequence 11 from Patent WO2017176404
GCATGCATGCAT
>LP962903.1 Sequence 10 from Patent WO2017176404
ATGCATGCATGC
>LP962804.1 Sequence 121 from Patent WO2017216136
AAAAATTGTTGA
>LP782869.1 Sequence 1 from Patent WO2018054571
TAGTTGAGCTGT
>LP960456.1 Sequence 20 from Patent WO2017216325
GGCATGAGCTTC
>LP900572.1 Sequence 36 from Patent EP3218483
CATTTCGACTCC
>LP900570.1 Sequence 34 from Patent EP3218483
CATTTCGACTCC
>LP781806.1 Sequence 3 from Patent WO2018054964
GATTGCATAGGA
>MA012192.1 WO 2018003339-A/40: Method for Cell-Specifically Contorling Nuclease
GGCGTGATGAGC
>MA012152.1 WO 2018003220-A/2059: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGGG
>MA012151.1 WO 2018003220-A/2058: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGGC
>MA012150.1 WO 2018003220-A/2057: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGGT
>MA012149.1 WO 2018003220-A/2056: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGGA
>MA012148.1 WO 2018003220-A/2055: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGCG
>MA012147.1 WO 2018003220-A/2054: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGCC
>MA012146.1 WO 2018003220-A/2053: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGCT
>MA012145.1 WO 2018003220-A/2052: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGCA
>MA012144.1 WO 2018003220-A/2051: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGTG
>MA012143.1 WO 2018003220-A/2050: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGTC
>MA012142.1 WO 2018003220-A/2049: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGTT
>MA012141.1 WO 2018003220-A/2048: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGTA
>MA012140.1 WO 2018003220-A/2047: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGAG
>MA012139.1 WO 2018003220-A/2046: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGAC
>MA012138.1 WO 2018003220-A/2045: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGAT
>MA012137.1 WO 2018003220-A/2044: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGAGACAGAA
>MA011053.1 WO 2018003220-A/960: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGTGTTCCACTG
>MA011052.1 WO 2018003220-A/959: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGCCATCATCAG
>MA011051.1 WO 2018003220-A/958: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GATAGATCGCAT
>MA011050.1 WO 2018003220-A/957: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GAGACTGCACTC
>MA011049.1 WO 2018003220-A/956: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CGTCGATCATCA
>MA011048.1 WO 2018003220-A/955: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GCGCGCTTATGA
>MA011047.1 WO 2018003220-A/954: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGTTGGATCAAC
>MA011046.1 WO 2018003220-A/953: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AAGAGCTGTGCC
>MA011045.1 WO 2018003220-A/952: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GTTCGATGATGG
>MA011044.1 WO 2018003220-A/951: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACGATACGTGGA
>MA011043.1 WO 2018003220-A/950: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACGATCATAGCC
>MA011042.1 WO 2018003220-A/949: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGCTCAGTAACA
>MA011041.1 WO 2018003220-A/948: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGCTCATTACGG
>MA011040.1 WO 2018003220-A/947: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CGCTAGGATCAC
>MA011039.1 WO 2018003220-A/946: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTGGTACCACGT
>MA011038.1 WO 2018003220-A/945: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CAAGTGTGATGA
>MA011037.1 WO 2018003220-A/944: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGTTAAGTTGGA
>MA011036.1 WO 2018003220-A/943: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CGCATGTTGTGC
>MA011035.1 WO 2018003220-A/942: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTCGCAGTTCCT
>MA011034.1 WO 2018003220-A/941: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AACATGGATACG
>MA011033.1 WO 2018003220-A/940: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GTCGATATATGG
>MA011032.1 WO 2018003220-A/939: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTGGTCACACGC
>MA011031.1 WO 2018003220-A/938: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGACGGTCTAGT
>MA011030.1 WO 2018003220-A/937: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TCTATGTAGACG
>MA011029.1 WO 2018003220-A/936: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AAGGCTAATGTC
>MA011028.1 WO 2018003220-A/935: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGAGCGTACACG
>MA011027.1 WO 2018003220-A/934: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GAATCTTCCGCG
>MA011026.1 WO 2018003220-A/933: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GTTGCTCACGTG
>MA011025.1 WO 2018003220-A/932: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AACCGGCTGTCT
>MA011024.1 WO 2018003220-A/931: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CGCAGGACGATT
>MA011023.1 WO 2018003220-A/930: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGCTTAGGTATG
>MA011022.1 WO 2018003220-A/929: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GTCAACGCTAAG
>MA011021.1 WO 2018003220-A/928: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACGCTGTTAGCA
>MA011020.1 WO 2018003220-A/927: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CAGTTGTGCTAT
>MA011019.1 WO 2018003220-A/926: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACTAACGCGACT
>MA011018.1 WO 2018003220-A/925: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGTGGAACCATG
>MA011017.1 WO 2018003220-A/924: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ATTAAGCCTAAG
>MA011016.1 WO 2018003220-A/923: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CACCTGCACGAT
>MA011015.1 WO 2018003220-A/922: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTCTCGTGTGCG
>MA011014.1 WO 2018003220-A/921: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTAAGACTTAAG
>MA011013.1 WO 2018003220-A/920: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGCCGAGACTTC
>MA011012.1 WO 2018003220-A/919: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTTGGCATGTAC
>MA011011.1 WO 2018003220-A/918: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGAGTAGGTCAG
>MA011010.1 WO 2018003220-A/917: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAGTCAACGTAG
>MA011009.1 WO 2018003220-A/916: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CGTCAACGTGGT
>MA011008.1 WO 2018003220-A/915: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTCGATATAGTT
>MA011007.1 WO 2018003220-A/914: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TACCGTCAAGTG
>MA011006.1 WO 2018003220-A/913: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACCGTCGCTTGA
>MA011005.1 WO 2018003220-A/912: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGGCATCCGTTG
>MA011004.1 WO 2018003220-A/911: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACGTCGGAAGGT
>MA011003.1 WO 2018003220-A/910: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AATTGGCTATAG
>MA011002.1 WO 2018003220-A/909: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGTCTGTATCAT
>MA011001.1 WO 2018003220-A/908: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TCCATCAGATAA
>MA011000.1 WO 2018003220-A/907: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGAAGTGATTAA
>MA010999.1 WO 2018003220-A/906: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACACACTTCTAG
>MA010998.1 WO 2018003220-A/905: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGTTACCGAGGA
>MA010997.1 WO 2018003220-A/904: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TACCTGGTCGGT
>MA010996.1 WO 2018003220-A/903: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTCGCGTTATTG
>MA010995.1 WO 2018003220-A/902: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGAAGTCGCCTC
>MA010994.1 WO 2018003220-A/901: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GGTTATGAAGAA
>MA010993.1 WO 2018003220-A/900: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GCAGAATTGCGA
>MA010992.1 WO 2018003220-A/899: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGTTCGCATACA
>MA010991.1 WO 2018003220-A/898: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGGCTGACAT
>MA010990.1 WO 2018003220-A/897: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ACTGAGGCGTTC
>MA010989.1 WO 2018003220-A/896: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGTCAAGAGATT
>MA010988.1 WO 2018003220-A/895: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GCCTCTGGTAAC
>MA010987.1 WO 2018003220-A/894: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CATCCACTAATC
>MA010986.1 WO 2018003220-A/893: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ATGTCGATCTAG
>MA010985.1 WO 2018003220-A/892: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTCCTCGTGGTT
>MA010984.1 WO 2018003220-A/891: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ATATATCTCAGC
>MA010983.1 WO 2018003220-A/890: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAAGATGCTTGA
>MA010982.1 WO 2018003220-A/889: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CCTGTTCTGATT
>MA010981.1 WO 2018003220-A/888: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CGCATGTATGCC
>MA010980.1 WO 2018003220-A/887: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GTGTTGCTACCA
>MA010979.1 WO 2018003220-A/886: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTACGTCCGCAA
>MA010978.1 WO 2018003220-A/885: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TCTCTAGTTCGG
>MA010977.1 WO 2018003220-A/884: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGCTAACTCTCC
>MA010976.1 WO 2018003220-A/883: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTGTCACAACTC
>MA010975.1 WO 2018003220-A/882: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTGCATGCATAA
>MA010974.1 WO 2018003220-A/881: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AATACTGGCTAA
>MA010973.1 WO 2018003220-A/880: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
AGAGCCAGTCGT
>MA010972.1 WO 2018003220-A/879: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTACTGGCACAA
>MA010971.1 WO 2018003220-A/878: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TCGCTAATGTAG
>MA010970.1 WO 2018003220-A/877: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ATTGAGAGCTAT
>MA010969.1 WO 2018003220-A/876: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TTGTGCTGGACT
>MA010968.1 WO 2018003220-A/875: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TGGATCCTTCAT
>MA010967.1 WO 2018003220-A/874: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTGCATTCACGA
>MA010966.1 WO 2018003220-A/873: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GCGGTCACATAT
>MA010965.1 WO 2018003220-A/872: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CCTACCTGTGGA
>MA010964.1 WO 2018003220-A/871: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GACGCATACCTC
>MA010963.1 WO 2018003220-A/870: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GTGCTTCAGGAG
>MA010962.1 WO 2018003220-A/869: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TAGTGGTCGTCA
>MA010961.1 WO 2018003220-A/868: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
TATACTACAAGC
>MA010960.1 WO 2018003220-A/867: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
CTTAAGGAGCGC
>MA010959.1 WO 2018003220-A/866: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
ATACTCCGAGAT
>MA010958.1 WO 2018003220-A/865: A method for producing a DNA library and a method for analyzing genomic DNA using the DNA library
GCTGTTGAACCG
>MA007250.1 JP 2018007683-A/61: HUMAN C-FMS ANTIGEN BINDING PROTEINS
GGGAAAGGGAAA
>MA004895.1 JP 2018008987-A/130: USE OF ANTI-CGRP OR ANTI-CGRP-R ANTIBODIES OR ANTIBODY FRAGMENTS TO TREAT OR PREVENT CHRONIC AND ACUTE FORMS OF DIARRHEA
GATCTTGACTTG
>LZ999062.1 JP 2018000057-A/960: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GGTGTTCCACTG
>LZ999061.1 JP 2018000057-A/959: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GGCCATCATCAG
>LZ999060.1 JP 2018000057-A/958: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GATAGATCGCAT
>LZ999059.1 JP 2018000057-A/957: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GAGACTGCACTC
>LZ999058.1 JP 2018000057-A/956: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CGTCGATCATCA
>LZ999057.1 JP 2018000057-A/955: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GCGCGCTTATGA
>LZ999056.1 JP 2018000057-A/954: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GGTTGGATCAAC
>LZ999055.1 JP 2018000057-A/953: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AAGAGCTGTGCC
>LZ999054.1 JP 2018000057-A/952: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GTTCGATGATGG
>LZ999053.1 JP 2018000057-A/951: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ACGATACGTGGA
>LZ999052.1 JP 2018000057-A/950: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ACGATCATAGCC
>LZ999051.1 JP 2018000057-A/949: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TGCTCAGTAACA
>LZ999050.1 JP 2018000057-A/948: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TGCTCATTACGG
>LZ999049.1 JP 2018000057-A/947: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CGCTAGGATCAC
>LZ999048.1 JP 2018000057-A/946: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CTGGTACCACGT
>LZ999047.1 JP 2018000057-A/945: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CAAGTGTGATGA
>LZ999046.1 JP 2018000057-A/944: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TGTTAAGTTGGA
>LZ999045.1 JP 2018000057-A/943: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CGCATGTTGTGC
>LZ999044.1 JP 2018000057-A/942: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TTCGCAGTTCCT
>LZ999043.1 JP 2018000057-A/941: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AACATGGATACG
>LZ999042.1 JP 2018000057-A/940: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GTCGATATATGG
>LZ999041.1 JP 2018000057-A/939: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TTGGTCACACGC
>LZ999040.1 JP 2018000057-A/938: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AGACGGTCTAGT
>LZ999039.1 JP 2018000057-A/937: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TCTATGTAGACG
>LZ999038.1 JP 2018000057-A/936: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AAGGCTAATGTC
>LZ999037.1 JP 2018000057-A/935: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AGAGCGTACACG
>LZ999036.1 JP 2018000057-A/934: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GAATCTTCCGCG
>LZ999035.1 JP 2018000057-A/933: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GTTGCTCACGTG
>LZ999034.1 JP 2018000057-A/932: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AACCGGCTGTCT
>LZ999033.1 JP 2018000057-A/931: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CGCAGGACGATT
>LZ999032.1 JP 2018000057-A/930: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AGCTTAGGTATG
>LZ999031.1 JP 2018000057-A/929: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GTCAACGCTAAG
>LZ999030.1 JP 2018000057-A/928: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ACGCTGTTAGCA
>LZ999029.1 JP 2018000057-A/927: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CAGTTGTGCTAT
>LZ999028.1 JP 2018000057-A/926: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ACTAACGCGACT
>LZ999027.1 JP 2018000057-A/925: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GGTGGAACCATG
>LZ999026.1 JP 2018000057-A/924: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ATTAAGCCTAAG
>LZ999025.1 JP 2018000057-A/923: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CACCTGCACGAT
>LZ999024.1 JP 2018000057-A/922: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TTCTCGTGTGCG
>LZ999023.1 JP 2018000057-A/921: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CTAAGACTTAAG
>LZ999022.1 JP 2018000057-A/920: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TGCCGAGACTTC
>LZ999021.1 JP 2018000057-A/919: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CTTGGCATGTAC
>LZ999020.1 JP 2018000057-A/918: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TGAGTAGGTCAG
>LZ999019.1 JP 2018000057-A/917: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TAGTCAACGTAG
>LZ999018.1 JP 2018000057-A/916: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CGTCAACGTGGT
>LZ999017.1 JP 2018000057-A/915: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CTCGATATAGTT
>LZ999016.1 JP 2018000057-A/914: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TACCGTCAAGTG
>LZ999015.1 JP 2018000057-A/913: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ACCGTCGCTTGA
>LZ999014.1 JP 2018000057-A/912: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AGGCATCCGTTG
>LZ999013.1 JP 2018000057-A/911: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ACGTCGGAAGGT
>LZ999012.1 JP 2018000057-A/910: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AATTGGCTATAG
>LZ999011.1 JP 2018000057-A/909: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TGTCTGTATCAT
>LZ999010.1 JP 2018000057-A/908: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TCCATCAGATAA
>LZ999009.1 JP 2018000057-A/907: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GGAAGTGATTAA
>LZ999008.1 JP 2018000057-A/906: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ACACACTTCTAG
>LZ999007.1 JP 2018000057-A/905: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GGTTACCGAGGA
>LZ999006.1 JP 2018000057-A/904: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TACCTGGTCGGT
>LZ999005.1 JP 2018000057-A/903: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TTCGCGTTATTG
>LZ999004.1 JP 2018000057-A/902: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AGAAGTCGCCTC
>LZ999003.1 JP 2018000057-A/901: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GGTTATGAAGAA
>LZ999002.1 JP 2018000057-A/900: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GCAGAATTGCGA
>LZ999001.1 JP 2018000057-A/899: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AGTTCGCATACA
>LZ999000.1 JP 2018000057-A/898: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TAAGGCTGACAT
>LZ998999.1 JP 2018000057-A/897: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ACTGAGGCGTTC
>LZ998998.1 JP 2018000057-A/896: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AGTCAAGAGATT
>LZ998997.1 JP 2018000057-A/895: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GCCTCTGGTAAC
>LZ998996.1 JP 2018000057-A/894: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CATCCACTAATC
>LZ998995.1 JP 2018000057-A/893: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ATGTCGATCTAG
>LZ998994.1 JP 2018000057-A/892: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TTCCTCGTGGTT
>LZ998993.1 JP 2018000057-A/891: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ATATATCTCAGC
>LZ998992.1 JP 2018000057-A/890: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TAAGATGCTTGA
>LZ998991.1 JP 2018000057-A/889: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CCTGTTCTGATT
>LZ998990.1 JP 2018000057-A/888: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CGCATGTATGCC
>LZ998989.1 JP 2018000057-A/887: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GTGTTGCTACCA
>LZ998988.1 JP 2018000057-A/886: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TTACGTCCGCAA
>LZ998987.1 JP 2018000057-A/885: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TCTCTAGTTCGG
>LZ998986.1 JP 2018000057-A/884: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TGCTAACTCTCC
>LZ998985.1 JP 2018000057-A/883: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TTGTCACAACTC
>LZ998984.1 JP 2018000057-A/882: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CTGCATGCATAA
>LZ998983.1 JP 2018000057-A/881: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AATACTGGCTAA
>LZ998982.1 JP 2018000057-A/880: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
AGAGCCAGTCGT
>LZ998981.1 JP 2018000057-A/879: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CTACTGGCACAA
>LZ998980.1 JP 2018000057-A/878: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TCGCTAATGTAG
>LZ998979.1 JP 2018000057-A/877: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ATTGAGAGCTAT
>LZ998978.1 JP 2018000057-A/876: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TTGTGCTGGACT
>LZ998977.1 JP 2018000057-A/875: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TGGATCCTTCAT
>LZ998976.1 JP 2018000057-A/874: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CTGCATTCACGA
>LZ998975.1 JP 2018000057-A/873: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GCGGTCACATAT
>LZ998974.1 JP 2018000057-A/872: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CCTACCTGTGGA
>LZ998973.1 JP 2018000057-A/871: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GACGCATACCTC
>LZ998972.1 JP 2018000057-A/870: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GTGCTTCAGGAG
>LZ998971.1 JP 2018000057-A/869: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TAGTGGTCGTCA
>LZ998970.1 JP 2018000057-A/868: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
TATACTACAAGC
>LZ998969.1 JP 2018000057-A/867: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
CTTAAGGAGCGC
>LZ998968.1 JP 2018000057-A/866: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
ATACTCCGAGAT
>LZ998967.1 JP 2018000057-A/865: A method for producing a DNA probe and a method for analyzing genomic DNA using the DNA probe
GCTGTTGAACCG
>MA016818.1 JP 2017536813-A/31: COMPOSITIONS AND METHODS FOR DETECTING AN RNA VIRUS
GACTCNNGAGTC
>MA016815.1 JP 2017536813-A/28: COMPOSITIONS AND METHODS FOR DETECTING AN RNA VIRUS
GAGTCNNNNNNN
>MA016657.1 JP 2017536804-A/1: INFLUENZA A VIRUS VARIANTS
AGCRAAAGCAGG
>MA015283.1 JP 2017538401-A/55: T CELL RECEPTORS DIRECTED AGAINST BOB1 AND USES THEREOF
GGCAGCGGAAGC
>MA015281.1 JP 2017538401-A/53: T CELL RECEPTORS DIRECTED AGAINST BOB1 AND USES THEREOF
CGCGCAAAGCGT
>MA014514.1 JP 2017537605-A/1: INFLUENZA A VIRUS VARIANTS
AGCRAAAGCAGG
>MI490229.1 Sequence 10 from patent US 9926595
AGCTAGCTAGCT
>MI490224.1 Sequence 5 from patent US 9926595
ACTGACTGACTG
>MI485040.1 Sequence 3 from patent US 9926592
AATCCCAATCCC
>MI484666.1 Sequence 334 from patent US 9926563
GTCGGCGACTCC
>MI484665.1 Sequence 333 from patent US 9926563
TCGGCGACTCCC
>MI484438.1 Sequence 106 from patent US 9926563
GAGCGGTTCGGT
>MI484437.1 Sequence 105 from patent US 9926563
CTTGCGACACCC
>MI484352.1 Sequence 20 from patent US 9926563
GCGGGATGGCAT
>MI484345.1 Sequence 13 from patent US 9926563
CCGCGGATCGCC
>MI484339.1 Sequence 7 from patent US 9926563
CTGCCCGCGGAT
>MI484322.1 Sequence 23 from patent US 9926559
ATTCACTTTCAT
>MI484321.1 Sequence 22 from patent US 9926559
TTCACTTTCATA
>MI484320.1 Sequence 21 from patent US 9926559
TCACTTTCATAA
>MI484318.1 Sequence 19 from patent US 9926559
CACTTTCATAAT
>MI484316.1 Sequence 17 from patent US 9926559
ACTTTCATAATG
>MI484314.1 Sequence 15 from patent US 9926559
CTTTCATAATGC
>MI484312.1 Sequence 13 from patent US 9926559
TTTCATAATGCT
>MI484310.1 Sequence 11 from patent US 9926559
TTCATAATGCTG
>MI484308.1 Sequence 9 from patent US 9926559
TCATAATGCTGG
>MI484029.1 Sequence 8 from patent US 9926556
GGATGTTCTCGA
>MI484028.1 Sequence 7 from patent US 9926556
TCGAGAACATCC
>MI482384.1 Sequence 249 from patent US 9926370
GCCTATGACTTG
>MI479863.1 Sequence 1 from patent US 9920386
ACTGGCCGAAAT
>MI476589.1 Sequence 197 from patent US 9920367
TTTTTTTTTTTT
>MI465839.1 Sequence 37 from patent US 9919058
NNNACCGGTNNN
>MI465833.1 Sequence 31 from patent US 9919058
TCGAGGCTTCTC
>MI465831.1 Sequence 29 from patent US 9919058
TCGTTCGTTCTC
>MI465823.1 Sequence 21 from patent US 9919058
GTCAGCGTCGAC
>MI465822.1 Sequence 20 from patent US 9919058
GTCATCGATGCA
>MI465821.1 Sequence 19 from patent US 9919058
GTCGACGTCGAC
>MI465820.1 Sequence 18 from patent US 9919058
GTCGACGCTGAC
>MI465819.1 Sequence 17 from patent US 9919058
GTCGTCGATGAC
>MI465816.1 Sequence 14 from patent US 9919058
GTCGACGTTGAC
>MI465815.1 Sequence 13 from patent US 9919058
GTCGGCGTCGAC
>MI465814.1 Sequence 12 from patent US 9919058
TCGAGCGTTCTC
>MI465811.1 Sequence 9 from patent US 9919058
GTCGGCGTTGAC
>MI465810.1 Sequence 8 from patent US 9919058
TCGAGGCTTCTC
>MI465809.1 Sequence 7 from patent US 9919058
TGCAGCGTTCTC
>MI464975.1 Sequence 9 from patent US 9915659
TGATTCTACACC
>MI464972.1 Sequence 3 from patent US 9915659
TACACAGGGTTA
>MI464960.1 Sequence 1 from patent US 9915655
ACAGCCAGCCGA
>MI464944.1 Sequence 131 from patent US 9914982
AAGAAGATGAGG
>MI464302.1 Sequence 11 from patent US 9914967
ACTTCAGCTGCC
>MI463104.1 Sequence 4 from patent US 9914929
GTACAGACCAAT
>MI463103.1 Sequence 3 from patent US 9914929
CTCCAGGGCTGA
>MI463102.1 Sequence 2 from patent US 9914929
CTACAGACTGGA
>MI463101.1 Sequence 1 from patent US 9914929
ATACAGACCTTA
>MI455739.1 Sequence 10 from patent US 9909174
AGCTAGCTAGCT
>MI455734.1 Sequence 5 from patent US 9909174
ACTGACTGACTG
>MI453005.1 Sequence 7416 from patent US 9909131
CGCACGTAATAA
>MI452995.1 Sequence 7406 from patent US 9909131
TGTGTGGAAGAC
>MI452981.1 Sequence 7392 from patent US 9909131
GGAGTAGTTAGG
>MI452967.1 Sequence 7378 from patent US 9909131
ATAATGGAACCC
>MI452959.1 Sequence 7370 from patent US 9909131
ATTGCATAATAA
>MI452956.1 Sequence 7367 from patent US 9909131
ATCATCTGCAAA
>MI452955.1 Sequence 7366 from patent US 9909131
TACTTGCTGGTA
>MI445740.1 Sequence 23 from patent US 9909126
GGTCTGGAGAGG
>MI445739.1 Sequence 22 from patent US 9909126
TGGAGAGGTTCT
>MI445738.1 Sequence 21 from patent US 9909126
CCTGGTCTGGAG
>MI445737.1 Sequence 20 from patent US 9909126
CAGCTCTGCCTA
>MI445736.1 Sequence 19 from patent US 9909126
GGCCAGCTCTGC
>MI445629.1 Sequence 64 from patent US 9909123
TCCATGATTTAT
>MI445593.1 Sequence 17 from patent US 9909123
CATCGAAAGTCC
>MI445592.1 Sequence 16 from patent US 9909123
TAGCCATTGTCG
>MI445591.1 Sequence 15 from patent US 9909123
TACGAGCCATTT
>MI445590.1 Sequence 14 from patent US 9909123
TCTTTCGCTCAC
>MI445589.1 Sequence 13 from patent US 9909123
GTTGGATCATTA
>MI445588.1 Sequence 12 from patent US 9909123
TCATGTTATGGC
>MI445587.1 Sequence 11 from patent US 9909123
CGAGCCATGTAT
>MI445586.1 Sequence 10 from patent US 9909123
TACGTGCCATAT
>MI445585.1 Sequence 9 from patent US 9909123
TTACGTGCCATT
>MI445584.1 Sequence 8 from patent US 9909123
ACGCATAATAAT
>MI445583.1 Sequence 7 from patent US 9909123
CGAGCCATAATA
>MI445582.1 Sequence 6 from patent US 9909123
ACTCGTGGCATA
>MI445581.1 Sequence 5 from patent US 9909123
AACATCGGAATG
>MI445580.1 Sequence 4 from patent US 9909123
TGTTTACCCATA
>MI445579.1 Sequence 3 from patent US 9909123
ACGAGGCATAAT
>MI445243.1 Sequence 679 from patent US 9909122
GTTTTAGAGCTA
>MI443951.1 Sequence 130 from patent US 9908921
CCCCACCCCGCC
>MI443884.1 Sequence 61 from patent US 9908921
TATCCGATGCCT
>MI442533.1 Sequence 9 from patent US 9904763
GGATCGAAATGG
>MI442506.1 Sequence 2 from patent US 9903861
TTTTTTTTTTTT
>MI442505.1 Sequence 1 from patent US 9903861
TTTTTTTTTTTT
>MI442504.1 Sequence 3 from patent US 9903859
ACCAGATTACAA
>MI442503.1 Sequence 2 from patent US 9903859
GGAGGACCAGTA
>MI442502.1 Sequence 1 from patent US 9903859
TAACATTCAGAG
>MI442285.1 Sequence 19 from patent US 9902997
TTAGGGTCAACA
>MI442282.1 Sequence 16 from patent US 9902997
TGGGTGTGTGTG
>MI441872.1 Sequence 32 from patent US 9902974
GACAAGCAGCGG
>MI441871.1 Sequence 31 from patent US 9902974
AAACTGCAAAAG
>MI441870.1 Sequence 30 from patent US 9902974
GATGAGGATGAC
>MI441725.1 Sequence 7 from patent US 9902971
AAGGCTAGTCCG
>MI441271.1 Sequence 279 from patent US 9902962
GCGGGAGGCGTG
>MI437939.1 Sequence 9 from patent US 9898575
GGATCGAAATGG
>MI437781.1 Sequence 14 from patent US 9896729
GGGGCCGGGGCC
>MI437780.1 Sequence 13 from patent US 9896729
GGCCCCGGCCCC
>MI437727.1 Sequence 12 from patent US 9896726
GGGTTGGATTGC
>MI437726.1 Sequence 11 from patent US 9896726
GGGTCGGATTGC
>MI437725.1 Sequence 10 from patent US 9896726
GGGTCGGATTGC
>MI437724.1 Sequence 9 from patent US 9896726
GGGTTGGATTGC
>MI437723.1 Sequence 8 from patent US 9896726
GGGTCGGATTGC
>MI437722.1 Sequence 7 from patent US 9896726
GGGTCGGACCGC
>MI437062.1 Sequence 91 from patent US 9896709
TTTTTTTTTTTT
>MI437052.1 Sequence 81 from patent US 9896709
AAAAAAAAAAAA
>MI436612.1 Sequence 74 from patent US 9896696
TTTTTTTGTTTT
>MI436591.1 Sequence 44 from patent US 9896696
TTTTTTTGTTTT
>MI436507.1 Sequence 20 from patent US 9896693
CCACCAACCCCC
>MI435708.1 Sequence 10 from patent US 9896515
CATATGGGATCC
>MI435707.1 Sequence 9 from patent US 9896515
CTCGAGTAATGA
>MI435700.1 Sequence 2 from patent US 9896515
TAATGACTCGAG
>MI435648.1 Sequence 83 from patent US 9896508
TTTGGAATGCAC
>MI435619.1 Sequence 14 from patent US 9896508
TTTGGAATGCAC
>MI435287.1 Sequence 18 from patent US 9896490
AGAAACAGGAGG
>MI435286.1 Sequence 17 from patent US 9896490
AGGAGCCGAAGA
>MI435285.1 Sequence 16 from patent US 9896490
AGAGGGAGGAGA
>MI435046.1 Sequence 136 from patent US 9895440
ATGTGTTGGAGT
>MI435042.1 Sequence 132 from patent US 9895440
ATGCCTAAGCGT
>MI435041.1 Sequence 131 from patent US 9895440
ATGCCTAAGCGT
>MI435040.1 Sequence 130 from patent US 9895440
ATGCCTAAGCGT
>MI435039.1 Sequence 129 from patent US 9895440
CCACACAGGCAT
>MI435037.1 Sequence 127 from patent US 9895440
GGGCGGGGGAGG
>MI435036.1 Sequence 126 from patent US 9895440
GGGCGGGGGAGG
>MI435035.1 Sequence 125 from patent US 9895440
GGGCGGGGGAGG
>MI435033.1 Sequence 123 from patent US 9895440
AAAGGTGGGCGG
>MI435032.1 Sequence 122 from patent US 9895440
AAAGGTGGGCGG
>MI435031.1 Sequence 121 from patent US 9895440
ACGCCCCAACAA
>MI435022.1 Sequence 112 from patent US 9895440
CCAACCAAGCAA
>MI435021.1 Sequence 111 from patent US 9895440
CCACCTACATAA
>MI435020.1 Sequence 110 from patent US 9895440
CCACCTACATAA
>MI435017.1 Sequence 107 from patent US 9895440
ACGCCTACTCTG
>MI435016.1 Sequence 106 from patent US 9895440
ACGCCTACTCTG
>MI435015.1 Sequence 105 from patent US 9895440
ACGCCTACTCTG
>MI435012.1 Sequence 102 from patent US 9895440
TTGCATGGGCTG
>MI435011.1 Sequence 101 from patent US 9895440
TTGCATGGGCTG
>MI435010.1 Sequence 100 from patent US 9895440
TTGCATGGGCTG
>MI435009.1 Sequence 99 from patent US 9895440
TTGCATGGGCTG
>MI435008.1 Sequence 98 from patent US 9895440
TTGCGTGGCCAG
>MI435007.1 Sequence 97 from patent US 9895440
TTGCGTGGCCAG
>MI435006.1 Sequence 96 from patent US 9895440
TTGCGTGGCCAG
>MI435005.1 Sequence 95 from patent US 9895440
TTGCGTGGCCAG
>MI435004.1 Sequence 94 from patent US 9895440
CCACCCCTGCAC
>MI435003.1 Sequence 93 from patent US 9895440
CCACCCCTGCAC
>MI435002.1 Sequence 92 from patent US 9895440
CTGCCCACACCT
>MI435000.1 Sequence 90 from patent US 9895440
CTTCCCACGCTC
>MI434997.1 Sequence 87 from patent US 9895440
TGGCGGGGGGGG
>MI434996.1 Sequence 86 from patent US 9895440
TGGCGGGGGGGG
>MI434994.1 Sequence 84 from patent US 9895440
CCTGCCACGCCA
>MI434993.1 Sequence 83 from patent US 9895440
CCTGCCACGCCA
>MI434986.1 Sequence 76 from patent US 9895440
TTACGTGGGTGC
>MI434985.1 Sequence 75 from patent US 9895440
TTACGTGGGTGC
>MI434984.1 Sequence 74 from patent US 9895440
TTACGTGGGTGC
>MI434981.1 Sequence 71 from patent US 9895440
GAGGGTGGGTGT
>MI434980.1 Sequence 70 from patent US 9895440
GAGGGTGGGTGT
>MI434979.1 Sequence 69 from patent US 9895440
GAGGGTGGGTGT
>MI434976.1 Sequence 66 from patent US 9895440
ACACACACTCAT
>MI434975.1 Sequence 65 from patent US 9895440
ACACACACTCAT
>MI434969.1 Sequence 59 from patent US 9895440
TTGTTGGGGCGG
>MI434968.1 Sequence 58 from patent US 9895440
CCTCCCTCTCAA
>MI434967.1 Sequence 57 from patent US 9895440
CCTCCCACACAC
>MI434966.1 Sequence 56 from patent US 9895440
CCTCCCACACAC
>MI434965.1 Sequence 55 from patent US 9895440
CCTCCCACACAC
>MI434964.1 Sequence 54 from patent US 9895440
CCTCCCACACAC
>MI434961.1 Sequence 51 from patent US 9895440
ACACTCCCGCAC
>MI434960.1 Sequence 50 from patent US 9895440
ACACTCCCGCAC
>MI434959.1 Sequence 49 from patent US 9895440
ACACCCACACTG
>MI434958.1 Sequence 48 from patent US 9895440
ACACCCACACTG
>MI434956.1 Sequence 46 from patent US 9895440
CCAACCACACAA
>MI434953.1 Sequence 43 from patent US 9895440
GTGCATAGGCTG
>MI434952.1 Sequence 42 from patent US 9895440
GTGCATAGGCTG
>MI434947.1 Sequence 37 from patent US 9895440
TTGCGTAGGCGG
>MI434946.1 Sequence 36 from patent US 9895440
TTGCGTAGGCGG
>MI434945.1 Sequence 35 from patent US 9895440
TTGCGTAGGCGG
>MI434944.1 Sequence 34 from patent US 9895440
TTGCGTAGGCGG
>MI434941.1 Sequence 31 from patent US 9895440
GCGCGTGGGCGG
>MI434940.1 Sequence 30 from patent US 9895440
GCGCGTGGGCGG
>MI434939.1 Sequence 29 from patent US 9895440
GCGCGTGGGCGG
>MI434938.1 Sequence 28 from patent US 9895440
GCGCGTGGGCGG
>MI434937.1 Sequence 27 from patent US 9895440
ACGCCCGCGCGT
>MI434936.1 Sequence 26 from patent US 9895440
ACGCCCGCGCGT
>MI434935.1 Sequence 25 from patent US 9895440
ACGCCCGCGCGT
>MI434934.1 Sequence 24 from patent US 9895440
ACGCCCGCGCGT
>MI434932.1 Sequence 22 from patent US 9895440
ACAGCCACGCGG
>MI434931.1 Sequence 21 from patent US 9895440
GAGCGTAGGCGG
>MI434930.1 Sequence 20 from patent US 9895440
GAGCGTAGGCGG
>MI434929.1 Sequence 19 from patent US 9895440
GAGCGTAGGCGG
>MI434928.1 Sequence 18 from patent US 9895440
GAGCGTAGGCGG
>MI434925.1 Sequence 15 from patent US 9895440
CCACCGCCGCCT
>MI434924.1 Sequence 14 from patent US 9895440
CCACCGCCGCCA
>MI434923.1 Sequence 13 from patent US 9895440
CAGCGCGGGCGG
>MI434922.1 Sequence 12 from patent US 9895440
CAGCGCGGGCGG
>MI434921.1 Sequence 11 from patent US 9895440
CAGCGCGGGCGG
>MI434920.1 Sequence 10 from patent US 9895440
CAGCGCGGGCGG
>MI433826.1 Sequence 5 from patent US 9890431
AATAAATCATAA
>MI433065.1 Sequence 13 from patent US 9890395
AAGGACACACTG
>MI433064.1 Sequence 8 from patent US 9890395
GTCTCGGATGCT
>MI427124.1 Sequence 36 from patent US 9890379
GCCGCCGCCGCC
>MI427123.1 Sequence 35 from patent US 9890379
GAAGAAGAAGAA
>MI427110.1 Sequence 22 from patent US 9890379
CCTGCCTGCCTG
>MI427109.1 Sequence 21 from patent US 9890379
CGGCGGCGGCGG
>MI427108.1 Sequence 20 from patent US 9890379
CTGCTGCTGCTG
>MI427107.1 Sequence 19 from patent US 9890379
GCGGCGGCGGCG
>MI427106.1 Sequence 18 from patent US 9890379
CAGCAGCAGCAG
>MI427076.1 Sequence 7 from patent US 9890375
TCCTAAGACCGC
>MI427075.1 Sequence 6 from patent US 9890375
TCGAGCTTGTCT
>MI425465.1 Sequence 50 from patent US 9889165
CATGAAGAAAAA
>MI425461.1 Sequence 45 from patent US 9889165
CATGAAGAAAAA
>MI424378.1 Sequence 3 from patent US 9886561
ACCCTTTGCAAC
>MI421388.1 Sequence 137 from patent US 9885042
GACAAGTGCAAT
>MI421387.1 Sequence 136 from patent US 9885042
GACAAGTGCAAT
>MI421386.1 Sequence 135 from patent US 9885042
GACAAGTGCAAT
>MI421385.1 Sequence 134 from patent US 9885042
GACAAGTGCAAT
>MI421384.1 Sequence 133 from patent US 9885042
GACAAGTGCAAT
>MI421383.1 Sequence 132 from patent US 9885042
GACAAGTGCAAT
>MI421382.1 Sequence 131 from patent US 9885042
GACAAGTGCAAT
>MI421381.1 Sequence 130 from patent US 9885042
GACAAGTGCAAT
>MI421380.1 Sequence 129 from patent US 9885042
GACAAGTGCAAT
>MI421379.1 Sequence 128 from patent US 9885042
GACAAGTGCAAT
>MI421378.1 Sequence 127 from patent US 9885042
GACAAGTGCAAT
>MI421377.1 Sequence 126 from patent US 9885042
GACAAGTGCAAT
>MI421376.1 Sequence 125 from patent US 9885042
GACAAGTGCAAT
>MI421375.1 Sequence 124 from patent US 9885042
GACAAGTGCAAT
>MI421374.1 Sequence 123 from patent US 9885042
GACAAGTGCAAT
>MI421373.1 Sequence 122 from patent US 9885042
GACAAGTGCAAT
>MI421372.1 Sequence 121 from patent US 9885042
GACAAGTGCAAT
>MI421371.1 Sequence 120 from patent US 9885042
GACAAGTGCAAT
>MI421370.1 Sequence 119 from patent US 9885042
GACAAGTGCAAT
>MI421369.1 Sequence 118 from patent US 9885042
GACAAGTGCAAT
>MI421368.1 Sequence 117 from patent US 9885042
GACAAGTGCAAT
>MI421367.1 Sequence 116 from patent US 9885042
GACAAGTGCAAT
>MI421366.1 Sequence 115 from patent US 9885042
GACAAGTGCAAT
>MI421365.1 Sequence 114 from patent US 9885042
GACAAGTGCAAT
>MI421212.1 Sequence 26 from patent US 9885040
TTATTCAACAAA
>MI421174.1 Sequence 2300 from patent US 9885037
CCAGGTAAGTAT
>MI419002.1 Sequence 125 from patent US 9885037
CAGTCTGCTTCG
>MI418985.1 Sequence 108 from patent US 9885037
CAGTCTGCTTCG
>MI418948.1 Sequence 69 from patent US 9885037
TCAGCGTGCGCC
>MI417733.1 Sequence 249 from patent US 9884912
GCCTATGACTTG
>MI417238.1 Sequence 20 from patent US 9884897
GAGNNNNNNACV
>MI416909.1 Sequence 5 from patent US 9884889
GTGTGTGTGTGT
>MI415134.1 Sequence 10 from patent US 9879309
AGCTAGCTAGCT
>MI415129.1 Sequence 5 from patent US 9879309
ACTGACTGACTG
>MI410236.1 Sequence 13 from patent US 9879222
TCTCTCTCTCTC
>MI409629.1 Sequence 249 from patent US 9879074
GCCTATGACTTG
>MI409062.1 Sequence 209 from patent US 9879053
AACAAGCCCCGG
>MI409061.1 Sequence 208 from patent US 9879053
AACAAGCCCCAG
>MI409060.1 Sequence 207 from patent US 9879053
GTGCGAGACCGT
>MI409059.1 Sequence 206 from patent US 9879053
GTGCGAGAGCGT
>MI393167.1 Sequence 24 from patent US 9878005
GAAASYGAAASY
>MI393166.1 Sequence 23 from patent US 9878005
GAAACCAAAAGT
>MI392650.1 Sequence 10 from patent US 9873956
AAAAAACCCCCC
>MI392647.1 Sequence 7 from patent US 9873956
AAAAAAAAAAAA
>MI392277.1 Sequence 32 from patent US 9873894
GACAAGCAGCGG
>MI392276.1 Sequence 31 from patent US 9873894
AAACTGCAAAAG
>MI392275.1 Sequence 30 from patent US 9873894
GATGAGGATGAC
>MI387788.1 Sequence 84 from patent US 9868955
CCCCCCTTNANN
>MI387787.1 Sequence 83 from patent US 9868955
TACTCCTTNATN
>MI387786.1 Sequence 82 from patent US 9868955
TACTCCTTNACN
>MI387785.1 Sequence 81 from patent US 9868955
TACTCCTTGGNN
>MI387784.1 Sequence 80 from patent US 9868955
TACTCCTTTTNN
>MI387783.1 Sequence 79 from patent US 9868955
TACTCCTTCCNN
>MI387782.1 Sequence 78 from patent US 9868955
TACTCCTTTANN
>MI387781.1 Sequence 77 from patent US 9868955
TACTCCTTCANN
>MI387780.1 Sequence 76 from patent US 9868955
TACTCCTTNANC
>MI387779.1 Sequence 75 from patent US 9868955
TACTCCTTNANT
>MI387778.1 Sequence 74 from patent US 9868955
TACTCCTTNANG
>MI387777.1 Sequence 73 from patent US 9868955
TACTCCAANANN
>MI387776.1 Sequence 72 from patent US 9868955
TACTCCGGNANN
>MI387775.1 Sequence 71 from patent US 9868955
TACTCCCCNANN
>MI387774.1 Sequence 70 from patent US 9868955
TACTCCNNNANN
>MI387773.1 Sequence 67 from patent US 9868955
TNCTCCTTNTNN
>MI387772.1 Sequence 66 from patent US 9868955
TNCTCCTTNGNN
>MI387771.1 Sequence 65 from patent US 9868955
TNCTCCTTNCNN
>MI387770.1 Sequence 64 from patent US 9868955
TNCTCCTTNNNN
>MI387769.1 Sequence 63 from patent US 9868955
TNCTCCTTNANN
>MI387767.1 Sequence 61 from patent US 9868955
TNCAGNAGNANN
>MI387766.1 Sequence 60 from patent US 9868955
TNCAGNTTNANN
>MI387765.1 Sequence 59 from patent US 9868955
TNCTCCTTANNA
>MI387764.1 Sequence 58 from patent US 9868955
TNCTCCTTNNAN
>MI387763.1 Sequence 57 from patent US 9868955
TNCTCCTTNAAA
>MI387762.1 Sequence 56 from patent US 9868955
TNCTCCTTNANA
>MI387761.1 Sequence 55 from patent US 9868955
TNCTCCTTNAAN
>MI387760.1 Sequence 54 from patent US 9868955
TACTCCTTAAAN
>MI387759.1 Sequence 53 from patent US 9868955
TACTCCTTAANN
>MI387758.1 Sequence 52 from patent US 9868955
TACTCCTTNANN
>MI387757.1 Sequence 51 from patent US 9868955
TCCTCCTTGAGN
>MI387756.1 Sequence 50 from patent US 9868955
TTCTCCTTGAGN
>MI387755.1 Sequence 49 from patent US 9868955
TACTCCTTGAGN
>MI387754.1 Sequence 48 from patent US 9868955
TNCTCCTTGAGN
>MI387741.1 Sequence 35 from patent US 9868955
TGCTCCTTGAGN
>MI387731.1 Sequence 25 from patent US 9868955
NGCTGCTCCTTG
>MI384788.1 Sequence 64 from patent US 9862990
ACCTACTTGCCT
>MI384748.1 Sequence 24 from patent US 9862990
NNGGAGNNNNNN
>MI384738.1 Sequence 14 from patent US 9862990
CACNNNNNNTCC
>MI384728.1 Sequence 4 from patent US 9862990
CGANNNNNNTGC
>MI382288.1 Sequence 3 from patent US 9862953
GGTTGGTGTGGT
>MI381421.1 Sequence 54 from patent US 9862946
CAGGCAGGCAGG
>MI381416.1 Sequence 48 from patent US 9862946
GCAGCAGCAGCA
>MI381413.1 Sequence 44 from patent US 9862946
AGCAGCAGCAGC
>MI381410.1 Sequence 40 from patent US 9862946
CAGCAGCAGCAG
>MI379944.1 Sequence 17 from patent US 9862742
GCATTTTTACCG
>MI379943.1 Sequence 16 from patent US 9862742
GCATTTTTACCG
>MI378777.1 Sequence 6 from patent US 9856530
GAACNNNNNCTC
>MI378773.1 Sequence 2 from patent US 9856530
CAANNNNNGTGG
>MI376357.1 Sequence 100 from patent US 9856474
ACCAGACTTTTT
>MI376355.1 Sequence 98 from patent US 9856474
AGCGGACTTTTT
>MI376353.1 Sequence 96 from patent US 9856474
AGCAGACTTTTT
>MI374232.1 Sequence 270 from patent US 9855332
GATCTTGACTTG
>XM_003860431.1 Leishmania donovani kinase-like protein (LDBPK_201380), partial mRNA
ATGCAGACATGA
>LZ997849.1 JP 2017535271-A/6: METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATION USING PAIRED GUIDE RNAS
AAGGCTAGTCCG
>LZ997455.1 JP 2017533721-A/36: COMPOUNDS AND METHODS FOR THE MODULATION OF PROTEINS
CATTTCGACTCC
>LZ997453.1 JP 2017533721-A/34: COMPOUNDS AND METHODS FOR THE MODULATION OF PROTEINS
CATTTCGACTCC
>LZ996266.1 JP 2017532962-A/21: Method
TTTNTTNNTTTN
>LZ996265.1 JP 2017532962-A/20: Method
AAAAAAAAAAAA
>LZ995640.1 JP 2017535256-A/3: Modified Enzymes
TTTTTTTTTTTT
>LZ993488.1 JP 2017534295-A/1: HIGH EFFICIENCY, HIGH THROUGHPUT GENERATION OF GENETICALLY MODIFIED MAMMALS BY ELECTROPORATION
GTTTTAGAGCTA
>LZ993087.1 JP 2017532955-A/4: METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING AND CORRECTION IN HEMATOPOIETIC STEM CELLS
ACTCCTGAGGAG
>LZ993082.1 JP 2017532028-A/7: ISOLATED OLIGONUCLEOTIDE AND USE THEREOF IN NUCLEIC ACID SEQUENCING
TCCTAAGACCGC
>LZ993081.1 JP 2017532028-A/6: ISOLATED OLIGONUCLEOTIDE AND USE THEREOF IN NUCLEIC ACID SEQUENCING
TCGAGCTTGTCT
>LZ992946.1 JP 2017532024-A/37: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
TCAGACCCTCGG
>LZ992945.1 JP 2017532024-A/36: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
CGCTTTCTGCAC
>LZ992944.1 JP 2017532024-A/35: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
CAGAGGAATAAA
>LZ992943.1 JP 2017532024-A/34: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
GCACTTCCCGTT
>LZ992942.1 JP 2017532024-A/33: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
TCACCGACGACA
>LZ992941.1 JP 2017532024-A/32: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
TCCTCTTTCCCT
>LZ992940.1 JP 2017532024-A/31: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
CCTTCTTTTCCT
>LZ992939.1 JP 2017532024-A/30: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
ATCTTAATCAAC
>LZ992938.1 JP 2017532024-A/29: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
TTTTTTTTTTTT
>LZ992937.1 JP 2017532024-A/28: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
CTCTTAAATATC
>LZ992936.1 JP 2017532024-A/27: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
CTGAGGTCACGG
>LZ992935.1 JP 2017532024-A/26: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
CTTAGTTCTTAG
>LZ992934.1 JP 2017532024-A/25: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
CTCGAGGCAAGA
>LZ992933.1 JP 2017532024-A/24: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
GACTGGACCGTC
>LZ992932.1 JP 2017532024-A/23: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
GATCACCTGCAC
>LZ992931.1 JP 2017532024-A/22: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
TCATACAGGCGG
>LZ992930.1 JP 2017532024-A/21: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
TAGAACAACAAG
>LZ992929.1 JP 2017532024-A/20: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
GAGCCTGAGATG
>LZ992928.1 JP 2017532024-A/19: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
GCATCTTTCCCG
>LZ992927.1 JP 2017532024-A/18: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
AATGCTGTTACG
>LZ992926.1 JP 2017532024-A/17: A DROPLET-BASED METHOD AND APPARATUS FOR COMPOSITE SINGLE-CELL NUCLEIC ACID ANALYSIS
AAAAAAAAAAAA
>LZ992766.1 JP 2017532018-A/117: COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES
AAAGATCCCAAA
>LZ992762.1 JP 2017532018-A/113: COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES
GGGGATCCCGCC
>LZ992752.1 JP 2017532018-A/103: COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES
AAAGATCCCAAA
>LZ992748.1 JP 2017532018-A/99: COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES
GGGGATCCCGCC
>LZ992687.1 JP 2017532018-A/38: COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES
GGCAGCGGAAGC
>LZ992685.1 JP 2017532018-A/36: COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES
CGCGCAAAGCGT
>LZ992219.1 JP 2017532001-A/306: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GGTAATTTCGTG
>LZ992218.1 JP 2017532001-A/305: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
AGTAAAGGCGCT
>LZ992217.1 JP 2017532001-A/304: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TAGCTAACCGTT
>LZ992216.1 JP 2017532001-A/303: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GTTAACAGCGTG
>LZ992215.1 JP 2017532001-A/302: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GGTCGTCATCAA
>LZ992214.1 JP 2017532001-A/301: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GTCGTGGACTAC
>LZ992213.1 JP 2017532001-A/300: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CTTCGCAAGGAG
>LZ992212.1 JP 2017532001-A/299: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
AAGATCGGTAGC
>LZ992211.1 JP 2017532001-A/298: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CGCGTCAGATAT
>LZ992210.1 JP 2017532001-A/297: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CTATGCCGTGCA
>LZ992209.1 JP 2017532001-A/296: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CGTACGGCACAG
>LZ992208.1 JP 2017532001-A/295: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
ACGCGTCAGATA
>LZ992207.1 JP 2017532001-A/294: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TCGACGACTCAC
>LZ992206.1 JP 2017532001-A/293: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CGACTTTTTGCA
>LZ992205.1 JP 2017532001-A/292: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TCGATGGTAAAC
>LZ992204.1 JP 2017532001-A/291: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GCGTTATCAGAA
>LZ992203.1 JP 2017532001-A/290: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CCCAAACGGTTA
>LZ992202.1 JP 2017532001-A/289: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CGTAGCCATGTT
>LZ992201.1 JP 2017532001-A/288: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TTTACCATCGAA
>LZ992200.1 JP 2017532001-A/287: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CGTGCCCTGAAC
>LZ992199.1 JP 2017532001-A/286: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CGAAAACGTGGC
>LZ992198.1 JP 2017532001-A/285: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CTTAGTCGGCCA
>LZ992197.1 JP 2017532001-A/284: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TAAAGCGACCCG
>LZ992196.1 JP 2017532001-A/283: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CACGAGGTATGC
>LZ992195.1 JP 2017532001-A/282: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CGGTGTATTGAG
>LZ992194.1 JP 2017532001-A/281: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
ACACCGAAAACG
>LZ992193.1 JP 2017532001-A/280: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GCAGGACGTCCG
>LZ992192.1 JP 2017532001-A/279: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TCACCCAAAGCG
>LZ992191.1 JP 2017532001-A/278: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
ACTATGCGTAGG
>LZ992190.1 JP 2017532001-A/277: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TTGACTGCGGCG
>LZ992189.1 JP 2017532001-A/276: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TGGGACACCGGT
>LZ992188.1 JP 2017532001-A/275: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GCCAACCCGCAC
>LZ992187.1 JP 2017532001-A/274: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CCCCTACGGCAC
>LZ992186.1 JP 2017532001-A/273: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
AGTGGCGATGAC
>LZ992185.1 JP 2017532001-A/272: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CGTCATGAATAA
>LZ992184.1 JP 2017532001-A/271: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CGATTCCTTCGT
>LZ992183.1 JP 2017532001-A/270: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CCAAACGGTTAA
>LZ992182.1 JP 2017532001-A/269: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TTCATAACCGGC
>LZ992181.1 JP 2017532001-A/268: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CGCTACATAGCA
>LZ992180.1 JP 2017532001-A/267: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
ACTCGATACCAT
>LZ992179.1 JP 2017532001-A/266: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
AGGAAGTATCGC
>LZ992178.1 JP 2017532001-A/265: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TTTACGCAGAGG
>LZ992177.1 JP 2017532001-A/264: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TGAGTCGTCGAG
>LZ992176.1 JP 2017532001-A/263: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TTCGAGCGATTT
>LZ992175.1 JP 2017532001-A/262: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GTCGGGGACTAT
>LZ992174.1 JP 2017532001-A/261: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
AAGGTCGCCCAT
>LZ992173.1 JP 2017532001-A/260: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TAACGTCGGAGC
>LZ992172.1 JP 2017532001-A/259: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TGCGCCTCCAGT
>LZ992171.1 JP 2017532001-A/258: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CCGATTCCTTCG
>LZ992170.1 JP 2017532001-A/257: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CTCCGTATCTCG
>LZ992169.1 JP 2017532001-A/256: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GCGTCAATGTTC
>LZ992168.1 JP 2017532001-A/255: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
ATCGTGCCCTAA
>LZ992167.1 JP 2017532001-A/254: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
ACACCGGTCTTC
>LZ992166.1 JP 2017532001-A/253: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GATTCATCAGCG
>LZ992165.1 JP 2017532001-A/252: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GAACCCGTCCTA
>LZ992164.1 JP 2017532001-A/251: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CGCCGGTGGAAT
>LZ992163.1 JP 2017532001-A/250: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TTTCAAGGCCGG
>LZ992162.1 JP 2017532001-A/249: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TCGTATCCCTAC
>LZ992161.1 JP 2017532001-A/248: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CAGGACGTCCGT
>LZ992160.1 JP 2017532001-A/247: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
ACTCCGTAGTGA
>LZ992159.1 JP 2017532001-A/246: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TCGTCGGGTGCA
>LZ992158.1 JP 2017532001-A/245: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GTCTCACGATCG
>LZ992157.1 JP 2017532001-A/244: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GAGTCGATACGC
>LZ992156.1 JP 2017532001-A/243: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
AACCAAGATACG
>LZ992155.1 JP 2017532001-A/242: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CACGAAATTACC
>LZ992154.1 JP 2017532001-A/241: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TACGGTAAGTCG
>LZ992153.1 JP 2017532001-A/240: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GCCTGTGCCGTA
>LZ992152.1 JP 2017532001-A/239: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
CGGTACTCTTAC
>LZ992151.1 JP 2017532001-A/238: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GCATGGTACGGA
>LZ992150.1 JP 2017532001-A/237: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GCCGAATTCCTC
>LZ992149.1 JP 2017532001-A/236: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
ATGGAAACGCAT
>LZ992148.1 JP 2017532001-A/235: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TGTCGCATGTTA
>LZ992147.1 JP 2017532001-A/234: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GGCGTTAATGAT
>LZ992146.1 JP 2017532001-A/233: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TAGGTCGACCAG
>LZ992145.1 JP 2017532001-A/232: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
ACGTCGCCTGAT
>LZ992144.1 JP 2017532001-A/231: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
ACTGCGTGTTAA
>LZ992143.1 JP 2017532001-A/230: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
ACTCCCCGTAGG
>LZ992142.1 JP 2017532001-A/229: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TCGGTGACATGT
>LZ992141.1 JP 2017532001-A/228: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
TAGCGGGTAAGC
>LZ991940.1 JP 2017532001-A/27: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GTTTTAGAGCTA
>LZ991938.1 JP 2017532001-A/25: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GTTTTAGAGCTA
>LZ991915.1 JP 2017532001-A/2: SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH OPTIMIZED FUNCTIONAL CRISPR-CAS SYSTEMS
GCTAGAATAGCA
>LZ991160.1 WO 2017209053-A/17: Novel genetically engineered vaccinia viruses
GCTAGCGAATTC
>LZ989882.1 JP 2017212998-A/351: METHODS OF TRANSCRIPTION ACTIVATOR LIKE EFFECTOR ASSEMBLY
TCGCGCAGCCAG
>LZ986350.1 JP 2017216961-A/29: Peptide library containing non natural amino acid
GGGGGAGGCAGC
>LY504984.1 KR 1020170020929-A/43: DNA AMPLIFICATION TECHNOLOGY
GGACGGGAAAAA
>LY502629.1 KR 1020170020505-A/6: NUCLEASE-MEDIATED DNA ASSEMBLY
AAGGCTAGTCCG
>LY502654.1 KR 1020170023118-A/7: METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATIONS AND METHODS OF USE
AAGGCTAGTCCG
>LY494530.1 KR 1020170017939-A/122: Antisense nucleic acid
CGCCGCCATTTC
>LY494529.1 KR 1020170017939-A/121: Antisense nucleic acid
CTGTTAGCCACT
>LY494526.1 KR 1020170017939-A/118: Antisense nucleic acid
TCTGTTAGCCAC
>LY494525.1 KR 1020170017939-A/117: Antisense nucleic acid
TTGTGTCTTTCT
>LY494522.1 KR 1020170017939-A/114: Antisense nucleic acid
CCGCCATTTCTC
>LY494004.1 KR 1020170036659-A/7: IMPROVED ASSAY METHODS
ACATCGGTAGTT
>LY493733.1 KR 1020170026332-A/9: METHODS AND COMPOSITIONS FOR MODIFYING GENOMIC DNA
GACNNNNNNGTC
>LY493732.1 KR 1020170026332-A/8: METHODS AND COMPOSITIONS FOR MODIFYING GENOMIC DNA
CCANNNNNNTGG
>LY493727.1 KR 1020170026332-A/3: METHODS AND COMPOSITIONS FOR MODIFYING GENOMIC DNA
CGANNNNNNTGC
>LY491720.1 KR 1020170057105-A/1: RGEN RNP delivery method using 5'-phosphate removed RNA
GTTTTAGAGCTA
>LY491393.1 KR 1020170056135-A/12: SNP marker regulating palmitoleic acid level in the pork and uses thereof
YTTGGGGTTGCT
>LY491388.1 KR 1020170056135-A/7: SNP marker regulating palmitoleic acid level in the pork and uses thereof
YCTCTCCAGCTT
>LY489241.1 KR 1020170043793-A/5: Recombinant EC-SOD gene optimized for plant expression and method for mass producing recombinant EC-SOD protein therefrom
CACGATGAGCTC
>LY486326.1 KR 1020170011800-A/2: composition for screening of proteasome inhibitor and method for screening of proteasome inhibitor using the same
AAGGACGAGCTG
>LY486309.1 KR 1020170011588-A/4: A method for diagnosing a metastasis of radiation-induced lung fibrosis and a diagnostic kit using the method
CTCCCTTCAATC
>LY513233.1 KR 1020170054537-A/23: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
ATTCACTTTCAT
>LY513232.1 KR 1020170054537-A/22: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TTCACTTTCATA
>LY513231.1 KR 1020170054537-A/21: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TCACTTTCATAA
>LY513229.1 KR 1020170054537-A/19: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
CACTTTCATAAT
>LY513227.1 KR 1020170054537-A/17: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
ACTTTCATAATG
>LY513225.1 KR 1020170054537-A/15: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
CTTTCATAATGC
>LY513223.1 KR 1020170054537-A/13: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TTTCATAATGCT
>LY513221.1 KR 1020170054537-A/11: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TTCATAATGCTG
>LY513691.1 KR 1020170056032-A/290: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TTTCACCTGGGT
>LY513690.1 KR 1020170056032-A/289: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TTTTCACCTGGG
>LY513689.1 KR 1020170056032-A/288: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CTTTTCACCTGG
>LY513686.1 KR 1020170056032-A/285: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
ACTTTTCACCTG
>LY513683.1 KR 1020170056032-A/282: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TTCACCTGGGTC
>LY513675.1 KR 1020170056032-A/274: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TCCTAGAAAGAA
>LY513674.1 KR 1020170056032-A/273: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
GTCCTAGAAAGA
>LY513673.1 KR 1020170056032-A/272: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
AGTCCTAGAAAG
>LY513670.1 KR 1020170056032-A/269: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CAGTCCTAGAAA
>LY513667.1 KR 1020170056032-A/266: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CCTAGAAAGAAA
>LY513659.1 KR 1020170056032-A/258: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CAATCAGTCCTA
>LY513658.1 KR 1020170056032-A/257: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CACAATCAGTCC
>LY513656.1 KR 1020170056032-A/255: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CCACAATCAGTC
>LY513653.1 KR 1020170056032-A/252: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
AATCAGTCCTAG
>LY513647.1 KR 1020170056032-A/246: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
ACAATCAGTCCT
>LY513573.1 KR 1020170056032-A/172: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TTTCACCTGGGT
>LY513572.1 KR 1020170056032-A/171: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TTTTCACCTGGG
>LY513571.1 KR 1020170056032-A/170: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CTTTTCACCTGG
>LY513568.1 KR 1020170056032-A/167: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
ACTTTTCACCTG
>LY513565.1 KR 1020170056032-A/164: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TTCACCTGGGTC
>LY513557.1 KR 1020170056032-A/156: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
TCCTAGAAAGAA
>LY513556.1 KR 1020170056032-A/155: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
GTCCTAGAAAGA
>LY513555.1 KR 1020170056032-A/154: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
AGTCCTAGAAAG
>LY513552.1 KR 1020170056032-A/151: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CAGTCCTAGAAA
>LY513549.1 KR 1020170056032-A/148: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CCTAGAAAGAAA
>LY513541.1 KR 1020170056032-A/140: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CAATCAGTCCTA
>LY513540.1 KR 1020170056032-A/139: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
ACAATCAGTCCT
>LY513539.1 KR 1020170056032-A/138: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CACAATCAGTCC
>LY513536.1 KR 1020170056032-A/135: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
CCACAATCAGTC
>LY513533.1 KR 1020170056032-A/132: SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
AATCAGTCCTAG
>LY513219.1 KR 1020170054537-A/9: COMPOSITION AND METHODS FOR MODULATING OF SMN2 SPLICING IN A SUBJECT
TCATAATGCTGG
>LY511119.1 KR 1020170054445-A/4: METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING AND CORRECTION IN HEMATOPOIETIC STEM CELLS
ACTCCTGAGGAG
>LY510980.1 KR 1020170040387-A/20: NUCLEIC ACIDS
CTACNNNNNNAG
>LY510889.1 KR 1020170049565-A/2: MODIFIED NUCLEOTIDES FOR SYNTHESIS OF NUCLEIC ACIDS, A KIT CONTAINING SUCH NUCLEOTIDES AND THEIR USE FOR THE PRODUCTION OF SYNTHETIC NUCLEIC ACID SEQUENCES OR GENES
GTCCGCTTGGCT
>LY510505.1 KR 1020170042794-A/430: MUTANT CSGG PORES
TTTTTTTTTTTT
>LY509907.1 KR 1020170036814-A/670: NOVEL RABBIT ANTIBODY HUMANIZATION METHODS AND HUMANIZED RABBIT ANTIBODIES
GCCTATGACTTG
>LY508213.1 KR 1020170036792-A/56: GENETIC TARGETING IN NON-CONVENTIONAL YEAST USING AN RNA-GUIDED ENDONUCLEASE
GTTTTAGAGCTA
>LY509335.1 KR 1020170042366-A/181: DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF
AGAGGTGACATG
>LY509030.1 KR 1020170036801-A/72: RNA-GUIDED SYSTEMS FOR PROBING AND MAPPING OF NUCLEIC ACIDS
CGAACAATCGTA
>LY509029.1 KR 1020170036801-A/71: RNA-GUIDED SYSTEMS FOR PROBING AND MAPPING OF NUCLEIC ACIDS
CGTAACTAACGA
>LY509028.1 KR 1020170036801-A/70: RNA-GUIDED SYSTEMS FOR PROBING AND MAPPING OF NUCLEIC ACIDS
TCGAATAGTCGT
>LY509027.1 KR 1020170036801-A/69: RNA-GUIDED SYSTEMS FOR PROBING AND MAPPING OF NUCLEIC ACIDS
CCAGACGAATCG
>LY509026.1 KR 1020170036801-A/68: RNA-GUIDED SYSTEMS FOR PROBING AND MAPPING OF NUCLEIC ACIDS
TCGTTACGACCA
>LY509025.1 KR 1020170036801-A/67: RNA-GUIDED SYSTEMS FOR PROBING AND MAPPING OF NUCLEIC ACIDS
CGAAGTACTACG
>LY509024.1 KR 1020170036801-A/66: RNA-GUIDED SYSTEMS FOR PROBING AND MAPPING OF NUCLEIC ACIDS
CGTACTGAACGA
>LY509023.1 KR 1020170036801-A/65: RNA-GUIDED SYSTEMS FOR PROBING AND MAPPING OF NUCLEIC ACIDS
TCGATAGTACGT
>LY509022.1 KR 1020170036801-A/64: RNA-GUIDED SYSTEMS FOR PROBING AND MAPPING OF NUCLEIC ACIDS
CCATACTCGTCG
>LY509021.1 KR 1020170036801-A/63: RNA-GUIDED SYSTEMS FOR PROBING AND MAPPING OF NUCLEIC ACIDS
CGTCGATTACCA
>LY506776.1 KR 1020170043543-A/6: MODIFIED OLIGONUCLEOTIDES AND METHODS FOR THEIR SYNTHESIS
TCTCTCCCTTCC
>LZ967202.1 JP 2017197545-A/14597: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
ATGGCCCTGTAG
>LZ958226.1 JP 2017197545-A/5621: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
ATGGCCCTGTAG
>LZ950764.1 JP 2016521993-A/106: DELIVERY, ENGINEERING AND OPTIMIZATION OF TANDEM GUIDE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
CGACCCTGGAAA
>LZ950721.1 JP 2016521993-A/63: DELIVERY, ENGINEERING AND OPTIMIZATION OF TANDEM GUIDE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
GTTTTAGAGCTA
>LZ948196.1 JP 2016521994-A/265: OPTIMIZED CRISPR-CAS DOUBLE NICKASE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
GGNNNNNNNNCC
>LZ948193.1 JP 2016521994-A/262: OPTIMIZED CRISPR-CAS DOUBLE NICKASE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
CCNNNNNNNNGG
>LZ948033.1 JP 2016521994-A/102: OPTIMIZED CRISPR-CAS DOUBLE NICKASE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
CGACCCTGGAAA
>LZ971690.1 JP 2017197545-A/19085: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
ATGGCCCTGTAG
>LZ950253.1 JP 2016521995-A/439: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GGNNNNNNNNCC
>LZ950250.1 JP 2016521995-A/436: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CCNNNNNNNNGG
>LZ950225.1 JP 2016521995-A/411: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GGTAATTTCGTG
>LZ950224.1 JP 2016521995-A/410: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
AGTAAAGGCGCT
>LZ950223.1 JP 2016521995-A/409: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TAGCTAACCGTT
>LZ950222.1 JP 2016521995-A/408: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GTTAACAGCGTG
>LZ950221.1 JP 2016521995-A/407: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GGTCGTCATCAA
>LZ950220.1 JP 2016521995-A/406: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GTCGTGGACTAC
>LZ950219.1 JP 2016521995-A/405: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CTTCGCAAGGAG
>LZ950218.1 JP 2016521995-A/404: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
AAGATCGGTAGC
>LZ950217.1 JP 2016521995-A/403: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGCGTCAGATAT
>LZ950216.1 JP 2016521995-A/402: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CTATGCCGTGCA
>LZ950215.1 JP 2016521995-A/401: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGTACGGCACAG
>LZ950214.1 JP 2016521995-A/400: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACGCGTCAGATA
>LZ950213.1 JP 2016521995-A/399: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TCGACGACTCAC
>LZ950212.1 JP 2016521995-A/398: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGACTTTTTGCA
>LZ950211.1 JP 2016521995-A/397: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TCGATGGTAAAC
>LZ950210.1 JP 2016521995-A/396: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCGTTATCAGAA
>LZ950209.1 JP 2016521995-A/395: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CCCAAACGGTTA
>LZ950208.1 JP 2016521995-A/394: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGTAGCCATGTT
>LZ950207.1 JP 2016521995-A/393: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TTTACCATCGAA
>LZ950206.1 JP 2016521995-A/392: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGTGCCCTGAAC
>LZ950205.1 JP 2016521995-A/391: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGAAAACGTGGC
>LZ950204.1 JP 2016521995-A/390: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CTTAGTCGGCCA
>LZ950203.1 JP 2016521995-A/389: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TAAAGCGACCCG
>LZ950202.1 JP 2016521995-A/388: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CACGAGGTATGC
>LZ950201.1 JP 2016521995-A/387: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGGTGTATTGAG
>LZ950200.1 JP 2016521995-A/386: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACACCGAAAACG
>LZ950199.1 JP 2016521995-A/385: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCAGGACGTCCG
>LZ950198.1 JP 2016521995-A/384: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TCACCCAAAGCG
>LZ950197.1 JP 2016521995-A/383: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACTATGCGTAGG
>LZ950196.1 JP 2016521995-A/382: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TTGACTGCGGCG
>LZ950195.1 JP 2016521995-A/381: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TGGGACACCGGT
>LZ950194.1 JP 2016521995-A/380: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCCAACCCGCAC
>LZ950193.1 JP 2016521995-A/379: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CCCCTACGGCAC
>LZ950192.1 JP 2016521995-A/378: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
AGTGGCGATGAC
>LZ950191.1 JP 2016521995-A/377: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGTCATGAATAA
>LZ950190.1 JP 2016521995-A/376: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGATTCCTTCGT
>LZ950189.1 JP 2016521995-A/375: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CCAAACGGTTAA
>LZ950188.1 JP 2016521995-A/374: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TTCATAACCGGC
>LZ950187.1 JP 2016521995-A/373: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGCTACATAGCA
>LZ950186.1 JP 2016521995-A/372: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACTCGATACCAT
>LZ950185.1 JP 2016521995-A/371: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
AGGAAGTATCGC
>LZ950184.1 JP 2016521995-A/370: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TTTACGCAGAGG
>LZ950183.1 JP 2016521995-A/369: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TGAGTCGTCGAG
>LZ950182.1 JP 2016521995-A/368: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TTCGAGCGATTT
>LZ950181.1 JP 2016521995-A/367: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GTCGGGGACTAT
>LZ950180.1 JP 2016521995-A/366: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
AAGGTCGCCCAT
>LZ950179.1 JP 2016521995-A/365: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TAACGTCGGAGC
>LZ950178.1 JP 2016521995-A/364: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TGCGCCTCCAGT
>LZ950177.1 JP 2016521995-A/363: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CCGATTCCTTCG
>LZ950176.1 JP 2016521995-A/362: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CTCCGTATCTCG
>LZ950175.1 JP 2016521995-A/361: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCGTCAATGTTC
>LZ950174.1 JP 2016521995-A/360: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ATCGTGCCCTAA
>LZ950173.1 JP 2016521995-A/359: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACACCGGTCTTC
>LZ950172.1 JP 2016521995-A/358: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GATTCATCAGCG
>LZ950171.1 JP 2016521995-A/357: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GAACCCGTCCTA
>LZ950170.1 JP 2016521995-A/356: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGCCGGTGGAAT
>LZ950169.1 JP 2016521995-A/355: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TTTCAAGGCCGG
>LZ950168.1 JP 2016521995-A/354: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TCGTATCCCTAC
>LZ950167.1 JP 2016521995-A/353: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CAGGACGTCCGT
>LZ950166.1 JP 2016521995-A/352: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACTCCGTAGTGA
>LZ950165.1 JP 2016521995-A/351: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TCGTCGGGTGCA
>LZ950164.1 JP 2016521995-A/350: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GTCTCACGATCG
>LZ950163.1 JP 2016521995-A/349: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GAGTCGATACGC
>LZ950162.1 JP 2016521995-A/348: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
AACCAAGATACG
>LZ950161.1 JP 2016521995-A/347: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CACGAAATTACC
>LZ950160.1 JP 2016521995-A/346: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TACGGTAAGTCG
>LZ950159.1 JP 2016521995-A/345: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCCTGTGCCGTA
>LZ950158.1 JP 2016521995-A/344: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGGTACTCTTAC
>LZ950157.1 JP 2016521995-A/343: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCATGGTACGGA
>LZ950156.1 JP 2016521995-A/342: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCCGAATTCCTC
>LZ950155.1 JP 2016521995-A/341: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ATGGAAACGCAT
>LZ950154.1 JP 2016521995-A/340: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TGTCGCATGTTA
>LZ950153.1 JP 2016521995-A/339: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GGCGTTAATGAT
>LZ950152.1 JP 2016521995-A/338: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TAGGTCGACCAG
>LZ950151.1 JP 2016521995-A/337: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACGTCGCCTGAT
>LZ950150.1 JP 2016521995-A/336: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACTGCGTGTTAA
>LZ950149.1 JP 2016521995-A/335: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACTCCCCGTAGG
>LZ950148.1 JP 2016521995-A/334: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TCGGTGACATGT
>LZ950147.1 JP 2016521995-A/333: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TAGCGGGTAAGC
>LZ949927.1 JP 2016521995-A/113: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGACCCTGGAAA
>LZ949887.1 JP 2016521995-A/73: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GTTTTAGAGCTA
>LZ949876.1 JP 2016521995-A/62: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GTTTTAGAGCTA
>LZ949711.1 JP 2016523082-A/439: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GGNNNNNNNNCC
>LZ949708.1 JP 2016523082-A/436: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CCNNNNNNNNGG
>LZ949683.1 JP 2016523082-A/411: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GGTAATTTCGTG
>LZ949682.1 JP 2016523082-A/410: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
AGTAAAGGCGCT
>LZ949681.1 JP 2016523082-A/409: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TAGCTAACCGTT
>LZ949680.1 JP 2016523082-A/408: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GTTAACAGCGTG
>LZ949679.1 JP 2016523082-A/407: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GGTCGTCATCAA
>LZ949678.1 JP 2016523082-A/406: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GTCGTGGACTAC
>LZ949677.1 JP 2016523082-A/405: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CTTCGCAAGGAG
>LZ949676.1 JP 2016523082-A/404: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
AAGATCGGTAGC
>LZ949675.1 JP 2016523082-A/403: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGCGTCAGATAT
>LZ949674.1 JP 2016523082-A/402: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CTATGCCGTGCA
>LZ949673.1 JP 2016523082-A/401: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGTACGGCACAG
>LZ949672.1 JP 2016523082-A/400: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACGCGTCAGATA
>LZ949671.1 JP 2016523082-A/399: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TCGACGACTCAC
>LZ949670.1 JP 2016523082-A/398: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGACTTTTTGCA
>LZ949669.1 JP 2016523082-A/397: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TCGATGGTAAAC
>LZ949668.1 JP 2016523082-A/396: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCGTTATCAGAA
>LZ949667.1 JP 2016523082-A/395: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CCCAAACGGTTA
>LZ949666.1 JP 2016523082-A/394: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGTAGCCATGTT
>LZ949665.1 JP 2016523082-A/393: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TTTACCATCGAA
>LZ949664.1 JP 2016523082-A/392: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGTGCCCTGAAC
>LZ949663.1 JP 2016523082-A/391: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGAAAACGTGGC
>LZ949662.1 JP 2016523082-A/390: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CTTAGTCGGCCA
>LZ949661.1 JP 2016523082-A/389: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TAAAGCGACCCG
>LZ949660.1 JP 2016523082-A/388: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CACGAGGTATGC
>LZ949659.1 JP 2016523082-A/387: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGGTGTATTGAG
>LZ949658.1 JP 2016523082-A/386: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACACCGAAAACG
>LZ949657.1 JP 2016523082-A/385: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCAGGACGTCCG
>LZ949656.1 JP 2016523082-A/384: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TCACCCAAAGCG
>LZ949655.1 JP 2016523082-A/383: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACTATGCGTAGG
>LZ949654.1 JP 2016523082-A/382: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TTGACTGCGGCG
>LZ949653.1 JP 2016523082-A/381: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TGGGACACCGGT
>LZ949652.1 JP 2016523082-A/380: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCCAACCCGCAC
>LZ949651.1 JP 2016523082-A/379: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CCCCTACGGCAC
>LZ949650.1 JP 2016523082-A/378: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
AGTGGCGATGAC
>LZ949649.1 JP 2016523082-A/377: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGTCATGAATAA
>LZ949648.1 JP 2016523082-A/376: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGATTCCTTCGT
>LZ949647.1 JP 2016523082-A/375: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CCAAACGGTTAA
>LZ949646.1 JP 2016523082-A/374: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TTCATAACCGGC
>LZ949645.1 JP 2016523082-A/373: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGCTACATAGCA
>LZ949644.1 JP 2016523082-A/372: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACTCGATACCAT
>LZ949643.1 JP 2016523082-A/371: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
AGGAAGTATCGC
>LZ949642.1 JP 2016523082-A/370: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TTTACGCAGAGG
>LZ949641.1 JP 2016523082-A/369: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TGAGTCGTCGAG
>LZ949640.1 JP 2016523082-A/368: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TTCGAGCGATTT
>LZ949639.1 JP 2016523082-A/367: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GTCGGGGACTAT
>LZ949638.1 JP 2016523082-A/366: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
AAGGTCGCCCAT
>LZ949637.1 JP 2016523082-A/365: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TAACGTCGGAGC
>LZ949636.1 JP 2016523082-A/364: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TGCGCCTCCAGT
>LZ949635.1 JP 2016523082-A/363: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CCGATTCCTTCG
>LZ949634.1 JP 2016523082-A/362: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CTCCGTATCTCG
>LZ949633.1 JP 2016523082-A/361: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCGTCAATGTTC
>LZ949632.1 JP 2016523082-A/360: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ATCGTGCCCTAA
>LZ949631.1 JP 2016523082-A/359: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACACCGGTCTTC
>LZ949630.1 JP 2016523082-A/358: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GATTCATCAGCG
>LZ949629.1 JP 2016523082-A/357: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GAACCCGTCCTA
>LZ949628.1 JP 2016523082-A/356: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGCCGGTGGAAT
>LZ949627.1 JP 2016523082-A/355: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TTTCAAGGCCGG
>LZ949626.1 JP 2016523082-A/354: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TCGTATCCCTAC
>LZ949625.1 JP 2016523082-A/353: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CAGGACGTCCGT
>LZ949624.1 JP 2016523082-A/352: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACTCCGTAGTGA
>LZ949623.1 JP 2016523082-A/351: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TCGTCGGGTGCA
>LZ949622.1 JP 2016523082-A/350: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GTCTCACGATCG
>LZ949621.1 JP 2016523082-A/349: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GAGTCGATACGC
>LZ949620.1 JP 2016523082-A/348: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
AACCAAGATACG
>LZ949619.1 JP 2016523082-A/347: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CACGAAATTACC
>LZ949618.1 JP 2016523082-A/346: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TACGGTAAGTCG
>LZ949617.1 JP 2016523082-A/345: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCCTGTGCCGTA
>LZ949616.1 JP 2016523082-A/344: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGGTACTCTTAC
>LZ949615.1 JP 2016523082-A/343: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCATGGTACGGA
>LZ949614.1 JP 2016523082-A/342: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GCCGAATTCCTC
>LZ949613.1 JP 2016523082-A/341: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ATGGAAACGCAT
>LZ949612.1 JP 2016523082-A/340: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TGTCGCATGTTA
>LZ949611.1 JP 2016523082-A/339: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GGCGTTAATGAT
>LZ949610.1 JP 2016523082-A/338: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TAGGTCGACCAG
>LZ949609.1 JP 2016523082-A/337: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACGTCGCCTGAT
>LZ949608.1 JP 2016523082-A/336: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACTGCGTGTTAA
>LZ949607.1 JP 2016523082-A/335: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
ACTCCCCGTAGG
>LZ949606.1 JP 2016523082-A/334: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TCGGTGACATGT
>LZ949605.1 JP 2016523082-A/333: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
TAGCGGGTAAGC
>LZ949385.1 JP 2016523082-A/113: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
CGACCCTGGAAA
>LZ949345.1 JP 2016523082-A/73: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GTTTTAGAGCTA
>LZ949334.1 JP 2016523082-A/62: DELIVERY, ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETING AND MODELING DISEASES AND DISORDERS OF POST MITOTIC CELLS
GTTTTAGAGCTA
>LZ951089.1 JP 2016521993-A/431: DELIVERY, ENGINEERING AND OPTIMIZATION OF TANDEM GUIDE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
AATTATTAATTA
>LZ951008.1 JP 2016521993-A/350: DELIVERY, ENGINEERING AND OPTIMIZATION OF TANDEM GUIDE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
GGNNNNNNNNCC
>LZ951005.1 JP 2016521993-A/347: DELIVERY, ENGINEERING AND OPTIMIZATION OF TANDEM GUIDE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
CCNNNNNNNNGG
>LZ949136.1 JP 2016524472-A/757: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GGNNNNNNNNCC
>LZ949133.1 JP 2016524472-A/754: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CCNNNNNNNNGG
>LZ949108.1 JP 2016524472-A/729: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GGTAATTTCGTG
>LZ949107.1 JP 2016524472-A/728: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
AGTAAAGGCGCT
>LZ949106.1 JP 2016524472-A/727: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TAGCTAACCGTT
>LZ949105.1 JP 2016524472-A/726: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GTTAACAGCGTG
>LZ949104.1 JP 2016524472-A/725: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GGTCGTCATCAA
>LZ949103.1 JP 2016524472-A/724: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GTCGTGGACTAC
>LZ949102.1 JP 2016524472-A/723: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CTTCGCAAGGAG
>LZ949101.1 JP 2016524472-A/722: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
AAGATCGGTAGC
>LZ949100.1 JP 2016524472-A/721: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CGCGTCAGATAT
>LZ949099.1 JP 2016524472-A/720: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CTATGCCGTGCA
>LZ949098.1 JP 2016524472-A/719: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CGTACGGCACAG
>LZ949097.1 JP 2016524472-A/718: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
ACGCGTCAGATA
>LZ949096.1 JP 2016524472-A/717: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TCGACGACTCAC
>LZ949095.1 JP 2016524472-A/716: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CGACTTTTTGCA
>LZ949094.1 JP 2016524472-A/715: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TCGATGGTAAAC
>LZ949093.1 JP 2016524472-A/714: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GCGTTATCAGAA
>LZ949092.1 JP 2016524472-A/713: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CCCAAACGGTTA
>LZ949091.1 JP 2016524472-A/712: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CGTAGCCATGTT
>LZ949090.1 JP 2016524472-A/711: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TTTACCATCGAA
>LZ949089.1 JP 2016524472-A/710: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CGTGCCCTGAAC
>LZ949088.1 JP 2016524472-A/709: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CGAAAACGTGGC
>LZ949087.1 JP 2016524472-A/708: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CTTAGTCGGCCA
>LZ949086.1 JP 2016524472-A/707: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TAAAGCGACCCG
>LZ949085.1 JP 2016524472-A/706: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CACGAGGTATGC
>LZ949084.1 JP 2016524472-A/705: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CGGTGTATTGAG
>LZ949083.1 JP 2016524472-A/704: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
ACACCGAAAACG
>LZ949082.1 JP 2016524472-A/703: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GCAGGACGTCCG
>LZ949081.1 JP 2016524472-A/702: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TCACCCAAAGCG
>LZ949080.1 JP 2016524472-A/701: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
ACTATGCGTAGG
>LZ949079.1 JP 2016524472-A/700: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TTGACTGCGGCG
>LZ949078.1 JP 2016524472-A/699: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TGGGACACCGGT
>LZ949077.1 JP 2016524472-A/698: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GCCAACCCGCAC
>LZ949076.1 JP 2016524472-A/697: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CCCCTACGGCAC
>LZ949075.1 JP 2016524472-A/696: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
AGTGGCGATGAC
>LZ949074.1 JP 2016524472-A/695: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CGTCATGAATAA
>LZ949073.1 JP 2016524472-A/694: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CGATTCCTTCGT
>LZ949072.1 JP 2016524472-A/693: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CCAAACGGTTAA
>LZ949071.1 JP 2016524472-A/692: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TTCATAACCGGC
>LZ949070.1 JP 2016524472-A/691: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CGCTACATAGCA
>LZ949069.1 JP 2016524472-A/690: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
ACTCGATACCAT
>LZ949068.1 JP 2016524472-A/689: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
AGGAAGTATCGC
>LZ949067.1 JP 2016524472-A/688: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TTTACGCAGAGG
>LZ949066.1 JP 2016524472-A/687: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TGAGTCGTCGAG
>LZ949065.1 JP 2016524472-A/686: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TTCGAGCGATTT
>LZ949064.1 JP 2016524472-A/685: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GTCGGGGACTAT
>LZ949063.1 JP 2016524472-A/684: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
AAGGTCGCCCAT
>LZ949062.1 JP 2016524472-A/683: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TAACGTCGGAGC
>LZ949061.1 JP 2016524472-A/682: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TGCGCCTCCAGT
>LZ949060.1 JP 2016524472-A/681: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CCGATTCCTTCG
>LZ949059.1 JP 2016524472-A/680: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CTCCGTATCTCG
>LZ949058.1 JP 2016524472-A/679: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GCGTCAATGTTC
>LZ949057.1 JP 2016524472-A/678: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
ATCGTGCCCTAA
>LZ949056.1 JP 2016524472-A/677: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
ACACCGGTCTTC
>LZ949055.1 JP 2016524472-A/676: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GATTCATCAGCG
>LZ949054.1 JP 2016524472-A/675: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GAACCCGTCCTA
>LZ949053.1 JP 2016524472-A/674: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CGCCGGTGGAAT
>LZ949052.1 JP 2016524472-A/673: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TTTCAAGGCCGG
>LZ949051.1 JP 2016524472-A/672: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TCGTATCCCTAC
>LZ949050.1 JP 2016524472-A/671: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CAGGACGTCCGT
>LZ949049.1 JP 2016524472-A/670: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
ACTCCGTAGTGA
>LZ949048.1 JP 2016524472-A/669: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TCGTCGGGTGCA
>LZ949047.1 JP 2016524472-A/668: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GTCTCACGATCG
>LZ949046.1 JP 2016524472-A/667: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GAGTCGATACGC
>LZ949045.1 JP 2016524472-A/666: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
AACCAAGATACG
>LZ949044.1 JP 2016524472-A/665: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CACGAAATTACC
>LZ949043.1 JP 2016524472-A/664: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TACGGTAAGTCG
>LZ949042.1 JP 2016524472-A/663: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GCCTGTGCCGTA
>LZ949041.1 JP 2016524472-A/662: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
CGGTACTCTTAC
>LZ949040.1 JP 2016524472-A/661: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GCATGGTACGGA
>LZ949039.1 JP 2016524472-A/660: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GCCGAATTCCTC
>LZ949038.1 JP 2016524472-A/659: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
ATGGAAACGCAT
>LZ949037.1 JP 2016524472-A/658: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TGTCGCATGTTA
>LZ949036.1 JP 2016524472-A/657: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
GGCGTTAATGAT
>LZ949035.1 JP 2016524472-A/656: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TAGGTCGACCAG
>LZ949034.1 JP 2016524472-A/655: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
ACGTCGCCTGAT
>LZ949033.1 JP 2016524472-A/654: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
ACTGCGTGTTAA
>LZ949032.1 JP 2016524472-A/653: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
ACTCCCCGTAGG
>LZ949031.1 JP 2016524472-A/652: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TCGGTGACATGT
>LZ949030.1 JP 2016524472-A/651: DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
TAGCGGGTAAGC
>LZ947990.1 JP 2016521994-A/59: OPTIMIZED CRISPR-CAS DOUBLE NICKASE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
GTTTTAGAGCTA
>LZ943126.1 JP 2016533182-A/9: METHODS AND SYSTEMS FOR IDENTIFYING DISEASE-INDUCED MUTATIONS
GGATCGAAATGG
>LZ985951.1 JP 2017529872-A/23: Aptamers for use against autoantibody-associated diseases
GGTTGGTGTGGT
>LZ976178.1 JP 2017197545-A/23573: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
ATGGCCCTTTAG
>LZ255086.1 JP 2016185991-A/54: PEPTIDE OLIGONUCLEOTIDE CONJUGATES
CAGGCAGGCAGG
>LZ255080.1 JP 2016185991-A/48: PEPTIDE OLIGONUCLEOTIDE CONJUGATES
GCAGCAGCAGCA
>LZ255076.1 JP 2016185991-A/44: PEPTIDE OLIGONUCLEOTIDE CONJUGATES
AGCAGCAGCAGC
>LZ255072.1 JP 2016185991-A/40: PEPTIDE OLIGONUCLEOTIDE CONJUGATES
CAGCAGCAGCAG
>LZ254283.1 JP 2016185981-A/3: Cancer diagnosis or treatment using an anti-Desmoglein3 antibody
TGGGGTGACTCT
>LZ254086.1 JP 2016182140-A/58: ENGINEERING AND OPTIMIZATION OF IMPROVED SYSTEMS, METHODS AND ENZYME COMPOSITIONS FOR SEQUENCE MANIPULATION
GTTTTAGAGCTA
>LZ253168.1 JP 2016182143-A/40: NOVEL DNA-BINDING PROTEINS AND USES THEREOF
CCAGAGNNNNNN
>LZ253167.1 JP 2016182143-A/39: NOVEL DNA-BINDING PROTEINS AND USES THEREOF
CCAGAGNNNNNN
>LZ253166.1 JP 2016182143-A/38: NOVEL DNA-BINDING PROTEINS AND USES THEREOF
GGTCTCNNNNNN
>LZ253165.1 JP 2016182143-A/37: NOVEL DNA-BINDING PROTEINS AND USES THEREOF
GGTCTCNNNNNN
>LZ253022.1 JP 2016171817-A/173: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GGTAATTTCGTG
>LZ253021.1 JP 2016171817-A/172: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
AGTAAAGGCGCT
>LZ253020.1 JP 2016171817-A/171: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TAGCTAACCGTT
>LZ253019.1 JP 2016171817-A/170: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GTTAACAGCGTG
>LZ253018.1 JP 2016171817-A/169: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GGTCGTCATCAA
>LZ253017.1 JP 2016171817-A/168: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GTCGTGGACTAC
>LZ253016.1 JP 2016171817-A/167: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CTTCGCAAGGAG
>LZ253015.1 JP 2016171817-A/166: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
AAGATCGGTAGC
>LZ253014.1 JP 2016171817-A/165: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CGCGTCAGATAT
>LZ253013.1 JP 2016171817-A/164: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CTATGCCGTGCA
>LZ253012.1 JP 2016171817-A/163: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CGTACGGCACAG
>LZ253011.1 JP 2016171817-A/162: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
ACGCGTCAGATA
>LZ253010.1 JP 2016171817-A/161: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TCGACGACTCAC
>LZ253009.1 JP 2016171817-A/160: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CGACTTTTTGCA
>LZ253008.1 JP 2016171817-A/159: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TCGATGGTAAAC
>LZ253007.1 JP 2016171817-A/158: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GCGTTATCAGAA
>LZ253006.1 JP 2016171817-A/157: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CCCAAACGGTTA
>LZ253005.1 JP 2016171817-A/156: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CGTAGCCATGTT
>LZ253004.1 JP 2016171817-A/155: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TTTACCATCGAA
>LZ253003.1 JP 2016171817-A/154: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CGTGCCCTGAAC
>LZ253002.1 JP 2016171817-A/153: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CGAAAACGTGGC
>LZ253001.1 JP 2016171817-A/152: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CTTAGTCGGCCA
>LZ253000.1 JP 2016171817-A/151: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TAAAGCGACCCG
>LZ252999.1 JP 2016171817-A/150: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CACGAGGTATGC
>LZ252998.1 JP 2016171817-A/149: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CGGTGTATTGAG
>LZ252997.1 JP 2016171817-A/148: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
ACACCGAAAACG
>LZ252996.1 JP 2016171817-A/147: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GCAGGACGTCCG
>LZ252995.1 JP 2016171817-A/146: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TCACCCAAAGCG
>LZ252994.1 JP 2016171817-A/145: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
ACTATGCGTAGG
>LZ252993.1 JP 2016171817-A/144: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TTGACTGCGGCG
>LZ252992.1 JP 2016171817-A/143: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TGGGACACCGGT
>LZ252991.1 JP 2016171817-A/142: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GCCAACCCGCAC
>LZ252990.1 JP 2016171817-A/141: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CCCCTACGGCAC
>LZ252989.1 JP 2016171817-A/140: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
AGTGGCGATGAC
>LZ252988.1 JP 2016171817-A/139: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CGTCATGAATAA
>LZ252987.1 JP 2016171817-A/138: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CGATTCCTTCGT
>LZ252986.1 JP 2016171817-A/137: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CCAAACGGTTAA
>LZ252985.1 JP 2016171817-A/136: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TTCATAACCGGC
>LZ252984.1 JP 2016171817-A/135: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CGCTACATAGCA
>LZ252983.1 JP 2016171817-A/134: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
ACTCGATACCAT
>LZ252982.1 JP 2016171817-A/133: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
AGGAAGTATCGC
>LZ252981.1 JP 2016171817-A/132: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TTTACGCAGAGG
>LZ252980.1 JP 2016171817-A/131: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TGAGTCGTCGAG
>LZ252979.1 JP 2016171817-A/130: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TTCGAGCGATTT
>LZ252978.1 JP 2016171817-A/129: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GTCGGGGACTAT
>LZ252977.1 JP 2016171817-A/128: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
AAGGTCGCCCAT
>LZ252976.1 JP 2016171817-A/127: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TAACGTCGGAGC
>LZ252975.1 JP 2016171817-A/126: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TGCGCCTCCAGT
>LZ252974.1 JP 2016171817-A/125: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CCGATTCCTTCG
>LZ252973.1 JP 2016171817-A/124: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CTCCGTATCTCG
>LZ252972.1 JP 2016171817-A/123: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GCGTCAATGTTC
>LZ252971.1 JP 2016171817-A/122: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
ATCGTGCCCTAA
>LZ252970.1 JP 2016171817-A/121: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
ACACCGGTCTTC
>LZ252969.1 JP 2016171817-A/120: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GATTCATCAGCG
>LZ252968.1 JP 2016171817-A/119: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GAACCCGTCCTA
>LZ252967.1 JP 2016171817-A/118: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CGCCGGTGGAAT
>LZ252966.1 JP 2016171817-A/117: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TTTCAAGGCCGG
>LZ252965.1 JP 2016171817-A/116: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TCGTATCCCTAC
>LZ252964.1 JP 2016171817-A/115: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CAGGACGTCCGT
>LZ252963.1 JP 2016171817-A/114: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
ACTCCGTAGTGA
>LZ252962.1 JP 2016171817-A/113: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TCGTCGGGTGCA
>LZ252961.1 JP 2016171817-A/112: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GTCTCACGATCG
>LZ252960.1 JP 2016171817-A/111: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GAGTCGATACGC
>LZ252959.1 JP 2016171817-A/110: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
AACCAAGATACG
>LZ252958.1 JP 2016171817-A/109: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CACGAAATTACC
>LZ252957.1 JP 2016171817-A/108: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TACGGTAAGTCG
>LZ252956.1 JP 2016171817-A/107: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GCCTGTGCCGTA
>LZ252955.1 JP 2016171817-A/106: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
CGGTACTCTTAC
>LZ252954.1 JP 2016171817-A/105: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GCATGGTACGGA
>LZ252953.1 JP 2016171817-A/104: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GCCGAATTCCTC
>LZ252952.1 JP 2016171817-A/103: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
ATGGAAACGCAT
>LZ252951.1 JP 2016171817-A/102: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TGTCGCATGTTA
>LZ252950.1 JP 2016171817-A/101: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GGCGTTAATGAT
>LZ252949.1 JP 2016171817-A/100: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TAGGTCGACCAG
>LZ252948.1 JP 2016171817-A/99: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
ACGTCGCCTGAT
>LZ252947.1 JP 2016171817-A/98: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
ACTGCGTGTTAA
>LZ252946.1 JP 2016171817-A/97: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
ACTCCCCGTAGG
>LZ252945.1 JP 2016171817-A/96: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TCGGTGACATGT
>LZ252944.1 JP 2016171817-A/95: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
TAGCGGGTAAGC
>LZ252862.1 JP 2016171817-A/13: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GTTTTAGAGCTA
>LZ252860.1 JP 2016171817-A/11: CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
GTTTTAGAGCTA
>LZ252616.1 JP 2016172767-A/26: Microemulsions with Adsorbed Macromolecules and Microparticles
ATTGACGTCAAT
>LZ252423.1 JP 2016171815-A/85: Compositions of asymmetric interfering RNA and uses thereof
CTGATATTGATG
>LZ252422.1 JP 2016171815-A/84: Compositions of asymmetric interfering RNA and uses thereof
TGATATTGATGG
>LZ252135.1 JP 2016168050-A/85: Compositions of asymmetric interfering RNA and uses thereof
CTGATATTGATG
>LZ252134.1 JP 2016168050-A/84: Compositions of asymmetric interfering RNA and uses thereof
TGATATTGATGG
>LZ251887.1 JP 2016168061-A/24: Thermostable mismatch endonucleases and uses thereof
ATGCCTACCGGA
>LZ251886.1 JP 2016168061-A/23: Thermostable mismatch endonucleases and uses thereof
ATGCCTAACGGA
>LZ251885.1 JP 2016168061-A/22: Thermostable mismatch endonucleases and uses thereof
ATGCCTATCGGA
>LZ251884.1 JP 2016168061-A/21: Thermostable mismatch endonucleases and uses thereof
ATGCCTAGCGGA
>LZ962714.1 JP 2017197545-A/10109: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
ATGGCCCTGTAG
>LZ249066.1 JP 2016165307-A/238: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GGTAATTTCGTG
>LZ249065.1 JP 2016165307-A/237: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
AGTAAAGGCGCT
>LZ249064.1 JP 2016165307-A/236: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TAGCTAACCGTT
>LZ249063.1 JP 2016165307-A/235: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GTTAACAGCGTG
>LZ249062.1 JP 2016165307-A/234: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GGTCGTCATCAA
>LZ249061.1 JP 2016165307-A/233: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GTCGTGGACTAC
>LZ249060.1 JP 2016165307-A/232: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CTTCGCAAGGAG
>LZ249059.1 JP 2016165307-A/231: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
AAGATCGGTAGC
>LZ249058.1 JP 2016165307-A/230: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGCGTCAGATAT
>LZ249057.1 JP 2016165307-A/229: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CTATGCCGTGCA
>LZ249056.1 JP 2016165307-A/228: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGTACGGCACAG
>LZ249055.1 JP 2016165307-A/227: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACGCGTCAGATA
>LZ249054.1 JP 2016165307-A/226: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TCGACGACTCAC
>LZ249053.1 JP 2016165307-A/225: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGACTTTTTGCA
>LZ249052.1 JP 2016165307-A/224: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TCGATGGTAAAC
>LZ249051.1 JP 2016165307-A/223: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GCGTTATCAGAA
>LZ249050.1 JP 2016165307-A/222: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CCCAAACGGTTA
>LZ249049.1 JP 2016165307-A/221: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGTAGCCATGTT
>LZ249048.1 JP 2016165307-A/220: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TTTACCATCGAA
>LZ249047.1 JP 2016165307-A/219: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGTGCCCTGAAC
>LZ249046.1 JP 2016165307-A/218: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGAAAACGTGGC
>LZ249045.1 JP 2016165307-A/217: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CTTAGTCGGCCA
>LZ249044.1 JP 2016165307-A/216: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TAAAGCGACCCG
>LZ249043.1 JP 2016165307-A/215: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CACGAGGTATGC
>LZ249042.1 JP 2016165307-A/214: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGGTGTATTGAG
>LZ249041.1 JP 2016165307-A/213: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACACCGAAAACG
>LZ249040.1 JP 2016165307-A/212: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GCAGGACGTCCG
>LZ249039.1 JP 2016165307-A/211: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TCACCCAAAGCG
>LZ249038.1 JP 2016165307-A/210: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACTATGCGTAGG
>LZ249037.1 JP 2016165307-A/209: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TTGACTGCGGCG
>LZ249036.1 JP 2016165307-A/208: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TGGGACACCGGT
>LZ249035.1 JP 2016165307-A/207: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GCCAACCCGCAC
>LZ249034.1 JP 2016165307-A/206: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CCCCTACGGCAC
>LZ249033.1 JP 2016165307-A/205: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
AGTGGCGATGAC
>LZ249032.1 JP 2016165307-A/204: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGTCATGAATAA
>LZ249031.1 JP 2016165307-A/203: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGATTCCTTCGT
>LZ249030.1 JP 2016165307-A/202: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CCAAACGGTTAA
>LZ249029.1 JP 2016165307-A/201: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TTCATAACCGGC
>LZ249028.1 JP 2016165307-A/200: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGCTACATAGCA
>LZ249027.1 JP 2016165307-A/199: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACTCGATACCAT
>LZ249026.1 JP 2016165307-A/198: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
AGGAAGTATCGC
>LZ249025.1 JP 2016165307-A/197: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TTTACGCAGAGG
>LZ249024.1 JP 2016165307-A/196: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TGAGTCGTCGAG
>LZ249023.1 JP 2016165307-A/195: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TTCGAGCGATTT
>LZ249022.1 JP 2016165307-A/194: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GTCGGGGACTAT
>LZ249021.1 JP 2016165307-A/193: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
AAGGTCGCCCAT
>LZ249020.1 JP 2016165307-A/192: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TAACGTCGGAGC
>LZ249019.1 JP 2016165307-A/191: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TGCGCCTCCAGT
>LZ249018.1 JP 2016165307-A/190: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CCGATTCCTTCG
>LZ249017.1 JP 2016165307-A/189: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CTCCGTATCTCG
>LZ249016.1 JP 2016165307-A/188: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GCGTCAATGTTC
>LZ249015.1 JP 2016165307-A/187: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ATCGTGCCCTAA
>LZ249014.1 JP 2016165307-A/186: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACACCGGTCTTC
>LZ249013.1 JP 2016165307-A/185: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GATTCATCAGCG
>LZ249012.1 JP 2016165307-A/184: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GAACCCGTCCTA
>LZ249011.1 JP 2016165307-A/183: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGCCGGTGGAAT
>LZ249010.1 JP 2016165307-A/182: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TTTCAAGGCCGG
>LZ249009.1 JP 2016165307-A/181: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TCGTATCCCTAC
>LZ249008.1 JP 2016165307-A/180: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CAGGACGTCCGT
>LZ249007.1 JP 2016165307-A/179: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACTCCGTAGTGA
>LZ249006.1 JP 2016165307-A/178: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TCGTCGGGTGCA
>LZ249005.1 JP 2016165307-A/177: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GTCTCACGATCG
>LZ249004.1 JP 2016165307-A/176: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GAGTCGATACGC
>LZ249003.1 JP 2016165307-A/175: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
AACCAAGATACG
>LZ249002.1 JP 2016165307-A/174: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CACGAAATTACC
>LZ249001.1 JP 2016165307-A/173: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TACGGTAAGTCG
>LZ249000.1 JP 2016165307-A/172: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GCCTGTGCCGTA
>LZ248999.1 JP 2016165307-A/171: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGGTACTCTTAC
>LZ248998.1 JP 2016165307-A/170: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GCATGGTACGGA
>LZ248997.1 JP 2016165307-A/169: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GCCGAATTCCTC
>LZ248996.1 JP 2016165307-A/168: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ATGGAAACGCAT
>LZ248995.1 JP 2016165307-A/167: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TGTCGCATGTTA
>LZ248994.1 JP 2016165307-A/166: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GGCGTTAATGAT
>LZ248993.1 JP 2016165307-A/165: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TAGGTCGACCAG
>LZ248992.1 JP 2016165307-A/164: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACGTCGCCTGAT
>LZ248991.1 JP 2016165307-A/163: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACTGCGTGTTAA
>LZ248990.1 JP 2016165307-A/162: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACTCCCCGTAGG
>LZ248989.1 JP 2016165307-A/161: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TCGGTGACATGT
>LZ248988.1 JP 2016165307-A/160: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TAGCGGGTAAGC
>LZ248850.1 JP 2016165307-A/22: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GTTTTAGAGCTA
>LZ248840.1 JP 2016165307-A/12: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GTTTTAGAGCTA
>LZ247039.1 JP 2016152818-A/175: COMPOSITIONS AND METHOD FOR DETECTING HUMAN PARVOVIRUS NUCLEIC ACID AND FOR DETECTING HEPATITIS A VIRUS NUCLEIC ACIDS IN SINGLE-PLEX OR MULTIPLEX ASSAYS
GGAAAATTAATC
>LZ247037.1 JP 2016152818-A/173: COMPOSITIONS AND METHOD FOR DETECTING HUMAN PARVOVIRUS NUCLEIC ACID AND FOR DETECTING HEPATITIS A VIRUS NUCLEIC ACIDS IN SINGLE-PLEX OR MULTIPLEX ASSAYS
GAATWATGAAAG
>LZ246565.1 JP 2016144474-A/335: PRODUCTS AND PROCESSES FOR MULTIPLEX NUCLEIC ACID IDENTIFICATION
TTATTCCCAGGT
>LZ245128.1 JP 2016127866-A/13: Compositions and Methods Related to Protein Displacement Therapy for Myotonic Dystrophy
CAGCAGCAGCAG
>LZ244506.1 JP 2016129516-A/238: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GGTAATTTCGTG
>LZ244505.1 JP 2016129516-A/237: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
AGTAAAGGCGCT
>LZ244504.1 JP 2016129516-A/236: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TAGCTAACCGTT
>LZ244503.1 JP 2016129516-A/235: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GTTAACAGCGTG
>LZ244502.1 JP 2016129516-A/234: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GGTCGTCATCAA
>LZ244501.1 JP 2016129516-A/233: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GTCGTGGACTAC
>LZ244499.1 JP 2016129516-A/231: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
AAGATCGGTAGC
>LZ244498.1 JP 2016129516-A/230: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGCGTCAGATAT
>LZ244497.1 JP 2016129516-A/229: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CTATGCCGTGCA
>LZ244496.1 JP 2016129516-A/228: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGTACGGCACAG
>LZ244495.1 JP 2016129516-A/227: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACGCGTCAGATA
>LZ244494.1 JP 2016129516-A/226: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TCGACGACTCAC
>LZ244493.1 JP 2016129516-A/225: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGACTTTTTGCA
>LZ244492.1 JP 2016129516-A/224: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TCGATGGTAAAC
>LZ244491.1 JP 2016129516-A/223: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GCGTTATCAGAA
>LZ244490.1 JP 2016129516-A/222: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CCCAAACGGTTA
>LZ244489.1 JP 2016129516-A/221: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGTAGCCATGTT
>LZ244488.1 JP 2016129516-A/220: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TTTACCATCGAA
>LZ244487.1 JP 2016129516-A/219: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGTGCCCTGAAC
>LZ244486.1 JP 2016129516-A/218: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGAAAACGTGGC
>LZ244485.1 JP 2016129516-A/217: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CTTAGTCGGCCA
>LZ244484.1 JP 2016129516-A/216: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TAAAGCGACCCG
>LZ244483.1 JP 2016129516-A/215: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CACGAGGTATGC
>LZ244482.1 JP 2016129516-A/214: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGGTGTATTGAG
>LZ244481.1 JP 2016129516-A/213: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACACCGAAAACG
>LZ244480.1 JP 2016129516-A/212: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GCAGGACGTCCG
>LZ244479.1 JP 2016129516-A/211: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TCACCCAAAGCG
>LZ244478.1 JP 2016129516-A/210: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACTATGCGTAGG
>LZ244477.1 JP 2016129516-A/209: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TTGACTGCGGCG
>LZ244476.1 JP 2016129516-A/208: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TGGGACACCGGT
>LZ244475.1 JP 2016129516-A/207: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GCCAACCCGCAC
>LZ244474.1 JP 2016129516-A/206: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CCCCTACGGCAC
>LZ244473.1 JP 2016129516-A/205: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
AGTGGCGATGAC
>LZ244472.1 JP 2016129516-A/204: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGTCATGAATAA
>LZ244471.1 JP 2016129516-A/203: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGATTCCTTCGT
>LZ244470.1 JP 2016129516-A/202: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CCAAACGGTTAA
>LZ244469.1 JP 2016129516-A/201: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TTCATAACCGGC
>LZ244468.1 JP 2016129516-A/200: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CGCTACATAGCA
>LZ244467.1 JP 2016129516-A/199: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACTCGATACCAT
>LZ244466.1 JP 2016129516-A/198: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
AGGAAGTATCGC
>LZ244465.1 JP 2016129516-A/197: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TTTACGCAGAGG
>LZ244464.1 JP 2016129516-A/196: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TGAGTCGTCGAG
>LZ244463.1 JP 2016129516-A/195: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TTCGAGCGATTT
>LZ244462.1 JP 2016129516-A/194: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GTCGGGGACTAT
>LZ244461.1 JP 2016129516-A/193: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
AAGGTCGCCCAT
>LZ244460.1 JP 2016129516-A/192: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TAACGTCGGAGC
>LZ244459.1 JP 2016129516-A/191: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
TGCGCCTCCAGT
>LZ244458.1 JP 2016129516-A/190: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CCGATTCCTTCG
>LZ244457.1 JP 2016129516-A/189: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
CTCCGTATCTCG
>LZ244456.1 JP 2016129516-A/188: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
GCGTCAATGTTC
>LZ244455.1 JP 2016129516-A/187: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ATCGTGCCCTAA
>LZ244454.1 JP 2016129516-A/186: ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
ACACCGGTCTTC
